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Abstract 
The Twin-arginine translocation (Tat) pathway of Escherichia coli has great potential for 
the export of biopharmaceuticals to the periplasm due to its ability to transport folded 
proteins, and its proofreading mechanism that allows correctly folded proteins to 
translocate. The translocation of protein to the periplasm will greatly aid the downstream 
processing of said biopharmaceuticals, bringing down costs and time necessary for their 
production.  Coupling the Tat-dependent protein secretion with the capability to form 
disulfide bonds in the cytoplasm of E. coli CyDisCo provides a powerful platform for the 
production of industrially challenging proteins.  
 
To learn more about the Tat pathway and its potential various proteomic studies were 
conducted: both to study the importance of the Tat pathway and to investigate the effects 
of exporting a folded substrate (scFv) to the periplasm using a Tat signal peptide, and the 
effects of expressing an export-incompetent misfolded variant on the E. coli cells. These 
studies identified characteristic changes occurring as a result of a lack of Tat pathway and 
the production of both a folded and a misfolded protein. Countering and compensating 
for these changes may result in higher yields of pharmaceutically relevant proteins 
exported to the periplasm. 
 
To prove that this platform is viable for industrial use scale up experiments were 
performed. The protein of interest (hGH) was successfully and efficiently exported to the 
periplasm during extended fed-batch fermentation, to the extent that it was the most 
abundant protein in the periplasm. The protein was shown to be homogeneous, disulphide 
bonded and active, and bioassays showed that the yields of purified periplasmic hGH 
were 5.4 g/L culture.  
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Taken together these data suggest that the Tat pathway and CyDisCo are attractive 
platforms for biotechnology. The proteomic studies gave us great insight into the changes 
occurring in the cells and various targets that would enhance protein production. Scale-
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%  Percent 
°C  Degrees Celsius 
µL  Microlitre 
µM  Micromolar 
µm  Micrometer 
aas  Amino acids 
ADP  Adenosine diphosphate 
ATP  Adenosine triphosphate 
bp  Base pair 
C  Cytoplasmic fraction 
CyDisCo Cytroplasmic Disulphide formation in E. coli 
DNA  Deoxyribonucleic acid 
dNTP  Deoxyribonucleotides  
ddNTP  Dideoxynucleotides 
E. coli  Escherichia coli 
ELISA  Enzyme-linked immunosorbent assay 
EM  Electron microscopy 
Erv1p  Yeast mitochondrial thiol oxidase 
g  Gram 
H  Histidine (his) 
hGH  Human growth hormone 
hPDI  Human Protein Disulphide Isomarase 
h  Hours 
IB  Inclusion bodies 
IPTG  Isopropyl β-D-thiogalactoside 
kDa  Kilodaltons 
L  Litre 
LB  Luria Bertani broth 
M  Membrane fraction 
M  Molar 
MBP  Maltose Binding Protein 
Min  Minute 
mL  Millilitre 
mM  Millimolar 
ng  Nanogram 
OD  Optical density 
OMV  Outer membrane vesicles  
P  Periplasmic fraction 
PAGE  Polyacrylamide gel electrophoresis  
PBS  Phosphate buffered saline 
PBS-T  Phosphate buffered saline and Tween 
PCR  Polymerase chain reaction 
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PMF  Proton motive force 
RNA  Ribonucleic acid 
rpm  Revolutions per minute 
RR  Twin-Arginine motif 
SDS  Sodium dodecylsulphate 
scFv  Single-chain variable-fragment from an antibody  
Sec  General Secretory pathway 
SR  SRP receptor 
SRP  Signal recognition particle 
Tat  Twin-Arginine Translocase 
TorA  Trimethylamine-N-oxide reductase 
TorA-  TorA signal peptide fused to following protein 
Tris  Tris (hydroxymethyl) aminomethane 
Tween20 Polyoxythylenesorbitan monolaurate 
UV  Ultraviolet 
V  Volts 
W  Wash 
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1.1 Recombinant proteins and their history 
Proteins are large nitrogen-based molecules composed of one or more long amino acid 
chains. They are an essential part of all living organisms and their study is of the utmost 
importance since proteins are responsible for a great variety of indispensable functions; 
from providing structural support to the cells and catalysing biochemical reactions, to 
acting as signalling molecules that allow the coordination of biological processes between 
different cells and organs. They are especially involved in defensive responses such as 
the immune response against viruses and bacteria where they bind to specific foreign 
particles (antibodies) or other stress responses where they are secreted to the exterior. 
Given their importance and the many roles that proteins are involved with, problems in 
their production, by over or underproduction, or in their correct localization can have 
catastrophic consequences for the organism.  
 
In many cases these protein-based problems are the direct cause of many documented 
diseases. To treat these diseases the production of that protein which is either lacking or 
incorrect, be it in structure or localization, is necessary. Initially during the 1950s they 
were obtained from natural sources such as animals or humans that already produced said 
protein, which was the case of insulin that was primarily purified from cows and pigs 
(Lens & Evertzen 1952). However, using proteins from natural sources had many 
unwanted side effects. For example, Human Growth Hormone (hGH) is a 22 kDa protein 
consisting of 191 amino acids (Lewis et al. 2018) used to treat burn injuries, wound 
healing, hipopituitarism and obesity (Isaksson et al. 1985) since it is safe to use even in 
high doses (van Loon 1998). hGH is naturally synthesized in humans by the somatotropic 
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cells of anterior pituitary, and historically used to be harvested from the pituitaries of 
cadavers. The use of this hGH led to several cases of Creutzfeld-Jacob disease, a prion-
related disease that causes irreversible nerve damage and in consequence a loss of 
memory, changes in personality, progressive loss of brain functions and mobility and 
finally death within a year (Abrams et al. 2011). This led to the necessity to produce safe 
prion free hGH with a preserved native structure. 
 
To circumvent these problems most biopharmaceutical industries currently employ 
recombinant proteins as their final commercialized product. Recombinant proteins are 
proteins obtained by the use of recombinant DNA that has been cloned in a system that 
supports expression and translation of that gene. Both the sequences of the recombinant 
DNA and the host system can be manipulated to produce large quantities of protein that 
is later purified. The high protein production not only facilitates the management of 
different diseases for the patients at a reasonable cost, but having more protein available 
per batch allows more assays and research to be performed without protein availability 
being an issue.  
 
Although recombinant proteins are the keystone of many biopharmaceutical industries, 
the technology that became its foundation is under fifty years old. It wasn’t until 1971 
(research published in 1972) that the first recombinant DNA experiments took place: 
Berg et al showed that they had developed a method for covalently joining DNA 
molecules to each other and re-circularizing the vector by successfully introducing the 
galactose operon of E. coli into SV40 DNA (a DNA segment containing the lambda phage 
genes) (Jackson et al. 1972). However, although the technology and knowledge was then 
available another five years passed before scientists at Genentech managed to express the 
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first protein from a chemically synthetic gene in E. coli: the somatostatin hormone peptide 
consisting of 14 amino acids. (Itakura et al. 1977). Since then the number of proteins 
produced in this manner has grown in an exponential manner and is now the main method 
for producing commercial proteins of biopharmaceutical worth.  
 
The rapid extension of this technique is also due to the critical advance of another two 
very interconnected techniques: chain-termination sequencing and polymerase chain 
reactions. Chain-termination sequencing, or Sanger sequencing, is the addition of 
ddNTPs (dideoxynucleotides), which lack the 3’ hydroxyl group required for the 
extension of the DNA chain, with dNTPs (deoxyribonucleotides) that do allow for the 
extension and a DNA polymerase along with the template and initial primer. This mixture 
will give a final product of varying lengths where the ddNTPs have been inserted and by 
separating each type of ddNTPs into four different mixtures and running them on a gel 
side by side the final sequence of the DNA may be easily obtained (Sanger et al. 1977).  
The first polymerase chain reactions on the other hand consisted in the use of a 
polymerase purified from the extreme thermophile Thermus aquaticus that had an 
optimum active temperature at 80 ℃ (Chien et al. 1976). This allowed for the exponential 
amplification of DNA by exposing the template, primers, dNTPs and polymerase to 
repeated cycles of heating and cooling to allow both DNA melting and DNA replication 
to occur in short periods of time (Mullis et al. 1986).  
 
It quickly became a race to commercialise and improve these techniques, competition 
driving down prices and making them affordable for many research laboratories. 
Radioactively or fluorescent labelling for automated detection of ddNTPs for Sanger 
sequencing and the development of thermocyclers for automated PCRs were soon 
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commercially available. Although these techniques are now considered essential in any 
research laboratory interested in protein production and have quickly evolved into 
efficient procedures, their development did not occur until quite a few years after the first 
recombinant DNA and protein experiments took place, giving us insight into how fast the 
field has changed and evolved in such a short period of time. It is not a surprise that for 
their discoveries both Berg and Sanger shared the Nobel prize in 1980, Mullis following 
in 1993, since their research laid the foundation for modern biotechnology and protein 
production.  
 
Finally, another important step necessary for the development of production strains was 
the study of the vectors themselves. A vector is a DNA molecule used to carry foreign 
genetic material into another cell where it can be replicated and/or expressed. Our main 
concern during this study was the use of plasmids, which are circular, double-stranded 
DNA molecules that are independent from the cell’s chromosomal DNA and occur 
naturally in bacteria, yeast and higher eukaryotic cells. They hold an either parasitic or 
symbiotic relationship with their host cell and are duplicated by hijacking the cell’s own 
replication machinery before cell division so that during segregation a minimum of one 
copy of plasmid DNA is present in each daughter cell. They can range in size from a few 
thousand base pairs to over 100 kb (Lodish et al. 2000). Out of all their characteristics the 
most important and useful is that they can be engineered for use as cloning and expression 
vectors by using a multi-cloning site and a selectable marker introduced in the plasmid to 
assure maintenance.  
 
These plasmids are many and varied, however another key breakthrough for protein 
production was the development of the tac promoters in 1982. The tac promoters are a 
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hybrid derived from the trp and lac promoters that allowed not only high levels of protein 
expression (between 7 and 11 times more than the lac promoter and between 2 and 3 
times more efficient than the trp promoter on its own), but the use of the lac promoter 
repression system allows for a tight control of expression (de Boer et al. 1983). The lac 
repression system can be derepressed with isopropyl β-D-thiogalactoside (IPTG), a 
molecular mimic of allolactose. IPTG binds to the lac repressor and releases the 
tetrameric repressor from the lac operator in allosteric manner. However unlike 
allolactose, IPTG contains a sulphur atom that creates a chemical bond that is non-
hydrolyzable by the cells, preventing thus the metabolization and degradation of the 
inducer and maintaining  a constant concentration of IPTG throughout the experiment 
(Beckwith 2013).  
 
Figure 1:  Mechanism of the (a) repression and (b) induction of the lac promoter in the presence of 





All of these discoveries in unison provided the foundation for the protein production 
technology we use today and have helped to shape the current biopharmaceutical 
landscape. Thanks to the development of these vectors protein expression in a large 
variety of hosts is possible, although each of these hosts carry their own advantages and 
disadvantages for production and must be chosen carefully and specifically for a 
determined task depending on the characteristics of the protein of interest.  
 
1.2 Host Systems 
Currently almost all biopharmaceuticals are produced in one of three host systems: 
bacteria (Escherichia coli), yeast (Saccharomyces cerevisiae, Pichia pastoris) and 
mammalian cells (Berlec & Štrukelj 2013) among others. Each of these hosts presents 
their own advantages and challenges for protein production, from lack of post-
translational modifications of the protein in bacteria to the ease of contamination and slow 
doubling time of mammalian cells. In this section, we will look more in depth at the 
different methods for protein production in each of these hosts.  
 
1.2.1 Mammalian systems 
The first host examined will be mammalian cells. Mammalian cells are the most often 
used expression system making up over half of the market of biopharmaceuticals 
approved in the United States and the European Union (Walsh 2014). The most 
commonly used cells are Chinese hamster ovary (CHO), human embryonic kidney (HEK-
293), human retina derived (PER-C6), baby hamster kidney (BHK), and mouse myeloma 
(NS0) (Zhu 2012). Of all the mentioned cells the most widespread in terms of protein 
production are CHO cells, which account for over 68% of the approved products 
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produced in mammalian systems as of 2014 (Walsh 2014) since not only do they have 
the additional benefit of being adaptable to not requiring supplementation with serum, 
such as fetal calf serum or bovine serum, making them safer since there is less risk of 
viral and prion contamination as well as making them more cost effective, but they also 
have been found to not allow the replication of important human viral pathogens 
(Bandaranayake & Almo 2014). However, although CHO cells present high yields of 
protein production, in the order of 2-6 g/L of antibody product, human cell lines are 
demonstrating incredible potential, with the PER-C6 cell line achieving over 25 g/L using 
high-density cell cultures and perfusion technology (Kuczewski et al. 2011).  
 
The main advantage of the mammalian cells is their ability to create post-translational 
modifications like gamma-carboxylation, hydroxylation, o-sulphation, amidation and 
most importantly, disulphide bond formation, proteolytic processing and glycosylation, 
which in many cases is necessary for the correct functioning of the biopharmaceutical 
(Walsh & Jefferis 2006). Since both proteolytic processing and disulphide bond 
formation can also be obtained with other expression systems, glycosylation has thus 
received the most attention especially for their importance in protein folding and stability, 
protein targeting and trafficking, ligand recognition and binding, biological activity, 
protein half-life and in evoking an immune response (Lee et al. 2015). Although 
glycosylation can be achieved using other eukaryotic systems such as yeast or insect cells, 
their abilities to replicate the correct glycosylation patterns necessary for human 
therapeutics are limited (Higel et al. 2016), making mammalian cells the best candidate 
for the more complex proteins requiring post-translational modifications.  
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However, the use of mammalian cell lines for recombinant protein production also 
presents unique challenges. The volumetric yields of protein produced from processes are 
generally low in comparison to the use of microorganisms (Walsh 2014), making the 
construction and maintenance of large and costly facilities necessary. These cultures also 
have a slower growth rate, meaning that to obtain high cell densities the process needs to 
be extended over time, increasing the chances of foreign contamination. The development 
of the cell lines are also laborious and time consuming: although transient gene expression 
is possible in which the heterologous protein is expressed from transfected DNA vectors 
that have not been integrated into the host genome, these tend to be unstable and not 
reliably replicated and passed down to the progeny during cell division, meaning that 
protein expression lasts for typically 10 days post-transfection with variable results 
between batches (Baldi et al. 2007). As of now, no transient gene expression systems 
have been approved for manufacturing of biopharmaceuticals since they have not yet 
proven that the method is apt for large scale production or that it can be effectively 
replicated between batches to the same standard.  To avoid these problems and maintain 
a uniform performance across batches stable gene expression by integrating the 
transfected DNA in the genome is essential. However, due to the random nature of 
integration, there is great variability between clones and a lengthy screening process is 
necessary to select the best candidates. These candidates will need to pass various phases 
of screening before establishing a cell bank and evaluating their efficacy for production, 
increasing the time of development of the biopharmaceutical.  
 
1.2.2 Yeast systems 
To decrease the time needed for the development of the biopharmaceutical other 
eukaryotic systems are further explored. One of the most interesting and lucrative 
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eukaryotic hosts are yeast: they combine the advantages of both prokaryotes (fast growth, 
easy genetic manipulation and scale-up as well as inexpensive growth media) and 
eukaryotes (ability to perform post-translational modifications). Historically, among 
yeast, Saccharomyces cerevisiae is the most widely used thanks to its well-known 
biochemistry, genetics and molecular biology (Siggers & Lesser 2008), as well as its 
history of producing heterologous protein for industry thanks to its natural adaptability to 
the harsh industrial conditions and its ability to correctly produce and secrete biologically 
active proteins (Huang et al. 2014; Jozala et al. 2016 ). Nevertheless, in recent years, other 
yeast are being used as hosts due to their various capabilities. Among these, Pichia 
pastoris (recently reclassified as Komagataella phaffii (Kurtzman 2009)), has gained 
remarkable attention due to the fact that it is an obligate aerobic yeast that can use 
methanol as a carbon source. This characteristic has allowed for the development of an 
expression system based on the utilization of the inducible AOX1 promoter (Cregg et al. 
2000). When compared to S. cerevisiae, P pastoris gives higher protein titres since it is 
not affected by the Crabtree effect (in which respiratory activity is repressed by the 
presence of free glucose (Deken, De 1966)) and so does not lose carbon by producing 
ethanol resulting in higher biomass formation and thus more recombinant protein 
(Mattanovich et al. 2012). P. pastoris has been used to produce human insulin, human 
serum albumin, hepatitis B vaccine, interferon-alpha 2b, trypsin and collagen among 
others (Vieira Gomes et al. 2018). 
 
Unfortunately, yeast hosts also present a series of disadvantages. Mainly, their 
glycosylation methods differ slightly from their mammalian counterparts in the way they 
form both N and O linked oligosaccharide structure on target proteins (Jung & Williams 
1997). Particularly, S. cerevisiae often adds additional sugars leading to the hyper-
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glycosylation of proteins and its N-glycans are highly mannose-rich whereas mammalian 
proteins are more complex and contain monosaccharides rarely present in yeast including 
galactose, fucose and sialic acid (Stanley et al. 2017). This limitation of its glycosylation 
abilities makes them unsuitable for the production of a number of glycosylated human 
therapeutic proteins. Advances in glyco-engineering of yeast and the expression of 
recombinant protein have shown significant promise (Hamilton & Gerngross 2007) 
(Wildt & Gerngross 2005)however the technology is still in the early research stages 
(Laurent et al. 2016) and it is not possible to predict whether a particular heterologous 
domain will be effective, although genetic libraries for construct screening and being 
developed (Nett et al. 2011). Another disadvantage is that expression levels of protein 
tend to be low in comparison with bacterial hosts and secretion of the protein to the media 
is ineffective and often limited to the periplasmic space or inclusion bodies, having a 
significant impact in the recovery of the recombinant protein.  
 
Overall, yeast are a good choice for difficult proteins that cannot be correctly made in 
bacterial hosts but that are flexible enough in their configuration to not need complex 
post-translational modifications.  
 
1.2.3 Other eukaryotic systems 
Before moving on to prokaryotes there are other lesser used eukaryotic systems of great 
interest for biopharmaceutical production that we will touch upon briefly. These systems 
are not as extended as the previously mentioned, however they have great untapped 
potential and with further development could become competitive host systems in the 
future market.  
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The first of these systems is that composed of filamentous fungi. Fungal systems such as 
Aspergillus and Tricoderma have a high secretion power due to their decomposer lifestyle 
in which the secretion of determined enzymes is indispensable, and using this to our 
advantage have allowed us to obtain yields of over 100 g/L (Landowski et al. 2016). 
However, their complexity and our relatively little understanding of their molecular 
biology and genetics (Su et al. 2012) have slowed down the development of potential 
competitive strains for protein production, and more basic research must be done in these 
areas to achieve efficient producing strains.  
  
The next system are insect cultures. A large number of cell lines have been established 
for the production of vaccines and viral pesticides, as well as for basic research in biology. 
The most extended system is the baculovirus system, in which a modified baculovirus 
(which has a restricted host range and is not infectious to vertebrates making it safe to 
work with) is used as a vector and infects the insect cells. The virus is typically prepared 
by inserting the DNA of the protein of interest under the polyhedron growth promoter 
(polh promoter) so that once infected the virus will produce the recombinant protein 
instead of the protective protein coat (Martínez-Solís et al. 2016). The production levels 
in this system tend to be very high, however, as the host cell infected with the virus will 
eventually die the recombinant gene cannot be continuously expressed meaning that they 
are difficult to use for continuous fermentation as constant re-infection is required 
(Balamurugan et al. 2006). Another drawback is that, as occurred with the yeast systems, 
insect cells have different glycosylation patterns such as in the lengths of oligosaccharides 
and in mannose content (Kost & Condreay 1999) from mammalian cells which can lead 




The final eukaryote host systems are transgenic plants and animals. They offer interesting 
alternatives to traditional fermentation with both advantages and disadvantages. Protein 
expression can be localized to different organs by controlling the tissue-specific 
regulatory sequences (to leaves or seeds in plants or to mammary glands in animals, for 
example), allowing for easier and constant recuperation of the protein of interest by 
processing the leaves and seeds or the milk among other strategies. However, the impact 
of disease and variable cultivation and growth conditions between specimens, as well as 
the time it takes for said plant or animal to reach a producing age (most usually adulthood) 
give us great variations in product yield between specimens over time, which does not 
make them ideal for the production of biopharmaceuticals in which annual targets must 
be met, although they can be used for medical purposes (Yin et al. 2007).   
 
1.2.4 Bacterial systems 
Finally, the last host system we will examine are bacterial hosts. Some bacterial hosts 
such as Bacillus subtilis and Bacillus megaterium, Gram positive and catalase positive 
bacterium found in soil, and Pseudomonas fluorescens and Pseudomonas putida, Gram 
negative bacterium found in plants and soil respectively, are being studied for the 
production of heterologous proteins at a large scale (Retallack et al. 2006) (Biedendieck 
2016) (Yue et al. 2017). However, out of all possible bacterial hosts the preferred on the 
market is Escherichia coli, for its rapid growth rate, as short as 20-30 minutes, its capacity 
for continuous fermentation at high densities and relatively low cost to maintain, and 
especially its well-known genetics, biochemistry and physiology which makes it easier 
to be manipulated into ideal hosts (Gibson et al. 2018). For this reason, we will examine 
the characteristics of E. coli in more detail further down.  
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1.3 Post-translational modifications in E. coli 
Unfortunately E. coli also has some major limitations for protein production. As 
commented before bacterial hosts have difficulties making the post translational 
modifications such as glycosylations, which can affect the bioactivity, function, structure, 
solubility, stability and half-life of functional proteins, acylations, phosphorylations and 
disulphide-bond formation.  
 
For the first kind of modification efforts are being made to produce strains capable of 
making mammalian like glycosylations (Ding et al. 2017), however our main interest lies 
in the last modification mentioned: disulphide-bonds. This modification is especially 
important for the correct folding of the protein in question and its lack can cause the 
unfolded protein to become insoluble and form inclusion bodies (Thomas & François 
Baneyx 1996). There are a few strategies to circumvent this problem, the first would be 
the export of the protein from the cytoplasm of E. coli, where it is made, to the periplasmic 
space of the cell which has an oxidizing environment and is rich in disulphide bond 
oxidoreductases, that catalyse the disulphide bridge formation as can be seen in the 
schematic representation of the process in Fig. 2. This system is ideal for proteins that 
can be translocated by the Sec translocation system, which facilitates the passage of 
unfolded protein, one amino acid at a time (Natale et al. 2008) from the cytoplasm to the 
periplasm. However, since the list of biopharmaceutically relevant proteins is long and 
varied, many of these proteins will have a quick folding mechanisms that will disqualify 
them for export via the Sec system.  
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Figure 2: Schematic of the periplasmic expression system for production of disulphide bonded proteins 
in E. coli. After translation, the fusion protein is transported to the periplasm via the Sec translocase system. 
The MalE signal sequence (red) is removed during this process, releasing the fusion protein (orange) into 
the periplasm where the Dsb machinery (DsbA, DsbB, DsbC, and DsbD) can assist with disulfide-bond 
formation. Figure adapted from (Klint et al. 2013). 
 
For those proteins that cannot be exported to the periplasm with the Sec translocation 
system the disulphide-bonds need to be formed in the cytoplasm. This has been originally 
done by genetically altering the host system, such as by the removal of the gor and trxB 
genes which are two naturally occurring reducing pathways as can be seen in Fig. 3, to 
make a Δgor/ΔtrxB strain which are commercially available from many suppliers. 
However, this is inefficient since there is no catalyst for the disulphide bond formation 
(Prinz et al. 1997). In recent years, the development of the CyDisCo system (cytoplasmic 
disulphide bond formation in E. coli) has allowed the formation of disulphide bonds in 
the cytoplasm while maintaining the reducing pathways intact  by expressing a catalyst 
of disulphide bond formation, sulfhydryl oxidase (Erv1p), and a catalyst of disulphide 
isomerization, human disulphide isomerase (PDI) (Hatahet et al. 2010). This allows for 
the efficient production of disulphide bonded eukaryotic proteins in the cytoplasm of E. 




Figure 3: Dual pathways for disulfide bond reduction in the cytoplasm of E. coli. Dual pathways for 
disulfide bond reduction in the cytoplasm of E. coli. On the knockout of both pathways the reduction of 
disulfide bonds is inhibited, but there is no active system to catalyze their formation. Figure replicated from 




Figure 4: Schematic showing the correct and incorrect folding of a protein by the CyDisCo system 
depending on the availability of oxidised PDI. To maintain PDI in an oxidized form Erv1p must be 




1.4 Protein Harvest 
1.4.1 Harvest from the Cytoplasm 
After obtaining correctly folded and disulphide bonded protein the next step is the harvest 
and purification of said protein. The first attempts to produce heterologous proteins in 
bacteria found the first obstacles as protein accumulation in insoluble deposits called 
inclusion bodies (Thomas & François Baneyx 1996). These inclusion bodies (IB) may be 
formed for a number of reasons such as high local protein concentration resulting in 
precipitation, insufficient chaperones to assist with protein folding or absence of PTMs 
of the foreign protein especially disulphide bridges due to the reducing environment of 
the cytoplasm. Depending on the method of harvest inclusion bodies can either be avoided 
or encouraged.  
 
To improve the solubility of the protein and avoid the formation of inclusion bodies a 
common strategy is to fuse the protein of interest to a soluble protein such as glutathione 
S-transferase (GST) or maltose binding protein (MBP). GST is a 26 kDa protein from 
Schistosoma japonicum that also acts as a purification tag as it binds to immobilized 
glutathione that can be used in an affinity chromatography system (Schäfer et al. 2015). 
MBP is a 42 kDa E. coli protein that enhances both solubility and expression, and also 
has the possibility of being used as a purification tag as it binds to amylose resin, however 
this fusion has shown low binding capacity for some of the proteins tested, making an 
additional affinity chromatography steps to achieve purity (Reuten et al. 2016). These 
fusion proteins can afterwards be easily removed thanks to specific protease cleavage 
sites engineered for downstream processing.  
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Taking the opposite approach, by decreasing solubility and placing the protein in 
inclusion bodies it is possible to harvest said inclusion bodies by differential 
centrifugation (Palmer & Wingfield 2004). Separating the protein of interest from the rest 
of the cytoplasmic content is a good way to protect the cells from the effects of toxic 
products or vice versa by protecting proteins that are particularly susceptible to 
degradation. The downstream processing of inclusion bodies (IBs) can be a simple 
operation in which the IBs are solubilized by the use of detergents and chaotropic agents 
(Yang et al. 2011). This technique is then only suitable for small, easily refolded proteins 
that will regain their biological activity even after this harsh treatment. 
 
1.4.2 Secretion to the Periplasm via the Sec and Tat Pathways 
As we have seen the protein can be harvested directly from the cytoplasmic space in the 
cells, however secretion of the protein to the periplasm has significant advantages over 
its accumulation in the cytoplasm (Yoon & Kim 2010; Overton 2014) since the secreted 
protein is no longer vulnerable to degradation by intracellular proteases and downstream 
recovery is aided by the lack of contaminating cellular components.  
 
As previously mentioned and shown in Fig 2 the general secretory mechanism to transport 
proteins from the cytoplasm to the periplasm is by use of the Sec translocation pathway. 
Sec translocation can occur through in two different ways: through co-translational or 
post-translational targeting. During co-translational targeting a signal recognition particle 
(SRP) binds to the signal sequence of the secretory protein while it emerges from the 
ribosome and the SRP/ribosome/protein chain is targeted to the Sec-translocase (Luirink 
et al. 2012). A signal recognition particle receptor (SR or FtsY) helps to transfer the SRP 
to the Sec-translocase. For post-translational targeting the protein is released from the 
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ribosome and is guided to the translocase by SecB, which recognizes an exportable pre-
protein by its N-terminal signal peptide and maintains the proteins in a translocation-
competent unfolded state (Driessen 2001). Sec translocase is composed of a protein 
conducting channel embedded in the membrane. This channel consists of three integral 
membrane proteins, SecY, SecE and SecG, and an ATPase, SecA, that drives the 
translocation at the expense of ATP (Mori & Ito 2001). SecA associates to the protein 
conducting channel and to either the ribosome or SecB to pass the unfolded protein 
through a narrow transmembrane channel formed by SecYEG (Veenendaal et al. 2004). 
As we have already discussed this method is only suitable for proteins with slow folding 
mechanics since Sec only facilitates the passage of unfolded protein.  In cases where the 
protein of interest needs to be folded in the cytoplasm due to its inherent folding 
mechanics an alternative transport system must be used: the Tat pathway. 
 
The Tat pathway, short for twin-arginine pathway due to the characteristic structure found 
in its signal peptides which will be touch upon later on, is highly selective for the transport 
of fully folded proteins (Berks 2015). The Tat system can not only transport folded 
proteins but it also discriminates against misfolded proteins (Sutherland et al. 2018), 
implying that there is a quality control or proofreading mechanism that recognizes 
correctly when proteins are correctly folded and have inserted necessary cofactors or 
metal ions (Natale et al. 2008) 
 
In E. coli the Tat system is made up of four functionally different membrane proteins: 
TatA, TatB, TatC and TatE (Patel et al. 2014). TatC is the most conserved of the Tat 
proteins and consists of six transmembrane helices (Behrendt et al. 2004), whereas TatA, 
TatB and TatE are sequence-related and possess a single N-terminal transmembrane ⍺-
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helix (Baglieri et al. 2012). TatC and TatB form a complex that acts as the initial 
recognition site for Tat substrates, whereas TatA and TatE are putative pore forming 
components that mediate the actual protein translocation event (Fröbel et al. 2012). A 
model for the transport mechanism can be seen in Fig 5. The amino acid sequences of 
TatA and TatE are more than 50% identical and they have overlapping functions (Sargent 
et al. 1998). It has been shown that the stoichiometry of the TatA/B/C components is 
crucial for the Tat pathway functioning (Leake et al. 2008), and an increase in the Tat-
dependent protein flux is possible only when tatABC are jointly overexpressed 
(Browning et al. 2017). TatB and TatC interact in a 1:1 stoichiometry (Bolhuis et al., 
2001)  and low resolution EM structures of TatBC revealed a hemispherical morphology, 
with an internal cavity where the signal peptide would be inserted (Tarry et al. 2009). Up 
to 7 copies of TatBC fit into the 11- to 17-nm reconstruction, and apparently, more than 
one substrate can bind at once (Ma and Cline, 2010). Cross-linking showed TatC is the 
primary interaction site of the signal peptide (Zoufaly et al. 2012) which inserts deeply 
into TatC by adopting a hairpin-like conformation (Ramasamy et al. 2013). Moreover, a 
range of tat mutants have been constructed to study the roles of Tat pathway components 
and determinate their phenotypes (Lee et al. 2002) Wexler et al. 2000). These studies 
suggest that both TatB and TatC are essential components of the Tat system and their 
deletion leads to complete mislocalization of selected Tat substrates. In contrast, single 
ΔtatA or ΔtatE mutations exhibit versatile defects, but no complete dysfunction in Tat-
transported protein localization.       
  
TatBC forms a receptor that binds Tat substrates at the membrane. This triggers TatA 
recruitment and oligomerization to form an active translocase (Berks et al. 2014). This 
oligomerization allows TatA complexes to be in the 100- to 500-kDa size range, allowing 
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for even the largest native Tat substrate, a formate dehydrogenase of approximately 150 
kDa (Berks et al. 2000), to pass. Low-resolution images of TatA have revealed a pore-
like complex of various diameters (8.5 to 13 nm) that would accommodate various 
substrate sizes (Gohlke et al., 2005). A lidlike feature was identified which presumably 
resides on the cis side of the inner membrane, as if the transporter were a trap door (Gouffi 
et al., 2004). Upon substrate docking onto TatBC, TatA protomers would assemble to suit 
the substrate size in an oligomeric ring format (Walther et al., 2013). A second model 
proposes TatA complexes destabilize the membrane when Tat substrate is bound 
(Rodriguez et al., 2013), by restricting the thickness to its own length. When no substrate 
is bound, TatA has an amphipathic helix (APH) that immerses itself into the membrane 
and elongating it. Upon substrate association, TatA reorients its APH outside of the 
membrane and this switch in conformation would be responsible for the destabilization. 





Figure 5: Model for Tat translocation in E. coli. Step 1: the TatBC complex binds the signal peptide of 
a substrate protein in an energy-independent step; the twin-arginine (RR) consensus motif in the signal 
peptide is specifically recognized by a site in TatC. The remainder of the signal peptide and the substrate 
passenger domain are close to TatB. Step 2: TatA protomers are recruited to the TatBC complex and 
polymerized. The resulting TatABC complex is the active translocation site. At this stage, the signal peptide 
is in contact with all three Tat components. Step 3: the passenger domain of the substrate protein crosses 
the membrane via the polymerized TatA component, and the signal peptide remains bound to the TatBC 
complex. Step 4: when the passenger domain has reached the far side of the membrane, the signal peptide 
is normally proteolytically removed by a signal peptidase, and TatA dissociates from TatBC and 
depolymerizes back to free protomers. Figure adapted from (Palmer & Berks 2012). 
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Proteins are targeted to the Tat apparatus by an N-terminal signal sequence containing a 
highly-conserved RR motif that is critical for the efficient recognition of Tat substrates 
(Stanley et al. 2000). In E. coli, at least 27 secreted proteins, see table 1 for a complete 
list, are predicted to be Tat-dependent and these proteins are involved in important 
functions e.g. energy metabolism, substrate uptake, cell envelope structure and 
pathogenicity (Berks et al. 2005). Interestingly, some of the redox proteins are reported 
to be transported via the Tat pathway yet they do not have a signal sequence of their own. 
These proteins use a so called ‘’hitchhiker mechanism’’ and form a multimeric complex 
with another protein containing a Tat signal (Rodrigue et al. 1999). As well as being used 
for complex proteins, the Tat pathway may be used for the export of slowly folding 
proteins, that would be exposed to a fast degradation process in a harsh periplasmic 






HyaA P69739 [NiFe] hydrogenase-1 subunit 
HybO P69741 [NiFe] hydrogenase-2 subunit 
HybA P0AAJ8 Electron transfer from hydrogenase-2 
NrfC P0AAK7 Electron transfer to nitrite reductase 
NapG P0AAL3 Electron transfer to nitrate reductase 
PaoA/YagT P77165 Aldehyde oxidoreductase iron-sulfur-binding subunit 
YdhX P77375 Uncharacterized ferredoxin-like protein YdhX 
TorA P33225 TMAO reductase catalytic subunit 
TorZ P46923 TMAO reductase-2 catalytic subunit 
NapA P33937 Nitrate reductase catalytic subunit 
YnfE P77374 DMSO reductase homolog 
YnfF P77783 DMSO reductase homolog 
DmsA P18775 DMSO reductase catalytic subunit 
FdnG P24183 Formate dehydrogenase-N catalytic subunit 
FdoG P32176 Formate dehydrogenase-O catalytic subunit 
MsrP/YedY P76342 
Protein-methionine-sulfoxide reductase catalytic 
subunit MsrP 
CueO P36649 Multi-copper oxidase 
SufI/FtsP P26648 Homologous to CueO [Cu ligands absent] 
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YahJ P77554 Uncharacterized protein 
WcaM P71244 Biosynthesis of colanic acid 
MdoD/YdcG P40120 Glucans biosynthesis protein 
EfeB/YcdB P31545 Deferrochelatase/peroxidase 
EfeO/YcdO P0AB24 Iron uptake system component  
YaeI P37049 Phosphodiesterase 
AmiA P36548 Cell wall amidase 
AmiC P63883 Cell wall amidase 
FhuD P07822 Ferrichrome binding protein 
Table 1: List of Tat substrates with their description and Uniprot database associated number. 
Table adapted from (Sargent et al. 2007).  
 
Although the Tat protein export system is not essential for the growth of E. coli, the lack 
of a functioning pathway causes significant growth defects. Blocking the Tat pathway 
results in mislocalization of Tat-dependent proteins. Among those, amidases AmiA and 
AmiC were reported to be important for a functional cell envelope phenotype and cell 
division process (Bernhardt & de Boer 2003; Ize et al. 2003). Their mis-localization leads 
to formation of long chains of cells, which appear to be defective in cell separation 
(Stanley et al. 2001).  
 
Recently, attention has been attracted by the application of Tat-dependent transport in 
protein expression and engineering. The Tat pathway in unison with the CyDisCo system 
already described is a promising tool for export of complex recombinant proteins and 
native E. coli proteins that fail to be secreted via the Sec pathway (Tinker et al. 2005). In 
particular, the proofreading mechanism allows for easier downstream purification as there 
is less protein heterogeneity in the periplasm sample.  
 
1.4.3 A better Tat: TatExpress 
As stated, the Tat pathway is used to export a very limited number of proteins to the 
periplasm and thus although it is constitutively expressed (Jack et al. 2001) the amount 
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of Tat protein available to form the pathway has always been limited. For this reason, a 
new strain was created with a pTac promoter introduced before the original promoter of 
Tat in the genome. This has shown notable increase in protein yields in the periplasm of 
E. coli and can be an interesting alternative to the other host systems we have reviewed 
in section 1.2.  
 
1.5 Aims of the project 
The main aim of this project is to harness the potential of the Tat pathway for its use as a 
production platform in an industrial setting. Tat offers several advantages over other 
platforms and its development alongside CyDisCo could be a welcome alternative for 
complex protein production in a quicker and cost-efficient system. We have set out to test 
whether native Tat and TatExpress could be scaled-up and produce competing quantities 
of heterologous protein in comparison with other platforms. To do so it is necessary to 
also acknowledge the importance of this pathway as well as study the effects its 
proofreading mechanism has on the integrity of the cell.  
2. Publication Summary 
2.1 Equal first author publication- Far-reaching consequences of tat deletion 
in Escherichia coli revealed by comprehensive proteome analyses.  
Katarzyna M. Dolata, Isabel Guerrero Montero, Wayne Miller, Susanne Sievers, 
Thomas Sura, Christian Wolff, Rabea Schlüter, Katharina Riedel, Colin Robinson, Far-
reaching cellular consequences of tat deletion in Escherichia coli revealed by 




For this project, I contributed in concept design, analysed the proteomic data, reviewed 
the literature available on proteins that showed important shifts in their regulation, made 
the figures and wrote the manuscript in collaboration with Katarzyna Dolata. The 
manuscript was revised by all the authors, especially Colin Robinson, Katharina Riedel 
and Susanne Sievers.  
 
For this study, we carried out a comparative proteomic analysis of E. coli wild type and 
ΔtatABCDE strain and additional experiments to quantify colanic acid was done after the 
data showed an upregulation of most of the genes in the operon for its biosynthesis. Since 
there is a link between colanic acid and biofilm formation (Gottesman & Stout 1991) a 
biofilm assay was also performed to assess whether the Δtat strain had triggered this 
response.  
 
The first set of proteins that was analysed was the effect of the Δtat mutation on the export 
of Tat-dependent substrates by reviewing how each protein interacts with the tat pathway. 
Unfortunately, only a handful of proteins were present in the samples, most likely due to 
the stress conditions in which the cells were grown, however we were able to establish 
sensible pattern to explain their behaviour and localization.  
 
The next set of proteins analysed were stress response proteins. A set of 98 proteins 
related to stress responses were categorized into 10 functional groups using Figfam 
classification and then manually curated. The categories were: protein folding and 
degradation, stress response, cell envelope stress and cell division and iron and 
molybdenum homeostasis. Each of these categories was individually studied to determine 
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the relationship between those proteins and what effect they were having or protecting 
the cell from having.  
 
Finally, electron micrographs were taken by Rabea Schlüter and interpreted by myself 






The paper as was sent for publication is as follows:  
2.1 Far-reaching consequences of tat deletion in Escherichia coli revealed by comprehensive 
proteome analyses.  
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In Escherichia coli, the Twin-arginine translocation (Tat) pathway secretes a set of folded 
proteins with important physiological functions to the periplasm and outer membrane. 
The loss of Tat secretion impairs outer membrane integrity and leads to decreased cell 
growth. Only recently, the Tat pathway has gained more attention due to its essential role 
in bacterial virulence and applications in the production of fully folded heterologous 
proteins. In this study, we investigated the influence of the deletion of all active Tat 
pathway components on the E. coli cells. The comprehensive proteomic analysis revealed 
activation of several stress responses and experimentally confirmed the dependence of 
certain proteins on the Tat system for export. We observed that a tat deletion triggers 
protein aggregation, membrane vesiculation, synthesis of colanic acid and biofilm 
formation. Furthermore, the mislocalization of Tat-dependent proteins disturbs iron and 
molybdenum homeostasis and impairs the cell envelope integrity. The results show that 
the functional Tat pathway is important for the physiological stability and that its 
dysfunction leads to a series of severe changes in E. coli cells.  
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The main systems transporting proteins across plasma membranes in bacteria are highly 
conserved. Most of the transported proteins are inserted into the membrane or exported 
to the periplasm via one of the three routes – the Sec machinery, the YidC insertase and 
the Tat system (Collinson et al., 2015; Lee et al., 2006; Petriman et al., 2018). In E. coli, 
most proteins are transported by the general secretory (Sec) pathway, yet a subset of 
periplasmic proteins are reported to be exported via the twin-arginine (Tat) pathway 
(Tullman-Ercek et al., 2007). These two systems use very different mechanisms to 
transport proteins to the periplasm; the Sec pathway transports proteins in an unfolded 
state, while the Tat pathway is highly selective for the transport of fully folded proteins 
(Berks, 2015; Müller and Klösgen, 2005). Remarkably, the Tat system can not only 
transport folded proteins, but also discriminate against misfolded proteins (Sutherland et 
al., 2018). This interesting feature implies the existence of a so-called proofreading and 
quality control mechanism that recognizes correctly folded proteins. However, despite 
growing research interest, not much is known so far about this mechanism.  
Unlike the quality control mechanism, the composition of the Tat translocon is well 
known. In E. coli, the Tat system comprises of four functionally individual membrane 
proteins - TatA, TatB, TatC and TatE (Bogsch et al., 1998; Patel et al., 2014). TatC is the 
most conserved of the Tat proteins and contains six transmembrane helices (Behrendt et 
al., 2004), whereas TatA/B/E are sequence-related and possess a single N-terminal 
transmembrane α-helix (Baglieri et al., 2018; Koch et al., 2012). Proteins TatC and TatB 
form a complex, which acts as an initial recognition site for Tat substrates. TatA is a 
putative pore forming component that may mediate the actual protein translocation event 
(Fröbel et al., 2012). This complex is recruited to the TatBC complex upon substrate 
binding (Rose et al., 2013). The amino acid sequences of TatA and TatE are more than 
50% identical but these proteins have overlapping functions, with TatB tightly bound to 
TatC in the substrate-binding complex. It has been shown that the stoichiometry of the 
TatA/B/C components is crucial for the Tat pathway functioning (Leake et al., 2008), and 
an appreciable increase in the Tat-dependent protein flux is possible only when tatABC 
are jointly overexpressed (Alami et al., 2002; Browning et al., 2017). Moreover, a range 
of tat mutants have been constructed to study the roles of Tat pathway components and 
determine their phenotypes (Lee et al., 2002; Wexler et al., 2000). These studies suggest 
that both TatB and TatC are essential components of the Tat system and their deletion 
2.1 Far-reaching consequences of tat deletion in Escherichia coli revealed by comprehensive 
proteome analyses.  
 
 39 
leads to complete mislocalization of selected Tat substrates. Furthermore, TatB has a 
function in stabilizing TatC since both proteins are suggested to form a complex. On the 
contrary, single ΔtatA or ΔtatE mutations exhibit diverse defects, but no complete 
dysfunction in Tat-transported protein localization. However, despite the number of 
studies analyzing tat mutants and focusing on the cellular consequences of the Tat 
secretion impairment in E. coli, none of them investigated the cell phenotype under 
simultaneous deletion of all tatABCDE genes. 
The Tat pathway operates independently of the Sec and YidC post-translational protein 
transport systems. Proteins are targeted to the Tat apparatus by an N-terminal signal 
sequence containing a highly-conserved RR motif that is critical for efficient recognition 
of Tat substrates (Alami et al., 2003; Stanley et al., 2000). However, it has been shown 
that signal sequences with a single mutation of an arginine residue are still transported by 
the Tat system (Ize et al., 2002; Summer et al., 2000). In E. coli, at least 29 secreted 
proteins are predicted to be Tat-dependent. These proteins are involved in important 
functions e.g. energy metabolism, substrate uptake, cell envelope structure and 
pathogenicity (Berks et al., 2002; Tullman-Ercek et al., 2007). Interestingly, some of the 
redox proteins are reported to be transported via the Tat pathway yet they do not have a 
signal sequence of their own. These proteins use a so-called ‘’hitchhiker mechanism’’ 
and form a multimeric complex with another protein containing a Tat signal (Rodrigue et 
al., 1999).  
Recently, attention has been attracted by the application of Tat-dependent transport in 
protein expression and engineering. The Tat pathway is a promising tool for export of 
complex recombinant proteins and native E. coli proteins that fail to be secreted via the 
Sec pathway (Tinker et al., 2005; Walker et al., 2015). In particular, the proofreading 
mechanism allows for easier downstream purification as there is less protein 
heterogeneity in the periplasm sample. Moreover, the role of the Tat pathway in bacterial 
pathogenesis is under investigation (Ball et al., 2016; Pradel et al., 2003; Ochsner et al., 
2002). Although the Tat protein export system is not essential for the growth of E. coli, 
the lack of a functioning pathway causes significant growth defects. 
Deletion of the Tat system results in mislocalization of Tat-dependent proteins. Among 
those, amidases AmiA and AmiC were reported to be important for a functional cell 
envelope phenotype and cell division process (Bernhardt et al., 2003; Ize et al., 2003). 
Their mislocalization leads to formation of long chains of cells, which appear to be 
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defective in cell separation (Stanley et al., 2001). Despite the clear importance of Tat-
dependent secretion in E. coli, our understanding of its biophysical underpinnings 
remains vague.  
In this study, we have sought to ascertain at a comprehensive level how E. coli responds 
to a defect in the Tat protein export pathway. The deletion mutant ΔtatABCDE has been 
used to determine the E. coli phenotype and proteome alterations under disruption of the 
Tat pathway. We describe several stress responses and novel phenotypes emerging from 
the Tat system's deletion. Moreover, we have experimentally identified a range of known 
Tat substrates and studied their localization.  
 
2. Materials and methods 
 
2.1. Cell culture and fractionation 
E. coli strains utilized for this study were MC4100 and a variant of said strain with a full 
tatABCD deletion and a partial tatE deletion (Table 1). Five mL Luria Bertani (LB) 
medium (10 g/L sodium chloride, 10 g/L tryptone, 5 g/L yeast extract) pre-cultures were 
inoculated from glycerol stocks and grown aerobically overnight at 30 °C, 200 rpm. The 
next day cultures were diluted to an OD600 of 0.05 in 25 mL fresh LB. Cultures were then 
grown at 37 °C, 200 rpm in 250 mL Erlenmeyer flasks for 5 hours. Cells equivalent to a 
density of OD600 of 10 (~12 mL) were taken and fractioned into cytoplasmic (C), 
membrane (M) and periplasmic (P) samples. Periplasmic (P) fractions were collected 
using an EDTA/lysozyme/cold osmotic shock method previously described (Randall and 
Hardy, 1986), with modifications (Pierce et al., 1997). Spheroplasts were further 
fractionated into cytoplasmic (C) and insoluble/membrane (M) fractions as described 
earlier (Pierce et al., 1997). Fractions of three biological replicates from each stain were 
prepared. 
Table 1. Strains and plasmids used in this work. 
Strains Description Reference/source 
MC4100 AraR, F2 araD139 DlacU169 rpsL150 relA1 
flB5301 deoC1 ptsF25 rbsR 
Wexler et al., 2000 
ΔtatABCDE (Δtat) MC4100 strain lacking tatABCDE genes, 
AraR 
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2.2. Inclusion bodies preparation 
Inclusion bodies (IBs) were separated from bacterial cultures grown in conditions 
described in the previous section. Cells were grown for 5 hours and harvested by 
centrifugation at 10.000 x g, 4 °C for 10 minutes. Pellets were resuspended in washing 
buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0) and cells were disrupted by French Press 
(operated at 16.000 to 18.000 psi) followed by a high-speed centrifugation at 22.000 x g. 
Unbroken cells, large cellular debris and the inclusion body proteins were washed twice 
with a washing buffer and IBs were isolated as described previously (Joliff et al., 1986). 
In short, pellets were resuspended in lysis buffer (5 M urea, 50 mM Tris-HCl, pH 8.0), 
incubated 15 minutes at room temperature and centrifuged for 30 minutes at 22.000 x g. 
The supernatant containing denatured proteins of IBs was separated and concentrated 
using Amicon® Ultra-0.5 centrifugal filters (Millipore).  
 
2.3. Proteomics sample preparation and LC−MS/MS analysis 
Protein concentration was determined by the Bicinchoninic Acid (BCA) Protein Assay 
(Thermo Fisher Scientific). Cytoplasmic proteins (100 μg) were reduced with TCEP, 
alkylated with iodoacetamide and digested in-solution using trypsin (Muntel et al., 2012). 
Desalting of peptides prior to mass spectrometry analysis using Stage tips, C18 material 
(Thermo Fisher Scientific) was performed according to the protocol described earlier 
(Rappsilber et al., 2007). For absolute protein quantification, a tryptic digest of yeast 
alcohol dehydrogenase (ADH1, Waters, USA) was added into the samples to a final 
concentration of 50 fmol/μL. The nanoACQUITYTM UPLCTM system (Waters) was used 
to separate and introduce peptides into the Synapt G2 (Waters) mass spectrometer. 
Parameters for liquid chromatography and IMSE were used as described previously 
(Zühlke et al., 2016).  
Proteins from periplasmic and membrane fractions (30 μg) were separated via 1D SDS-
PAGE, the entire gel lanes cut into ten pieces each. Proteins from isolated inclusion 
bodies (30 μg) were run via 1D SDS-PAGE 5-6 mm into the resolving gel and the bands 
containing proteins were cut out of the gel. Proteins were digested with trypsin (Promega, 
USA) overnight. Peptides were purified using ZipTip C18 tips (Millipore). The eluted 
peptides were subjected to LC-MS/MS analysis performed on a Proxeon nLC 1200 
coupled online to an Orbitrap Elite (Thermo Fisher Scientific) mass spectrometer. 
Peptides were separated on in-house self-packed columns (id 100 μm, od 360 μm, length 
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200 mm; packed with 3.6 µm Aeris XB-C18 reversed-phase material (Phenomenex)) in 
an 80 min nonlinear gradient from 1% acetonitrile and 0.1% acetic acid to 95% 
acetonitrile, 0.1% acetic acid. To obtain a better separation of peptides of the IBs fraction, 
peptides were separated on in-house self-packed columns (id 100 μm, od 360 μm, length 
200 mm; packed with ReproSil-Pur 120 C18-AQ, 3 µm material (Maisch)) in a 180 min 
nonlinear gradient. A full MS scan (resolution of 60,000) was acquired using the 
automatic data-dependent mode of the instrument. After acquisition of the full MS 
spectra, up to 20 dependent scans (MS/MS) were performed according to precursor 
intensity by collision-induced dissociation fragmentation (CID) in the linear ion trap. The 
mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner 
repository with the dataset identifier PXD008803 (username: reviewer18233@ebi.ac.uk, 
password: FfgJJudJ). 
 
2.4. Protein identification and quantification 
MS/MS spectra of cytoplasmic samples were searched against an E. coli K12 MC4100 
UniProt/Swissprot database (Proteome ID: UP000017782, 3985 protein entries, version 
January 2017) with added laboratory contaminants and yeast ADH1 sequence (Zühlke et 
al., 2016). MS/MS spectra of periplasmic and membrane samples were searched against 
the above-mentioned database using MaxQuant software (version 1.5.8.3) (Cox and 
Mann, 2006). The search was performed with the Andromeda search algorithms (Cox et 
al., 2011). Search parameters were set as follows: a minimal peptide length of six amino 
acids, up to two missed cleavages, carbamidomethylation of cysteine specified as a fixed 
modification, N-terminal protein acetylation and methionine oxidation were set as 
variable modifications. The false discovery rate (FDR) was estimated and protein 
identifications with FDR< 1% were considered acceptable. A minimum of two unique 
peptides per protein was required for relative quantification using the label free 
quantification (LFQ) algorithm provided by MaxQuant. 
 
2.5. Protein functional analysis and subcellular localization prediction  
The Student’s t test requiring a p-value of < 0.05 was subsequently conducted to 
determine proteins with significant alterations in protein abundance. Changes in protein 
abundance of Δtat vs. wild type (WT) were presented with a log2 fold change 
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(Supplementary Table 1). If the proteins were identified in only one of the strains in three 
biological replicates, they were added to the list of ON/OFF proteins. Heat maps were 
generated with Prism 7 (GraphPad) and the protein biological functions were assigned 
based on their FIGfam roles according to The SEED (http://pubseed.theseed.org/) 
(Overbeek et al., 2014) complemented with manual curation. The protein subcellular 
localization was assigned based on the E. coli specific STEP database (STEPdb) 
(Orfanoudaki and Economou, 2014). 
 
2.6. Transmission electron microscopy (TEM) 
Cells were fixed (1 % glutaraldehyde, 4 % paraformaldehyde, 0.2 % picric acid, 50 mM 
sodium azide in 5 mM HEPES buffer pH 7.4) at 4 °C and stored at the same temperature 
until further processing. Subsequently to embedding in low gelling agarose, cells were 
postfixed in 2 % osmium tetroxide in washing buffer (50 mM cacodylate buffer pH 7, 10 
mM magnesium chloride, 10 mM calcium chloride) for 1 h at 4 °C. After dehydration in 
a graded series of ethanol (20 %, 30 %, 50 % for 10 min each step; 70 % ethanol with 0.5 
% uranyl acetate for 30 min at 4 °C; 90 %, 96 %, 100 % ethanol) the material was 
embedded in AGAR 100 resin. Sections were cut on an ultramicrotome (Reichert 
Ultracut, Leica UK Ltd, Milton Keynes, UK), stained with 4 % aqueous uranyl acetate 
for 3 min followed by lead citrate for 1 min and analyzed with a transmission electron 
microscope LEO 906 (Zeiss, Oberkochen, Germany). Afterwards, the micrographs were 
edited by using Adobe Photoshop CS6. 
 
2.7. Crystal violet biofilm assay 
A quantitative biofilm assay was performed in 96-well polystyrene plates as described 
previously (O'Toole, 2011). Briefly, cells were inoculated from overnight cultures grown 
in LB and Belitsky minimal medium (Stülke et al., 1993), diluted in replicates in both 
media to an initial turbidity of 0.05 at 600 nm and grown at 37 °C without shaking. Cell 
density (turbidity at 600 nm) was measured after 24 and 48 hours in a microtiter plate 
reader (BioTek Synergy™ Mx) and analyzed with Gen5TM version 2.0 software. After 
removing the supernatants, biofilms were stained with crystal violet and absorbance at 
550 nm was measured. Total biofilm was normalized by bacterial growth for each strain 
and represented as biofilm formation index (BFI). Each data point was averaged from at 
least 20 replicate wells. 
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2.8. Quantification of colanic acid 
Colanic acid was quantified by measuring L-fucose, the sugar component which is 
exclusively found in this exopolysaccharide (EPS) (Stevenson et al., 1996). Samples of 
E. coli biofilm, growing in the wells of 6-well polystyrene plates for 48 h, were collected 
and colanic acid concentration was measured based on previously described method 
(Obadia et al., 2007). Biofilm samples were boiled for 15 minutes to inactivate EPS-
degrading enzymes and release EPS from the cell surface. In the next step, samples were 
centrifuged at 14.000 x g for 30 minutes at 4 °C, after cooling down to room temperature. 
The supernatants were collected, and polysaccharides were precipitated with 70 % 
ethanol overnight. Samples were subjected to centrifugation at 14.000 x g for 30 minutes 
at 4 °C. The pellet was diluted to 0.2 mL with distilled water and mixed with 0.8 mL of 
H2SO4/H2O (6:1; v/v). The mixture was heated at 100 °C for 20 min and cooled down to 
room temperature. For each sample, absorbance at 396 nm and 427 nm, before and after 
addition of 100 μL of cysteine hydrochloride, was measured. The absorption due to this 
reaction was subtracted from the total absorption of the sample, as described earlier 
(Obadia et al., 2007). A L-fucose (Sigma-Aldrich) calibration curve was used (0–
100 μg/mL) to determine the fucose concentration. The values for E. coli biofilm samples 
were normalized by cell turbidity at 600 nm. 
 
3. Results and discussion 
3.1. Comparative proteomic analysis of E. coli subfractions  
In this study, we carried out a comparative proteomic analysis of E. coli wild type and 
ΔtatABCDE strains. To efficiently identify and quantify proteomic changes, three 
different subcellular fractions were investigated, i.e. periplasmic and cytoplasmic protein 
fractions as well as an insoluble protein fraction containing mainly membrane proteins. 
The application of subcellular compartment fractionation was previously shown to 
improve protein identification, especially for membrane and periplasmic proteins (Brown 
et al., 2010). However, the common limitation of subfractionation methods are the 
impurities of highly abundant cytoplasmic proteins in periplasmic and membrane 
fractions (Brown et al., 2010; Wolff et al., 2008). To validate a high resolution and good 
depth coverage of periplasmic and membrane proteins in the subcellular fractions, we 
have calculated the abundance of protein impurities in all the fractions based on signal 
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intensities (Table 2). As expected, the analysis of relative protein abundances points to 
cross-contamination in all the subfractions of E. coli MC4100 and to significantly higher 
levels of cytoplasmic contaminants for membrane and periplasmic fractions of the E. coli 
Δtat mutant. These results are not surprising, given the fact that some tat deletion strains 
have been reported to present cell envelope disruption and cytoplasmic protein leakage 
(Ize et al., 2003). Based on the high content of cytoplasmic proteins in the periplasmic 
fraction of the E. coli ΔtatABCDE, but not the control strain, we conclude that the 
complete deletion of the Tat system leads to a disruption of the inner membrane and 
cytoplasmic protein leakage during fractionation. Collectively, our results indicate that 
the fractionation protocol distinctively enriched subcellular fractions, however, due to the 
Δtat membrane impairment, it was not possible to obtain a comparable protein 
enrichment rate for both strains. 
Table 2. Distribution of enriched proteins and protein impurities observed in subcellular 
fractions via LC-MS/MS. 
 
E. coli MC4100 E. coli MC4100 Δtat 








Cytoplasm 76.58 23.42 73.23 26.77 
Periplasm 66.88 33.12 31.75 68.25 
Membrane 66.88 33.12 50.27 49.73 
 
a Total recovery shows the percentage of the total abundance, calculated from LFQ intensities, of proteins 
identified in a certain subfraction and assigned to this subfraction by STEPdb. 
b Protein impurities shows the percentage of the total abundance, calculated from LFQ intensities, of 
proteins identified in a certain subfraction but assigned to other subfractions by STEPdb. 
 
3.2. Pleiotropic effects in an E. coli tat mutant 
Various reports have demonstrated that ΔtatAE and ΔtatC E. coli mutants display 
pleiotropic phenotypes. The most prominent effect of the Tat-system impairment is the 
formation of filamentous, chain like structures (Fig. 1), comprised of cells which fail to 
undergo a complete cell division (Stanley et al., 2001). This phenotype is assumed to be 
the result of mislocalization of amidases AmiA and AmiC. Both proteins are involved in 
splitting the murein septa and the separation of cells. It has been shown that the chain 
forming phenotype can be complemented by overexpression of AmiB (Bernhardt et al., 
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2003). Here, we decided to investigate if the simultaneous deletion of tatABCDE will 
contribute to the discovery of novel phenotypes of the E. coli tat mutants.  
In addition to previously reported findings, this study revealed an increase in inclusion 
body formation (Fig. 1B) and membrane vesiculation in the E. coli tat mutant (Fig. 1C) 
compared to the wild type (Fig. 1A). Inclusion body formation occurs naturally in bacteria 
as a result of the accumulation of unfolded proteins. In our study, the tat mutant strain 
formed inclusion body-like aggregates in moderately higher amounts than the wild type. 
Thus, we conducted a proteomic analysis to investigate whether there is any difference in 
the composition of the IB fraction between the wild type and the mutant (Supplementary 
Table 2). Several cytoplasmic proteins such as GroEL and DnaK, the main drivers of 
protein folding (in concert with their co-chaperones DnaJ-GrpE and GroES, 
respectively), IbpA and ClpB have been found to be more abundant in the IB fraction of 
the mutant strain compared to the WT. Together, these proteins have been already 
identified as real cytoplasmic components of E. coli IBs (Carrio et al., 2002) and GroEL 
itself may promote IBs formation via clustering of small aggregates. Interestingly, we 
could identify the cell division protein ZipA in Δtat IBs. This protein is essential for cell 
division, as it binds with FtsZ protein and forms the septal ring structure that mediates 
cell division in E. coli (Brown et al., 2010). Together with the mislocalization of AmiA 
and AmiC, the lack of functioning of ZipA may contribute to the formation of long-chains 
of cells in the E. coli Δtat mutant.  
The second novel phenotype we observed in Δtat E. coli cells was the formation of outer 
membrane vesicles (OMV). Several cells formed OMVs, especially the cells who failed 
to undergo complete division (Fig. 1C). This phenotype is most likely induced in response 
to the state of the cell envelope and the accumulation of overexpressed or misfolded 
proteins. In conclusion, the ΔtatABCDE mutation in E. coli results not only in the 
formation of long chains of cells, as previously reported for ΔtatAE and ΔtatC mutants, 
but also in the production of OMVs and increased formation of IBs, which may serve as 
a complementary mechanism for managing stress at the cell envelope. 
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Figure 1. Transmission electron micrographs of E. coli MC4100 (WT) (A1-A3) and 
Δtat (B1-B3, C1-C3) strains at different magnifications. The cells were grown 
aerobically in LB medium for 5 hours. The mutant strain shows morphological changes 
such as formation of 1. Long chains of cells, 2. Inclusion bodies and 3. Outer membrane 
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3.3. The effect of Δtat mutation on the export of Tat-dependent substrates 
The genome of E. coli is predicted to encode between 22 and 34 proteins with a Tat signal 
peptide (Bendtsen et al., 2005; Dilks et al., 2003; Robinson and Bolhuis, 2001; Tullman-
Ercek et al., 2007). These predictions are primarily based on the properties of the signal 
peptides; however, confirming their status as Tat dependent substrates is difficult due to 
the fact that some of the signal peptides are also capable of directing export of 
heterologous proteins to the periplasm through the Sec pathway (Blaudeck et al., 2001; 
Blaudeck et al., 2003; Stanley et al., 2002) and this pathway is essential for the viability 
of the cells (Economou, 2005). Current studies have shown that the Tat system is used to 
directly export 27 proteins to the periplasm and indirectly export another 8 using the 
hitchhiker mechanism described before (Berks et al., 2005; Tullman-Ercek et al., 2007). 
Out of the 27 reported, we only identified 8 Tat substrates and 3 of the hitchhiker proteins 
(Fig. 2). The presence of so few Tat substrates is most likely due to the low stress 
conditions in which the cells were grown, as well as the phase in which they were 
harvested (exponential). Many of Tat-dependent proteins have been found to be 
expressed only under certain conditions such as anaerobic growth (HyaA, HybO, NrfC, 
TorA and TorZ) (Hussain et al., 1994; Méjean et al., 1994; Sawers and Boxer, 1986), 
presence of cinnamaldehyde at a low pH (YagT) (Neumann et al., 2009) or hydroxyurea 
(FhuD) (Davies et al., 2009). The expression of some of the Tat substrates can be also 
inhibited by other proteins like NarL (YnfE, YnfF, YnfG and once again TorA) and NarP 
(FdnH) (Constantinidou et al., 2005). The rest of the Tat substrates have been shown not 
to be essential for the growth conditions tested (SufI, YahJ, MdoD, YaeI, Ycb and FdoH) 
(Gerdes et al., 2003). Within these 8 identified Tat substrates and 3 hitchhiker proteins 
we could discern 3 different localization and expression profiles. 
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Figure 2. Protein abundance of Tat substrates in E. coli Δtat vs. WT. The table shows 
Tat substrates their abundance which increased or decreased due to the Tat pathway 
deletion. Proteins are grouped according to their localization pattern. The functional 
classification and accession numbers were adopted from UniProt. The average ratios 
(log2 fold change) of the protein abundance in Δtat vs. WT are shown. The fold change 
in the abundance is marked with shading; blue – decreased abundance, orange- increased 
abundance. Significantly different results were marked with asterisks, (*) P<0.05, (**) 
P<0.01, (***) P<0.001. 
 
The first four proteins examined were HybA, EfeB, AmiA and AmiC as they were found 
to be exclusively present in the periplasm of the WT, but not in the Δtat strain, strongly 
suggesting that they are exported exclusively by Tat. HybA and EfeB (previously YcdB) 
seem to be lacking entirely in all other fractions of Δtat strain, presumably due to 
degradation in the absence of export. The up-regulation of hybA and efeB genes 
expression in the E. coli ΔtatC strain has been already shown (Ize, et al., 2004), thus we 
assume that the absence of HybA and EfeB in our Δtat mutant might be due to 
degradation inside the cell. On the other hand, the levels of AmiA and AmiC accumulated 
in the membrane fraction of the WT as well as in the Δtat mutant. This suggests that there 
is an inherent stability in these proteins that allows for an excess of protein to associate 
with the membrane without sequestration in insoluble bodies. When analyzing the content 
of IBs formed in the Δtat strain, no traces of these proteins were determined. This suggests 
that their presence in the membrane fraction is due to the association of these proteins 
with the inner membrane of the cells, but not in inclusion bodies.  
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Another two Tat dependent substrates, CueO and NapA, were identified in the periplasm 
of the Δtat strain. However, they were not as abundant and found in much lower quantity 
than in the WT, suggesting that instead of using Sec as a secondary translocation 
mechanism these traces of protein are artifacts of the fractionation process discussed 
before. When comparing the amount of protein present in WT and mutant, we found that 
both proteins accumulate in the membrane fraction of the Δtat strain. In the case of CueO 
this accumulation only happens in Δtat, implying that the protein either associates with 
the membrane or causes aggregation into inclusion bodies.  
The next group contains two Tat substrates, FdnG and DmsA. Due to their tight 
association with inner membrane proteins they are not present in the periplasmic fraction. 
FdnG is associated with the transmembrane protein FdnI, whereas DmsA form a complex 
with DmsB and DmsC (Stanley et al., 2002). Both FdnI and DmsC are not present in our 
samples, probably because of the difficulty to identify transmembrane proteins using the 
proteomics methods described in this study (Rabilloud, 2012). We observe a dramatic 
decrease in abundance of FdnG and DmsA in Δtat cells. The presence of FdnG and DmsA 
in the Δtat cells is most likely due to their association to the inner membrane on the 
cytosolic side. Since we did not identify them in the IB fraction, we assume they do not 
aggregate.  
The final group of Tat substrates are the hitchhiker proteins: DmsB, HyaB and HybC. 
DmsB is completely undetected in the Δtat cells. Both HyaB and HybC form multimeric 
complexes with HyaA and HybO, respectively to be correctly co-transported across the 
membrane with the help of the chaperons HyaE and HybE (Berks et al., 2005; Palmer et 
al., 2005). Neither HyaA nor HybO were identified, although they are both located 
upstream in their operons, followed by their hitchhiker counterparts. However, both of 
these proteins have transmembrane domains (Hatzixanthis et al., 2003) meaning that, as 
described before, their identification is analytically challenging. HyaB was not present in 
Δtat cells and HybC was downregulated, however the abundance values were not 
statistically significant. In both cases the amount of protein we expect to find are minimal 
since both operons are under promotors that are induced under anaerobiosis. It is likely 
then that both HyaB and HybC are either being produced on their own, or alongside HyaA 
and HybO, but these last two are degraded before they can be exported since the cells are 
not under anaerobiosis, meaning that their hitchhikers are not able to cross the inner 
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membrane to the periplasm and in the case of HyaB in Δtat cells begin being degraded as 
well.  
 
3.4. Proteome changes linked to the loss of Tat export 
Deactivation of the Tat apparatus causes profound stress in E. coli cells. The global 
analysis of gene regulation has shown the effect of tatC deletion on the expression of 
genes involved in cell envelope associated functions, iron and copper homeostasis and 
polysaccharide synthesis (Ize et al., 2004). However, to our knowledge, there have been 
no studies on the effects of tatABCDE deletion on the E. coli proteome. Thus, in this study 
we decided to characterize the effect of the loss of all known Tat secretion components 
on proteins located in the periplasm, membrane, and cytoplasm. A set of 98 proteins 
related to stress response were identified and represented in the heat map (Fig. 3) 
(Supplementary Table 3). Changes in protein abundance between the E. coli tat mutant 
and its parental strain were shown as log2 fold changes. 
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Figure 3. Heat map of changes in the abundance of stress response proteins between 
E. coli Δtat and the WT. A set of 98 proteins related to stress responses were categorized 
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into 10 functional groups using Figfam classification. The heat map shows proteins 
involved in: protein folding and degradation (A, A1), stress responses (B, B1) cell 
envelope stress and cell division (C) and iron and molybdenum homeostasis (D). Proteins 
represented in panels A1 and B1 were identified in high abundance in the periplasmic 
fraction, however according to STEPdb they are cytoplasmic proteins. The changes in 
protein abundance between E. coli Δtat and the parental strain are represented as mean 
log2 fold change and are depicted in a color gradient from blue (decreased protein 
abundance in Δtat) to yellow-green (increased protein abundance in Δtat). Significant 
results were marked with asterisks, (*) P<0.05, (**) P<0.01, (***) P<0.001. 
 
3.4.1. Activation of chaperones and proteases in periplasm 
E. coli cells upregulate the expression of chaperones and proteases in response to cellular 
and environmental stress. We observed that the abundances of several chaperones and 
proteases were increased in the cytoplasmic and periplasmic fractions of the tat mutant 
cells (Fig. 3A). Among the upregulated chaperones in the cytoplasm, the most prominent 
increase in the protein abundance was observed for the HscA chaperone which is required 
for the assembly of iron-sulfur clusters (Takahashi and Nakamura, 1999). Moreover, two 
of the major chaperone systems DnaK/J/GrpE and GroEL/GroES also become 
upregulated as a consequence of the tat deletion. DnaK is one of the most abundant and 
essential stress inducible chaperones (Bukau and Walker, 1989), it works together with 
its co-chaperones DnaJ and GrpE to facilitate de-novo protein folding in stressed E. coli 
cells. GroEL is accompanied by its cofactor GroES, and together they are essential for 
viability under all growth conditions tested (Favetet al., 1998). Furthermore, a number of 
additional proteins, including ClpB, HtpG, IbpA/B and HslO, are induced under stress 
conditions to prevent and/or repair stress-induced damage in the E. coli proteome 
(Hoffmann et al., 2004; Schröder et al., 1993; Thomas and Baneyx, 2000). Proteases work 
together with chaperones and form the cell quality control system of E. coli. These 
proteolytic enzymes degrade damaged, misfolded or unassembled polypeptides, which 
become harmful when accumulated in the cell. The main cytoplasmic proteases such as 
Lon, ClpP/X and HslV/U are present in the cytoplasmic fraction of E. coli Δtat in high 
amounts. The periplasmic fraction shows activation of DegP/Q proteases. In addition, we 
observed the increase in the abundance of cytoplasmic proteases and chaperones in the 
periplasmic fraction of the Δtat (Fig. 3A1). We assume that most of the cytoplasmic 
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proteins observed in the periplasmic fraction are technical impurities of the osmotic shock 
separation process (Brown et al., 2010; Yaagoubi et al., 1994). However, considering 
their upregulation in both the cytoplasmic and periplasmic fractions, the induction of 
chaperones and proteases in the tat mutant remains unquestionable. We also hypothesize 
that the upregulation of some cytoplasmic proteins such as GroEL and DnaK may suggest 
their actual presence in the periplasm. It has been previously reported that a high load of 
cytoplasmic aggregates can result in their secretion to the periplasm together with GroEL 
and DnaK (Mar Carrió and Villaverde, 2005). In conclusion, the observed increase in the 
abundance of chaperones and proteases is most likely a reaction to the perturbations 
caused by mislocalization and cytoplasmic accumulation of Tat substrates, and the loss 
of their function in the cell, which disturbs the whole network of proteins that are directly 
or indirectly involved in Tat secretion.  
 
3.4.2. Cellular stress responses  
Our analysis has also revealed the induction of proteins involved in the stress response to 
heat, oxidation, changes in osmolarity and cold (Fig. 3B). Interestingly, we observed that 
PspF, the transcriptional activator of the stress-induced psp operon, is present only in the 
E. coli tat mutant. The Psp response is induced by perturbations in the integrity and 
energization of the inner membrane. PspF initiates the Psp response which has been 
shown to become active with defects of the Sec secretion system (Jones et al., 2003) and 
enhances the efficiency of the Tat pathway function (Delisa et al., 2004) when the 
translocation apparatus becomes saturated. Furthermore, most of the upregulated 
oxidative stress related proteins were also identified in the periplasmic fraction (Fig. 
3B1). For example, thioredoxin TrxC which reduces disulfide bridges and methionine 
sulfoxide formed by reactive oxygen species during the oxidative stress. TrxC is induced 
by OxyR in the cytoplasm, however it is also present in the periplasm of the tat mutant. 
It has been shown that some small cytoplasmic proteins such as thioredoxin and 
superoxide dismutase (SodA) can be released from the cytoplasm through the 
mechanosensitive ion channel of large conductance (MscL) during osmotic shock (Ajouz 
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3.4.3. Cell envelope stress 
It has been previously observed that E. coli tat mutants have impaired membrane integrity 
which results in outer membrane permeability and depletion of peptidoglycans (Ize et al., 
2004). One possible explanation for this defect of cell envelope integrity is the 
mislocalization of amidases AmiA and AmiC, involved in cell wall metabolism. To 
combat stress resulting from the disruption of the peptidoglycan layer and compensate 
for its depletion, E. coli upregulates proteins involved in the cell wall biogenesis pathway. 
The proteomic analysis revealed an increased abundance of proteins MurA/B/D/E/F (Fig. 
3C), which take part in the synthesis of murein. Most likely, the cell senses the depletion 
of peptidoglycans in the membrane and escalates their synthesis. In addition, we observed 
an increase of proteins involved in colanic acid synthesis. This polysaccharide is 
produced in response to changes in the environment, that may damage the outer 
membrane, and it protects the cell capsule of E. coli (Gottesman and Stout, 1991). The 
upregulation of proteins involved in colanic acid synthesis is described in the next section 
(3.5). The phenotypic analysis has shown that ΔtatABCDE, similar to ΔtatC (Ize et al., 
2004), is impaired in the cell separation stage of cell division. Here, we identified some 
important proteins for the cell division process which may be co-responsible for the 
formation of long chains of cells in the E. coli tat mutant. We determined the upregulation 
of MinC, cell division inhibitor protein (Conti et al., 2015), and MraZ whose 
overproduction was reported to be lethal and perturb cell division (Eraso et al., 2014). 
Together with these findings we observed a dramatic downregulation of transcriptional 
regulator protein BolA which is involved in the coordination of genes that control cell 
physiology and cell division (Aldea et al., 1988).  
 
3.4.4. Iron and molybdenum homeostasis 
The Tat secretion pathway is involved in the transport of iron. Many of the known Tat 
substrates bind Fe-S cofactors, and EfeB is directly involved in the iron uptake by 
extracting iron from heme in E. coli cells. We believethat tat deletion regulatory 
influences the expression of the ferric citrate transport (fec) operon. We observed that 
FecA is not present in the periplasmic fraction of Δtat and it is significantly 
downregulated (-10 log2 fold change) in the insoluble fraction. Since FecA binds (Fe3+ 
citrate)2 to the outer membrane and initiates transcription of the fec transport genes, its 
absence in the cell most likely results in cessation of the Fec-dependent transport, which 
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explains the absence of FecE transporter in the E. coli tat mutant. In addition, we found 
several other proteins e.g. YggX, Dps, Bfr, Fdx, PreA and FdoH, important for 
maintaining the cell iron homeostasis, to be downregulated in the of E. coli Δtat (Fig. 
3D). Proteins YggX and Dps are known for their protective role under iron imbalance 
conditions in E. coli (Almiron et al., 1992; Pomposiello et al., 2003), so their 
downregulation in the cytoplasm is clearly related to the stress response. We have also 
observed the downregulation of several proteins important for molybdenum uptake. This 
unbalance in molybdenum homeostasis may be due to the dramatic decrease in DmsA, 
which is the largest subunit that binds molybdenum at its active site in E. coli (Trieber et 
al., 1996). 
 
3.5. Δtat mutation provokes synthesis of colanic acid capsular polysaccharide 
It has previously been observed that the ΔtatC strain responds to envelope stress by 
upregulation of genes involved in the cell envelope synthesis. Expression of the cps 
operon was shown to be induced (more than 2-fold difference compared to parental strain) 
only under anaerobic conditions (Ize et al., 2004). The results of our study not only 
showed the induction of cps operon proteins in ΔtatABCDE under aerobic conditions, but 
also the exclusive presence of nearly all the cps proteins in the tat mutant when compared 
with the parental strain. In short, we observed an induction of most of the cps genes 
responsible for the production of colanic acid, an exopolysaccharide necessary for the 
formation of the three-dimensional structure of E. coli biofilms (Danese et al., 2000). 
Fourteen out of 20 proteins involved in this cluster are present in our dataset, notably 13 
of them only in the Δtat strain (Fig. 4A-B). Of all the proteins in the cps cluster only one 
of them has a Tat signal peptide: WcaM (Stevenson et al., 1996). However, WcaM was 
not present in the obtained proteomic data, and neither were Wzx or WcaB/D, which were 
assumed to be also upregulated. These proteins are inner transmembrane proteins, which 
makes them highly difficult to solubilize and detect using standard proteomics. In 
conclusion, the identification of proteins up- and downstream from WcaM, Wzx, 
WcaB/D may suggest an induction of the entire csp operon. The fact that most of the 
proteins were identified only in the Δtat strain, but not in the WT, strongly suggests the 
dependence of colanic acid formation on the Tat secretion deficiency in the cell. 
Moreover, the upregulation of the colanic acid synthesis in Δtat was also mirrored by an 
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Figure 4. Induction of colanic acid synthesis in E. coli Δtat. Genetic organization of E. 
coli colanic acid synthesis (cps) cluster (A). Genes which protein products were 
synthesized upon tat mutation were marked. Table representing induced proteins of 
colanic acid synthesis and their cellular localization (B). Concentrations of colanic acid 
in E. coli WT and Δtat grown in LB liquid medium were compared (C). To quantify 
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colanic acid, concentration of its specific component, L-fucose, was measured. LB liquid 
medium was used as a control. Bars represent geometric means ± standard deviations 
from three parallel samples. A Student’s t-test was applied to determine statistical 
significance, (***) P<0.001. 
 
3.6. Colanic acid synthesis promotes biofilm formation in E. coli Δtat 
In the previous section (3.5) we showed that the deletion of tat genes leads to induction 
of a set of proteins involved in the synthesis of colanic acid, which are not present in the 
wild type. Based on this observation and the fact that this exopolysaccharide is required 
for development of biofilm in E. coli, we decided to investigate biofilm formation of the 
tat mutant in comparison to wild type cells. A biofilm forms when bacteria adhere to 
surfaces in aqueous environments. Ultimately, a biofilm is formed to protect bacteria from 
stressful environmental factors, although it is known that certain cellular changes such as 
DNA damage, oxidative stress (Gier et al., 2008) and iron depletion (Garcia et al., 2015) 
also promote biofilm development. In fact, it is often believed that any stress may trigger 
biofilm formation as a means of protection. To comparatively quantify biofilm formation 
of mutant and WT, a biofilm assay based on the ability of bacteria to adhere to plastic 
surface of microtiter plates was performed. To this end, cells were grown in standard LB 
medium to mirror the conditions of the proteomic experiment. Biofilm formation was 
also assessed for cells grown in minimal medium, since it has been reported that a strong 
biofilm formation in E. coli can be observed mostly in minimal media (Naves et al., 
2008). Biofilm formation was defined as the intensity of crystal violet stained cells 
divided by optical density of the upper culture. The obtained results showed enhanced 
biofilm formation ability of E. coli Δtat, especially after 48 hours in both media (Fig. 5). 
These results may seem surprising, especially taking into account the previously reported 
decrease in biofilm formation of a ΔtatC mutant (Ize et al., 2004). Nevertheless, it has to 
be noted that biofilm formation is a highly complex phenomenon that is initiated via 
numerous pathways depending on the strain, medium and environment. Apart from the 
colanic acid, the presence of IBs in the tat mutant may account for the observed biofilm 
production. It has been shown that IBs formation is associated with an abnormal 
phenotype involving cell clustering and the development of biofilm-like characteristics 
(Lee at al., 2008). In conclusion, we assume that the higher biofilm-forming capacity of 
E. coli Δtat is acquired as a response to stress generated by the loss of Tat-secretion and 
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can be attributed to the upregulation of colanic acid cluster proteins in the mutant, not 
observed in the wild type.  
 
 
Figure 5. Biofilm formation of E. coli WT and Δtat. The ability to form a biofilm was 
assessed using a polystyrene microtiter plate biofilm assay described under “Materials 
and methods”. Cultures were grown anaerobically in two media: LB and Belitsky 
minimal medium. The biofilm absorbance was measured after 24 and 48 hours. Error bars 
indicate standard deviations calculated from 20 replicates. 
 
4. Conclusions 
We have presented a global view of cellular consequences of a tatABCDE deletion, that 
to the best of our knowledge, is so far the most comprehensive analysis of the proteome 
changes due to the Tat apparatus deficiency in E. coli. Apart from the already known 
filamentous chain-like phenotype of E. coli Δtat, we identified the production of OMVs 
and increased inclusion body formation as novel phenotypes of tat mutants. Our 
proteomic analysis has revealed the upregulation of proteins involved in protein folding, 
degradation and response to heat, oxidation, osmolarity, and cold. In addition, the 
impairment of E. coli outer membrane resulted in the induction of proteins responsible 
for cell wall biogenesis. The tat deletion negatively affects the synthesis of iron and 
molybdenum transporters and imbalances their homeostasis in the cell. Finally, we have 
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shown that a simultaneous deletion of tatABCDE genes leads to the activation of proteins 
responsible for colanic acid synthesis, which contributes to the biofilm formation in tat 
mutant.  
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coli revealed by comprehensive proteome analyses. Microbiological Research, 218, 97–
107.  
2.2.1 Contribution 
For this project, I heavily contributed in concept and experimental design, performed the 
experiments, analysed the proteomic data, reviewed the literature available on proteins 
that showed important shifts in their regulation, made the figures and wrote the 
manuscript in collaboration with Katarzyna Dolata. The manuscript was revised by all 
the authors, especially Colin Robinson, Katharina Riedel and Susanne Sievers.  
 
For this study, we looked into the effects a misfolded protein not exportable by Tat would 
have on the E. coli cells. To do so I constructed a vector via molecular cloning that only 
contained the CyDisCo components to compare it with a vector containing both CyDisCo 
and a TorA-scFv and a second vector with CyDisCo and a TorA-scFv-26tail. The TorA-
scFv-26tail is derived from the TorA-scFv of the first vector but has an additional 26 
random amino acids added to the C-terminus. Both vectors have been used before in 
(Jones et al. 2016), which had shown that the TorA-scFv-26tail could not be exported to 
the periplasm due to its lack of correct folding. I transformed the three vectors and tested 
for expression of the scFv and misfolded scFv by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting (Figure 3), and 
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performed comparative densitometry on the band-intensities before taking samples 3h 
post induction for proteomic analysis. The samples were sent to the University of 
Greifswald and processed between Katarzyna Dolata and myself before mass spec 
analysis. 
 
I also made growth curves with the three transformants by measuring the OD600 every 30 
minutes of 3 replicates. Samples were taken of induced and un-induced culture and an 
additional control with no plasmid was also added to test the metabolic burden being 
suffered by the cells producing the protein. I graphed the results (Figure 1) and I 
calculated the specific growth rate (Table 2).  
 
The proteomic results were analyzed by both myself and Katarzyna Dolata. A Venn 
diagram (Figure 4a) comparing the proteins found in the three samples and Voronoi maps  
(Figure 4b-d) showing the categorization of these proteins according to TIGRfam and 
manual curation. These figures were extremely useful to help pinpoint which routes were 
being affected by folded and misfolded protein production.  
 
The proteomic data suggested changes in the concentration of tat proteins available under 
different conditions. To further study this phenomenon, I prepared samples for RT-qPCR 
analysis pre-induction and at various points post induction. The samples were sent to 
UCB, where Gilles Malherbe had designed the primers, and the RT-qPCR experiment 
and the analysis of the results was done by Gilles Malherbe and myself. The relative 
transcription levels resulting from this experiment were graphed in Figure 5. The 
proteomic data also suggested that the misfolded scFv induced the expression of Ag43, 
an outer membrane protein that confers bacterial cell to cell aggregation (Woude & 
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Henderson 1980), so a sedimentation assay accompanied by phase-contrast microscopy 
was also performed to determine if aggregation was happening in that transformant.   
 
Finally, electron micrographs were taken by Rabea Schlüter and interpreted by myself 
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2.2.2 Publication 
The paper as was sent for publication is as follows:  
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The Twin-arginine translocation (Tat) pathway of Escherichia coli has great potential for 
the export of biopharmaceuticals to the periplasm due to its ability to transport folded 
proteins, and its proofreading mechanism that allows correctly folded proteins to 
translocate. Coupling the Tat-dependent protein secretion with the formation of disulfide 
bonds in the cytoplasm of E. coli CyDisCo provides a powerful platform for the 
production of industrially challenging proteins. In this study, we investigated the effects 
on the E. coli cells of exporting a folded substrate (scFv) to the periplasm using a Tat 
signal peptide, and the effects of expressing an export-incompetent misfolded variant. 
Results  
Cell growth is decreased when either the correctly folded or misfolded scFv is expressed 
with a Tat signal peptide. However, only the production of misfolded scFv leads to cell 
aggregation and formation of inclusion bodies. The comprehensive proteomic analysis 
revealed that both conditions, recombinant protein overexpression and misfolded protein 
accumulation, lead to downregulation of membrane transporters responsible for protein 
folding and insertion into the membrane while upregulating the production of chaperones 
and proteases involved in removing aggregates. These conditions also differentially affect 
the production of transcription factors and proteins involved in DNA replication. The 
most distinct stress response observed was the cell aggregation caused by elevated levels 
of antigen 43. Finally, Tat-dependent secretion causes an increase in tatA expression only 
after induction of protein expression, while the subsequent post-induction analysis 
revealed lower tatA and tatB expression levels, which correlate with lowered TatA and 
TatB protein abundance. 
Conclusions 
The study identified characteristic changes occurring as a result of the production of both 
a folded and a misfolded protein, but also highlights an exclusive unfolded stress 
response. Countering and compensating for these changes may result in higher yields of 
pharmaceutically relevant proteins exported to the periplasm.  
Keywords  
Escherichia coli CyDisCo, Twin-arginine transport, recombinant protein, disulfide bond 
formation, misfolding, proteome, stress response 
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Escherichia coli is a popular expression platform for the production of recombinant 
proteins of therapeutic interest due to the ease and relative low cost with which it can be 
rapidly grown and modified in controlled laboratory and industrial settings. Among its 
advantages over other cell factories we highlight the simplification of downstream 
processing if the protein of interest is exported to the periplasmic space. Since E. coli 
does not naturally export many proteins into the periplasm the recovery of the protein of 
interest will occur with minimal contamination of unwanted host cytosolic proteins, DNA 
or endotoxins [1]. 
The export of the recombinant protein to the periplasmic space most typically occurs via 
the Sec transport pathway 'naturally' and in most industrial applications. In this pathway, 
an unfolded substrate with a cleavable N-terminal signal peptide is recognized and 
transported through the membrane-bound Sec translocase to the periplasm where it is then 
folded to a functional state. This is also the primary means of producing disulfide-bonded 
proteins due to the oxidizing environment of the periplasm [2, 3]. One of the major 
disadvantages of this system is the inability of the Sec pathway to successfully export 
highly complex proteins that rapidly fold in the cytoplasm before they reach the 
translocase or that have post-translational modifications such as cofactor insertions, 
which is the case of many biotechnologically relevant proteins. To circumvent this 
problem another transport pathway that transports fully folded proteins exists: the Tat 
system. This system, named for the twin arginine motif highly conserved in the signal 
peptides that localize the proteins to the transporter [4], has been shown not only to 
transport folded proteins from the cytoplasm to the periplasm [5, 6], but also to have a 
useful although poorly understood proofreading mechanism that blocks the export of 
proteins unless they are tightly folded and have the appropriate co-factors in place. By 
exploiting this system, heterologous proteins harvested from the periplasm will 
potentially contain a very low degree of protein heterogeneity, making it easier and more 
cost effective for downstream processing after harvest. Moreover, this export system is 
naturally capable of transporting proteins up to 150 kDa [7] which potentially allows the 
transport of relatively complex proteins [8]. The Tat system has also an important role in 
maintaining cellular homeostasis in E. coli [9]. 
Nevertheless, many proteins of biopharmaceutical interest are too complex to fully fold 
in the cytoplasm because disulfide bonds cannot properly form in the non-oxidizing 
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cytoplasm of E. coli. There are several routes available to avoid this problem, either by 
expressing proteins that fold tightly without the need of disulfide bonds [10] or by using 
strains with an oxidizing cytoplasm [11, 12]. One of these strains is the CyDisCo 
(Cytoplasmic Disulfide bond formation in E. coli) strain which expresses a yeast 
mitochondrial thiol oxidase, Erv1p and the human protein disulfide isomerase, PDI both 
lacking secretion signals [13]. The expression of these two proteins allows the formation 
of disulfide bonds in the cytoplasm, which leads to the correct folding of the protein and 
thus to its export to the periplasm via the Tat pathway [14]. 
In this study we sought to understand the physiological changes that result from the 
expression of a recombinant protein in both its correctly folded state and in a deliberately 
misfolded state using an E. coli CyDisCo platform. The expression of heterologous 
proteins in E. coli often results in protein misfolding and aggregation because the cell is 
not able to sustain non-physiological rates of expression. For its industrial application, 
the production process must be optimized to achieve high protein yields. Thus, under 
protein production process conditions it is important to identify stress parameters to 
circumvent and improve the process efficiency. For this reason, we were interested in 
characterizing the changes that occur during the expression of a misfolded Tat substrate, 
in order to understand whether additional responses occur. The substrate used was an 
scFv antibody construct that is efficiently exported by Tat while the 'misfolded' variant 
contains a 26-residue C-terminal extension that blocks export by Tat [14]. Both proteins 
were synthesised with an N-terminal TorA signal peptide that directs export by Tat. For 
our study, we used a comprehensive proteomic approach to monitor the changes in cell 
physiology and proteome caused by recombinant protein secretion, misfolding and 
aggregation. 
Methods 
Bacterial strains and plasmids  
The E. coli strain utilized for this study was W3110. All plasmids (Table 1) are derived 
from pET23 and have a Ptac promoter before the signal peptide or CyDisCo components 
and a 6xHis-tag after the scFv and mutated scFv. pIGM01 was constructed by PCR 
amplification using pHAK13 as a template and primers Empty_CyD_F (5’-
GAAGGAGATATTATGAAAGCCATCG-3’) and Empty_CyD_R (5’-
CACCTAAACGGACTGGCTGTTT-3’) as forward and reverse primers. PCR solutions 
were made using 1 μL template DNA (100 ng/μL), 1 μL dNTPs (200 μM final), 10 μL 5 
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× GC buffer, 1.25 μL of each primer (0.5 μM final), 0.5 μL Phusion High-fidelity DNA 
polymerase (2 U/μL stock, New England Biolabs, UK) and made up to a final volume of 
50 μL with milliQ H2O. PCR was then carried out in Biometra T3 Thermocycler 
(Biometra Anachem, UK) as per Phusion polymerase instructions with an annealing 
temperature of primer Tm minus 5 °C and annealing time extended to 10 min. PCR 
product was then treated with 1 μL DpnI restriction enzyme (New England Biolabs, UK) 
for 1 hour at 37 °C to digest template DNA and then heat inactivated for 20 min at 80 °C. 
2 μL of the product were mixed with 1 μL of ligase buffer, 1 μL of T4 DNA ligase (Roche) 
and made up to a final volume of 10 μL with milliQ H2O before incubation overnight at 
4 °C. The next day 5 μL ligation product was used to transform 100 μL E. coli W3110 
competent cells. Final plasmid sequence was confirmed by GATC-Biotech before use in 
this study. 
Table 1. Plasmids used in this work 
Plasmid Function Reference/source 
pHAK13 TorA-scFvM wild type with CyDisCo 
 
[14] 
pAJ22  TorA-scFvM-C-term26 (additional - 
SNAIIIIITNKDPNSSSVDKLAAALE′ 3′ to C-
terminus) with CyDisCo 
 
[14] 
pIGM01 CyDisCo  This study 
 
Cell culturing, sampling and fractionation  
5 mL Luria-Bertani (LB) medium (10 g/L sodium chloride, 10 g/L tryptone, 5 g/L yeast 
extract) pre-cultures were inoculated from glycerol stocks and grown aerobically 
overnight at 30 °C, 200 rpm with 1:1000 antibiotic (5 μL, 1 M ampicillin). The next day 
cultures were diluted to OD600 of 0.05 in 50 mL fresh LB and antibiotic and set in 
triplicate. Cultures were then grown at 30 °C, 200 rpm in 250 mL Erlenmeyer flask and 
samples were taken every 30 min for an OD600 reading. At OD600 of 0.4-0.6 plasmids 
were induced with 0.5 mM IPTG (25 μL, 1 M IPTG). After 3h induction, cells equivalent 
to a density of OD600 of 10 (~8 mL) were taken and fractioned into cytoplasmic (C), 
insoluble/membrane (M), periplasmic (P) and inclusion bodies (IBs) samples. 
Periplasmic (P) fractions were collected using an EDTA/lysozyme/cold osmotic shock 
method previously described [15], with modifications [16]. Spheroplasts were further 
fractionated into inclusion bodies by centrifugation at 5.000 rpm for 15 min at 4 °C before 
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separating the cytoplasmic (C) and insoluble/membrane (M) fractions as described earlier 
[16]. Fractions of three biological replicates from each strain were prepared. 
The specific growth rate μ was calculated from three consecutive OD600 measurements 
and using the time points of 1.5 hours as the initial point and 4.5 hours as the final point 
of the exponential phase. The growth rate was calculated as previously described by 
McKay et al. [17]: 
 
µ =




where x1 and x2 are the absorbance values measured at 600 nm at 1.5 hours and 4.5 hours, 
respectively.   
Doubling time for the exponentially growing cultures was calculated as: 
 




Protein expression analysis by Western blot 
Protein was transferred to PVDF-membrane (GE Healthcare, Buckinghamshire, UK) by 
wet-western-blotting, with electrophoresis for 1 h at 80 V, 300 A. The PVDF membrane 
was then immersed in blocking solution (2.5% (w/v) skimmed milk powder in 50 mL 1 
× PBS-Tween20 (0.1%)) and incubated at 4 °C overnight. The following day the 
membrane was washed 3 × for 5 min with 1 × PBS-Tween20 (0.1%) before incubation 
with primary antibody (3.5 μL anti-6-His (Life Technologies, CA, USA) in 20 mL 1 × 
PBS-Tween20 (0.1%), 3% (w/v) BSA) for 1 h at room temperature. Membranes were 
then washed 3 × for 5 min with 1 × PBS-Tween20 (0.1%) before incubation with 
secondary antibody (4 μL anti-Mouse HRP conjugate (Promega, WI, USA) in 20 mL 1 × 
PBS-Tween20 (0.1%)) for 1 h at room temperature. Finally, membranes were washed for 
3 × for 5 min with 1 × PBS-Tween20 (0.1%). Immunoreactive bands were detected using 
an enhanced chemiluminescence (ECL) kit (BioRad, Herts, UK) following 
manufacturer's instructions. Bands were visualised using BioRad Gel-doc 
chemiluminescence imager and associated software. Comparative densitometry of band-
intensities was also carried out on a BioRad Gel-doc imager with an Image Lab™ 
Software 4.1. 
2.2 Comparative proteome analysis in an Escherichia coli CyDisCo strain identifies stress 
responses related to protein production oxidative stress and accumulation of misfolded protein 
 77 
 
Transmission electron microscopy analysis 
The cells were fixed (1 % glutaraldehyde, 4 % paraformaldehyde, 0.2 % picric acid, 50 
mM sodium azide in 20 mM HEPES buffer pH 7.4) for 5 min at 40 °C by using a 
microwave processor for laboratory use (H2500 Microwave Processor, Energy Beam 
Sciences Inc. East Granby, Connecticut, USA), and then for 30 min at room temperature. 
Finally, samples were stored overnight at 4 °C until further processing. Subsequent to 
embedding in low gelling agarose, cells were postfixed in 2 % osmium tetroxide in 
washing buffer (20 mM cacodylate buffer pH 7, 10 mM calcium chloride) for 1 h at room 
temperature, followed by en bloc staining with 2 % uranyl acetate in 0.05 % sodium 
chloride for 30 min at room temperature and washing steps in between. After dehydration 
in graded series of ethanol (20 %, 30 %, 50 %, 70 %, 90 % for 10 min each step, 96 % 
two times for 10 min, 100 % ethanol three times for 10 min) the material was embedded 
in AGAR 100 resin. Sections were cut on an ultramicrotome (Reichert Ultracut, Leica 
UK Ltd, Milton Keynes, UK), stained with 4 % aqueous uranyl acetate for 3 min followed 
by lead citrate for 30 sec and analyzed with a transmission electron microscope LEO 906 
(Zeiss, Oberkochen, Germany). Afterwards, the micrographs were edited by using Adobe 
Photoshop CS6. 
 
Protein digestion and LC-MS analysis 
The protein concentration was measured by the Bicinchoninic Acid (BCA) Protein Assay 
(Thermo Fisher Scientific). Cytoplasmic proteins (100 µg) were reduced with TCEP, 
alkylated with iodoacetamide and digested in-solution using trypsin as described by 
Muntel et al. [18]. Desalting of peptides prior to mass spectrometry analysis using Stage 
tips, C18 material (Thermo Fisher Scientific) was performed according to the protocol by 
Rappsilber et al. [19]. For the absolute quantification of proteins from cytoplasmic 
fraction, the peptide mix of a tryptic digest of yeast alcohol dehydrogenase (Waters, USA) 
was spiked to a final concentration of 50 fmol/μL. The nanoACQUITYTM UPLCTM 
system (Waters) was used to separate peptides and introduce the sample into the Synapt 
G2 (Waters) mass spectrometer. Parameters for liquid chromatography and IMSE were 
used as described previously by Zühlke et al. [20]. 
Proteins from periplasmic and membrane fractions (30 μg) were separated via 1D SDS-
PAGE and the protein staining was followed by Bradford method [21]. The entire gel 
2.2 Comparative proteome analysis in an Escherichia coli CyDisCo strain identifies stress 
responses related to protein production oxidative stress and accumulation of misfolded protein 
 78 
lanes were cut into ten pieces each and proteins digested with trypsin (Promega, USA) 
overnight. Peptides were purified using ZipTip C18 tips (Millipore). The eluted peptides 
were subjected to LC-MS/MS analysis performed on a Proxeon nLC 1200 coupled online 
to an Orbitrap Elite (Thermo Fisher Scientific) mass spectrometer. Peptides were 
separated on in-house self-packed columns (id 100 μm, od 360 μm, length 200 mm; 
packed with 3.6 µm Aeris XB-C18 reversed-phase material (Phenomenex)) in an 80 min 
nonlinear gradient from 1% acetonitrile and 0.1% acetic acid to 95% acetonitrile, 0.1% 
acetic acid. A full MS scan (resolution of 60,000) was acquired using the automatic data-
dependent mode of the instrument. After acquisition of the full MS spectra, up to 20 
dependent scans (MS/MS) were performed according to precursor intensity by collision-
induced dissociation fragmentation (CID) in the linear ion trap. The mass spectrometry 
proteomics data have been deposited to the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the 
dataset identifier PXD010078 (username: reviewer91495@ebi.ac.uk, password: 
gZ9aEwDr). 
 
Protein identification and quantification 
The MSE spectra of cytoplasmic samples were processed using PLGS v 3.0 and searched 
against a randomized E. coli K12 W3110 UniProt/Swissprot database (Proteome ID: 
UP000000318, 4 257 entries, version December 2017) with added amino acid sequences 
of scFv, mutated scFv, yeast mitochondrial thiol oxidase, Erv1p and human protein 
disulfide isomerase, PDI, laboratory contaminants and yeast ADH1 sequence. Processing 
and search parameters were described earlier [20]. MS/MS spectra of periplasmic and 
membrane samples were searched against the above-mentioned database, excluding yeast 
ADH1, using MaxQuant software (version 1.5.8.3) [22]. Peptide search was performed 
with the Andromeda search algorithms [23]. For positive protein identification the 
following criteria had to be met: a minimal peptide length of six amino acids, up to two 
missed cleavages, carbamidomethylation of cysteine specified as a fixed modification, 
N-terminal protein acetylation and methionine oxidation were set as variable 
modifications. The false discovery rate (FDR) was estimated and protein identifications 
with FDR< 1% were considered acceptable. A protein had to be identified in at least two 
out of 3 biological replicates, and a minimum of two unique peptides per protein was 
required for relative quantification using the label free quantification (LFQ) algorithm 
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provided by MaxQuant. The Student’s t test requiring a p-value of < 0.05 was 
subsequently conducted to determine proteins with significant alterations in protein 
abundance. Changes in protein abundance of the E. coli CyDisCo strains expressing the 
protein of interest vs. wild type (WT) were presented with a log2 fold change (FC). If 
proteins were quantified in only one of the strains, and were identified in three biological 
replicates, they were added to the list of identified ON/OFF proteins. 
 
Functional analysis and data visualization 
The protein biological functions were assigned based on their TIGRfam roles according 
to The SEED (http://pubseed.theseed.org/) [24] complemented with manual curation. If 
the protein was identified in more than one fraction, the subcellular localization was 
assigned based on the E. coli specific STEP database (STEPdb) [25]. Voronoi treemaps 
were created using the Paver software (DECODON GmbH) [26]. 
 
Transcriptional analysis 
The cells were harvested right before induction, 30 min and 3 hours after induction, and 
then normalized using the absorbance measurement. The total RNAs were extracted using 
RNeasy Plus Mini Kit (Qiagen) with RNAprotect Bacteria Reagent (Qiagen) according 
to the manufacturer’s instructions. The reverse transcription was performed using 
SuperScript IV Reverse Transcriptase (Invitrogen). Finally, the real-time PCR was run in 
a QuantStudio 7 Flex (Applied Biosystems) using TaqMan Gene Expression Master Mix 
in a 20 µL reaction volume with the protocol: 10 min at 95 °C and 40 cycles of 15 sec at 
95 °C, 1 min at 60 °C. The gene rrsH encoding 16S ribosomal RNA was used as a 
reference and the ΔΔCt was averaged over triplicate measurements. 
 
Phase contrast microscopy 
Cells were grown in LB medium with ampicillin up to OD600 of 0.5 and after that induced 
with 0.5 mM IPTG. Next, cells were incubated for 3 hours at 30 °C and 180 rpm. For 
microscopy 10 μL bacterial culture were pipetted onto a thin layer of 1.5 % agar (Sigma-
Aldrich). Samples were photographed with an AxioCam MRm (Zeiss) camera mounted 
on an Axio Imager 2 (Zeiss) fluorescence microscope through an EC Plan-Neofluar 
100x/1.3 oil objective. Images were acquired with ZEN 2011 software and exported as 
TIFF file format.  
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Cells were assessed for cell aggregation by monitoring of sedimentation. Overnight 
cultures of the strains were adjusted to the same OD600 and grown to an OD600 of 0.5. 
Subsequently, bacterial cultures were induced with 0.5 mM IPTG and grown for another 
3 hours. Next, 5 mL samples were placed in sterile 10 mL tubes and 1 mL samples were 
transferred to a cuvette and covered with Parafilm. Samples were always prepared in 3 
replicates each and incubated for 24 hours at 30 °C without shaking. Images were 
acquired using a digital camera. Percentage aggregation was measured as previously 
described [27]. 
 
Results and discussion 
Physiological characterization of scFv-secreting CyDisCo strains 
A first indication of stress in scFv expressing cells was the metabolic burden. Metabolic 
burden occurs when the expression of a recombinant protein causes a decrease in 
generation time by diverting the resources of the cells towards protein production and 
plasmid maintenance [28]. Under the same growth conditions, we observed that the cells 
reach stationary plateau at different ODs when the plasmid is present and induced (Fig. 
1). These different conditions tax the cells in different ways: when induction occurs, the 
cells reached the stationary plateau at a lower OD while expressing the protein of interest 
in both folded and misfolded state in comparison to those expressing only the CyDisCo 
components. In case of the cells producing the correctly folded scFv, this additional 
growth stress is most likely due to the recombinant protein synthesis and its export to the 
periplasm of the protein: although Tat transport does not consume ATP it uses the proton 
motive force to export the proteins to the periplasm [29], causing an energetic and 
resource deficit in comparison to the control. In case of the misfolded scFv, the resources 
are diverted to the synthesis of a recombinant protein in a large quantity, which unlike 
the correctly folded scFv, is not secreted to the periplasm but deposited in inclusion 
bodies (visible in Fig. 2C). When embedded in IBs, protein is devoid of any biological 
activity and primarily cannot be used again in the cell. Cells lacking a plasmid and hence 
not producing a heterologous protein, reached a maximum OD significantly higher than 
that when expressing recombinant protein. In summary, the highest metabolic burden is 
experienced by the cells producing both the CyDisCo components and the protein of 
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interest (POI), however there is no clear difference between cells producing the correctly 
folded scFv and those producing the misfolded protein. Although the doubling times for 
all the strains were very similar (Table 2) we could observe that the lowest metabolic 
burden occurs when the cells do not have a plasmid followed by cells containing a non-
induced plasmid since these reached much higher ODs. 
For the proteomic study the time point of 3 hours post induction was chosen since this 
coincided with the complete growth arrest for the cells producing the correctly folded 




Growth comparison of E. coli CyDisCo induced and uninduced strains expressing 
folded, misfolded and no protein of interest (POI) as well as a control without 
plasmid. Linear (A) and semilogarithmic (B) display of E. coli growth. Cultivations were 
performed at 30 °C and 200 rpm for all conditions. Average growth and standard 
deviation of at least three independent experiments are shown. The dashed and dotted 
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Transmission electron micrographs of E. coli CyDisCo: control (A), scFv (B) and 
misfolded scFv (C) expressing strains. The cells were grown aerobically in LB medium 
for 3 hours post-induction with IPTG. The strain expressing misfolded TorA-scFv shows 
the formation of inclusion bodies (marked with arrowheads). Scale bar = 2 µm. 
 
Table 2 Comparison of the growth rate and doubling time of the exponential phase and 
maximum OD reached by the cultures after 7 hours 
Strains Specific growth 
rate* (h-1) 
Doubling time* (h) Maximum OD 
(at 600 nm) 
Induced No POI 0.75 ± 0.018 0.92 ± 0.022 2.08 
Induced ScFv 0.74 ± 0.005 0.94 ± 0.006 1.71 
Induced Misfolded 0.69 ± 0.013 1.01 ± 0.019 1.64 
Uninduced No POI 0.66 ± 0.022 1.05 ± 0.035 2.52 
Uninduced ScFv 0.69 ± 0.019 1.01 ± 0.028 2.23 
Uninduced 
Misfolded 
0.72 ± 0.016 0.96 ± 0.022 2.70 
Empty 0.76 ± 0.018 0.91 ± 0.021 3.73 
 
Cultivations were performed at 30 °C and 200 rpm for all conditions. The cells were 
grown aerobically in LB medium for 7 hours and induced with IPTG after 2.5 hours. The 
data for the calculation of the growth rate and generation time during the exponential 
phase was taken from time points at 1.5 hours and 4.5 hours. * Average from three 
replicates, ± standard deviation.  
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Total expression of Tat-targeted scFv and misfolded scFv 
The misfolded scFv (mf_scFv), consisting of an additional 26-residue unstructured tail at 
the C-terminus of the folded scFv, is not transported to the periplasm since the Tat 
system’s proofreading mechanism detects it as unfolded [14]. Fig. 2C shows that IBs are 
formed in the cells expressing the unfolded protein, while Fig. 3 shows that the unfolded 
scFv is also unprocessed: the signal peptide has not been cleaved and hence the protein 
runs higher on the SDS gel. A similar phenomenon occurs with the correctly folded scFv 
since a fraction of the uncleaved protein is also found in inclusion bodies, whereas the 
bulk of the protein is correctly exported to the periplasm and a small proportion remains 
in the cytoplasm. In both cases we can observe that there is less accumulation in inclusion 
bodies for the folded scFv and a densitometry analysis shows that the protein present in 
inclusion bodies in the unfolded scFv is 6.86 times more abundant than that of the folded. 
This accumulation in IBs in the cytoplasm may be due to the low abundance of Tat 
machinery available to transport the protein across the inner membrane, since over-
expression of the Tat components leads to more efficient export [30]. Finally, it has been 
previously shown and discussed that the presence of the mature-sized scFv in the 
cytoplasm may be due to early cleavage taking place by cytoplasmic peptidases [10]. 
 
Fig. 3 
Accumulation of the scFv construct and its misfolded variant in CyDisCo cells.  
TorA-scFv and the misfolded TorA-scFv constructs were expressed in E. coli cells 
together with Erv1p and PDI, CyDisCo components. After expression, cells were 
fractionated into cytoplasmic (C), membrane (M), periplasmic (P) and inclusion body 
(IB) samples and extracted proteins separated via SDS-PAGE.  
 
Impact of elevated scFv secretion and misfolded scFv accumulation on the E. coli 
proteome 
In the previous section, we showed that the expression of TorA-scFv in CyDisCo cells 
results in a high secretion of the protein to the periplasm and minor accumulation in IBs, 
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whereas the misfolded version aggregates in the IB fraction. Both processes are likely to 
cause some similar proteome stress responses associated with recombinant protein 
production, but we were most interested to determine whether diverse responses occurred 
due to the intensified secretion of scFv and its accumulation in the periplasm, or an 
aggregation of oxidized misfolded scFv in the cytoplasm. 
To study the stress responses, we performed a subcellular fractionation and applied LC-
IMSE and LC-MS/MS approaches for a comprehensive proteome analysis. Quantification 
of cytoplasmic, periplasmic and membrane/insoluble proteins was performed for samples 
harvested 3 hours post-induction (Supplementary Table 1). In our study we identified a 
total of 1629 proteins shared between three studied E. coli strains (Fig. 4 A). Among 
these, 441 proteins of the strain secreting scFv and 393 proteins of the strain expressing 
mf_scFv exhibited an at least two-fold change in expression when compared to the 
control (Supplementary Table 2). Changes in the amount of proteins are visualized by 
Voronoi treemaps (Fig. 4 B-D). The proteins are clustered by their functional category 
(TIGRfam complemented with manual curation) so that functionally related gene 
products are localized in one cluster. We distinguished several patterns of changes in the 
abundance of functionally related proteins and described them in the following section, 
providing log2 FC ratios for statistically significant results (p < 0.05). The first conclusion 
is that the expression of misfolded protein results in downregulation of many proteins 
involved in general metabolism and membrane transport. In addition, strains expressing 
either misfolded or correctly folded scFv, showed a high number of significant changes 
mostly in proteins associated with protein folding and degradation, oxidative stress, 
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Fig. 4 
Analysis of E. coli CyDisCo proteome changes in the strains expressing scFv and 
misfolded scFv vs. an empty plasmid control. Venn diagram showing the number of 
unique and shared proteins identified in E. coli CyDisCo strains (A). Proteome changes 
are shown as the change in protein abundance (log2 ratio) of strains expressing: TorA-
scFv vs. control (B) and TorA-mf_scFv vs. control (C). Changes in protein abundance 
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were color coded: orange indicates increase in the scFv and scFv (misfolded) proteome, 
gray indicates unidentified, and blue indicates decrease in the scFv and scFv (misfolded) 
proteome. Additionally, proteins which were identified in scFv expressing strains but not 
in the control strain were colored red (ON proteins) and proteins identified only in control 
strain but not in scFv expressing strains were colored navy blue (OFF proteins). The 
treemap legend shows the classification of the E. coli proteome according to TIGRfam 
annotations with manual adjustments (D). 
 
Folded vs. misfolded scFv stress response affecting transcription factors and DNA 
replication 
The adaptation to changes in growth conditions is often regulated by alternative sigma 
factors and anti-sigma factors [31]. Sigma factors are multi-domain subunits of the 
bacterial RNA polymerase and essential for the initiation of transcription. They are 
involved in the recognition of promoters and participate in the initial steps of RNA 
synthesis [32]. The proteomic analysis revealed that there was an increase in the levels of 
different sigma factors in the cells producing misfolded and folded scFv. This observation 
confirms that these cells are compensating for the additional production of the protein of 
interest by increasing the capacity of the cells to handle the metabolic burden. However, 
the results for the upregulation of transcription factors identified in our study failed to 
reach the desired level of statistical significance, thus they will be not discussed in detail.  
Additionally, we observed an upregulation of many proteins involved in DNA replication 
occurring only in the cells producing the correctly folded TorA-scFv. For example, a 
single-stranded DNA-binding protein Ssb (1.46 log2 FC scFv vs. control) or even a 
protein as essential in DNA replication as PolA (DNA polymerase I) (0.85 log2 FC scFv 
vs. control in the cytoplasmic fraction) were found to be upregulated in scFv producing 
strain whereas the cells expressing mf_scFv showed no change. The upregulation of 
proteins involved in DNA replication only in cells producing the folded protein suggests 
that, even though according to the growth curve all three conditions seem to either have 
reached (scFv and mf_scFv) or be entering (control) the stationary phase, the strain 
producing folded scFv is maintaining expression of proteins involved in DNA replication, 
repair and recombination [33]. 
Finally, we would like to highlight the upregulation of RlmJ (previously known as YhiR) 
in both strains producing folded and misfolded protein (1.40 and 0.76 log2 FC, 
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respectively). RlmJ is involved in the catabolism of external DNA [34] and has been 
identified to repress cell-to-cell plasmid transfer [35]. Notably, the abundance of RlmJ is 
lower in the cells producing mf_scFv, meaning that even though the misfolded protein 
stress seems to be partially responsible for the observed upregulation, this effect is greater 
with the production and transport of a folded protein to the periplasm. 
 
Protein folding and degradation processes 
To assure the proteome stability and functionality during high-rate protein expression, E. 
coli activates the proteome quality control system termed the proteostasis network [36, 
37]. This system consists of several complex protein machines that under stress 
conditions maintain proteome homeostasis by a proper regulation of protein folding and 
degradation processes. Here, we identified main chaperones and proteases upregulated 
upon scFv and mf_scFv expression in CyDisCo and describe their functional implication 
in proteome stability. 
DnaK-DnaJ-GrpE, and GroEL-GroES are the best characterized molecular chaperones in 
the cytoplasm of E. coli. Both systems can recognize unfolded proteins, refold or direct 
them to the cellular protein degradation machinery [38]. We observed the upregulation 
of chaperones from above mentioned systems in the cytoplasmic fraction of E. coli 
expressing the recombinant protein. However, the highest abundance of these proteins 
was observed in the membrane fraction containing IBs, and the upregulation of GroES-
GroEL and DnaK was notably increased in the strain expressing mf_scFv (GroES, 2.33; 
GroEL, 1.43; DnaK, 1.10 log2 FC mf_scFv vs. control). This observation correlates with 
our previous results and confirms the aggregation of moderate amounts of scFv in the 
cytoplasm and the high-level accumulation of mf_scFv in IBs. Moreover, the abundance 
of ClpB, a chaperone cooperating with DnaK to reactivate strongly aggregated proteins 
[39], was significantly increased in cells producing scFv and mf_scFv (2.39 and 2.84 log2 
FC, respectively). The inclusion body formation in the CyDisCo scFv and mf_scFv 
strains was also confirmed by the presence of IbpA, a heat shock protein with a strong 
ability to associate to protein aggregates, that was not identified in the empty plasmid 
control strain, in which we did not find any traces of IBs. Additionally, several other 
chaperones such as HtpG involved in de-novo protein folding in the cytoplasm [40]; Spy 
(2.37 and 2.25 log2 FC) inhibiting protein aggregation and promoting refolding in the 
periplasm [41]; and Skp (1.44; 1.48), SurA(1.36; 1.24), BepA (1.46; 1.14) accelerating 
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folding and improving insertion of outer membrane proteins [42, 43], were found to be 
highly abundant in the scFv and mf_scFv expressing strains, respectively. The 
accumulation of protein aggregates in the cytoplasm of E. coli CyDisCo is followed by 
activation of protein degradation machineries. We observed the upregulation of the 
ATPase components ClpA and ClpX of the Clp protease, Lon and HslV/U, together with 
periplasmic proteases DegP/Q. All these proteins are responsible for recognition, 
resolubilization and degradation of unfolded proteins. The highest difference between the 
abundance of scFv and mf_scFv expressing strains and the control was identified for 
periplasmic DegP and DegQ (1.53, 2.56; 1.85, 3.10 log2 FC for scFv and mf_scFv, 
respectively) proteases. This suggests that in both conditions, scFv secretion to the 
periplasm and mf_scFv aggregation in the cytoplasm, the cell envelope is exposed to 
unfavourable and harmful changes.  
The high upregulation of periplasmic proteases in the strain expressing misfolded scFv is 
particularly interesting. This could indicate that some of the protein is in fact successfully 
exported to the periplasm, rather than being blocked by the Tat proofreading machinery, 
and subsequently degraded. However, a previous study showed no evidence whatsoever 
for transport of this misfolded substrate to the periplasm and in our view it is more likely 
that the cell either senses the production of precursor protein and upregulates expression, 
or the proteases are upregulated as part of a general stress response. 
Oxidative stress and redox regulation in the cytoplasm 
The principle behind disulfide bond formation in the CyDisCo strain, as described before, 
is the co-expression of Erv1p and PDI in the cytoplasm. This system allows the oxidation 
of a dithiol to a disulfide in the cytoplasm, and at the same time does not require the 
disruption of any naturally occurring reduction pathways. The expression of two 
exogenous oxidases changes the cytoplasm into an oxidized environment, where the 
disulfide bonds can form efficiently, which is proven by the effective secretion of 
disulfide bond-containing scFv to the periplasm through the Tat system (Fig. 3). 
However, since the oxidative state of the cytoplasm does not occur naturally, we expected 
that this will provoke an oxidative stress response and changes in the abundance of redox 
proteins. 
Indeed, the proteomic analysis revealed the upregulation of several proteins related to 
oxidative stress response. Among these, major thiol-disulfide oxidoreductases: 
thioredoxin TrxA, glutaredoxin GrxA, together with thiol-specific peroxidase Bcp, were 
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upregulated in strains expressing scFv (with statistically significant upregulation only in 
mf_scFv). The upregulation of oxidoreductases was significantly higher in the strain 
producing misfolded scFv, probably due to the increased protein accumulation in IBs 
(e.g. GrxA, 1.19; TrxA, 2.02, Bcp, 2.08 log2 FC mf_scFv vs. control). In the cytoplasm 
of E. coli, thioredoxin and glutathione/glutaredoxin systems are required for the reduction 
of proteins that become oxidized, and thus they maintain the redox homeostasis [11]. 
However, during severe oxidative stress both systems can be overwhelmed, or their 
protein function can shift from reductase to oxidase, leaving cytosolic proteins 
susceptible to oxidation. It has been shown that thioredoxins and glutaredoxins can act as 
oxidases when exported to the oxidizing periplasm [44, 45] and both, TrxA and TrxC, 
shift their function to oxidases in a trxB mutant [46]. A related point to consider is the 
fact that in the periplasm of E. coli, which is an oxidizing environment, other thioredoxin-
related proteins such as DsbA, B, C, D, G catalyze the disulfide-bond formation and 
rearrangement. Thus, it appears that the function of thioredoxins and glutaredoxins is 
influenced by the redox potential of the cellular environment and in an oxidized 
cytoplasm of E. coli CyDisCo they will promote disulfide bond formation, rather than 
their reduction. 
In conclusion, the production of disulfide bond-containing scFv in CyDisCo increases the 
abundance of cellular redox proteins in the cytoplasm. We hypothesize that the abundance 
of those proteins is regulated by the amount of oxidized protein aggregates in the 
cytoplasm, thus it is larger in the mf_scFv strain. Since the oxidizing potential of the 
cytoplasm in CyDisCo strains is not compromised, we assume that the redox processes 
are either not efficient, or in the oxidizing environment the oxidoreductases function is 





It was interesting to note that the components of three major secretion machineries such 
as the Sec pathway, Tat system and YidC showed similar changes in their abundance in 
CyDisCo strains expressing scFv and its misfolded variant. Essentially, we might expect 
to find Tat components more abundant in the strain secreting high levels of scFv to the 
periplasm. However, we observed moderately lower levels of TatA and TatB, as well as 
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a higher level of TatE in CyDisCo strains expressing scFv and mf_scFv. We elaborate on 
this point in the next section. 
The amounts of Sec system components showed an increased abundance in strains 
producing recombinant protein, with a log2 FC higher than 1 for SecB and SecE. The Sec 
protein translocation pathway is involved in transport of most of the membrane-bound 
and secreted proteins (reviewed in [47]). The upregulation of Sec machinery is likely to 
be an effect of elevated oxidative stress in the periplasm and changes in the cell envelope, 
to which the cell is responding by secretion of cytoprotective stress proteins. The Sec 
system is responsible for insertion of a large number of proteins into the E. coli 
membrane, however some of the membrane proteins require YidC activity for their 
insertion [48]. Interestingly, in our samples YidC was found in lowered amounts in the 
E. coli secreting scFv (-2.29 log2 FC) and mf_scFv (-2.57 log2 FC). Additionally, we 
have also observed a drastic decrease in the amount of ABC transporter proteins 
responsible for the utilization of di- and tripeptides. In E. coli, the oligopeptide transport 
systems play a main role in nutrition, but the transported peptides also serve as substrates 
for integral membrane assembly and take part in the functioning of quorum-sensing 
pathways [49]. In this study, particularly the substrate-binding proteins (SBPs) of the 
main E. coli peptide transporters were present in much-decreased amounts (DppA, -5.74, 
-5.60; OppA, -3.68, - 2.97 and MppA, OFF, -3.04 log2 FC in scFv vs. control and 
mf_scFv vs. control, respectively). These SBPs recognize the substrate and subsequently 
deliver it to the translocator, thus the decrease in the SBPs amount reduces the peptide 
transport rate. Moreover, some essential components of other transport systems such as 
maltose (MalE/M/T/Y), glutathione (GsiB), Tol-Pal (TolB, CpoB) and lipid (Blc), or 
osmoregulated- periplasmic glucan (OPG) biosynthesis pathway (MdoB) were 
downregulated. One feature that these downregulated proteins have in common is their 
role in membrane protein synthesis and membrane maintenance under stress conditions. 
This suggests that the scFv expression in the E. coli CyDisCo causes the membrane 
impairment through a decrease in number of membrane transporters. We hypothesize that 
this observed decrease in membrane transporters abundance can be an effect of YidC 
downregulation, since it has an important role in membrane protein folding and insertion 
into the membrane [50, 51]. Generally, it is plausible that downregulation of so many 
transporter proteins involved in metabolite uptake is a consequence of previously 
mentioned metabolic burden that occurs in cells expressing scFv and mf_scFv. The non-
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stressed cells (empty plasmid control) are still in exponential phase, showing higher 
metabolic and biosynthetic activity than cells expressing POI, already in stationary phase 
at the harvesting time. 
 
Decrease of tat genes transcription when expressing a Tat substrate 
The proteomic analysis showed a moderate increase in the abundance of TatE (0.37; 0.89 
log2 FC for the scFv and mf_scFv vs. control, respectively) and a decrease of TatA and 
TatB proteins (however not statistically significant) in cells expressing scFv and 
misfolded scFv in comparison to the control. These observations raised the question of 
whether the expression of tatA and tatB genes is downregulated or the proteins have a 
shorter half-life upon overexpression of a Tat substrate. To address this question, an RT-
qPCR experiment was conducted on the cells grown under the same conditions as for the 
proteomic study and reported relatively to the control (Fig. 5). A time course experiment 
was run including points just before and after induction, to assess the impact of IPTG on 
the cells. Only one significant change was observed due to induction; an increase of 69% 
was detected between pre- and post-induction samples for tatA expression with the folded 
scFv. Therefore, the induction has an immediate impact on expression level of tatA only 
when expressing a Tat-suitable substrate. Since the tatABCD genes are part of a single 
operon, this result means that the genes experience a differential transcription. Moreover, 
the higher transcription of tatA compared to tatB matches the previously established fact 
that E. coli contains more TatA than TatB proteins [52].  
After induction, a significant decrease of transcription levels of tatA and tatB genes is 
observed when expressing TorA-scFv, whether correctly or incorrectly folded, by over 
30 %. This decrease matches the lower abundance of TatA and TatB proteins detected 3 
hours after induction. Therefore, less TatA and TatB proteins are expressed by the cell 
upon overexpression of a Tat substrate no matter whether it can fold correctly or not. 
These observations are surprising, given that the cells are expressing such high amounts 
of Tat substrate. The decrease in the amount of Tat operon being expressed seems to be 
partly compensated by the increase of TatE protein available in the cell. TatA and TatE 
share 53% homology and have overlapping functions. It has been shown that individual 
deletions of TatA and TatE are still functional, however the double deletion blocks export 
to the periplasm via the Tat pathway [53]. This preference for the use of either TatA or 
TatE is understudied and may be due to the additional stress conditions of the study or 
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for a determined preference for the TorA signal peptide employed. Another explanation 
for this behaviour may be the fact that the Tat pathway exports few and complex proteins 
to the periplasm, many of them involved in cell division, biofilm formation and 
pathogenicity [7]. These proteins are in most cases not needed in high concentrations in 
the periplasm, and this negative feedback loop may be responsible for assuring that the 
export remains low to avoid toxicity in the periplasm. 
 
Fig. 5  
Transcription levels of tatA and tatB genes calculated from RT-qPCR measurements 
when expressing folded scFv (dark grey) or misfolded scFv (light grey) at four 
different time points after normalization to the control vector. The mean and standard 
deviations of three replicates are shown. * p < 0.02. 
 
Misfolded scFv expression induces Ag43-mediated aggregation in E. coli CyDisCo 
cells 
Our proteome studies revealed significantly higher (5.71 log2 FC) abundance of antigen 
43 (Ag43) in the strain expressing a misfolded scFv. Ag43 is an outer membrane protein 
that confers bacterial cell-to-cell aggregation [54]. To our knowledge, the formation of 
cell aggregates connected with Ag43 expression has not yet been reported as a 
consequence of a cellular stress caused by the accumulation of misfolded protein in the 
cytoplasm. To verify if Ag43 upregulation promotes the cell aggregation in our strain, we 
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first performed phase-contrast microscopy (Fig. 6 A1-3). Additionally, since the cell 
aggregation leads to enhanced sedimentation, we applied a simple sedimentation assay 
(Fig. 6 B) and calculated the aggregation rate in all CyDisCo strains (Fig. 6 C). Indeed, a 
comparison of the aggregation and sedimentation rate of these strains confirmed that the 
E. coli expressing misfolded scFv shows enhanced sedimentation and aggregation. We 
propose that the increase in the abundance of Ag43 is related to the lowered abundance 
of the transcription factor OxyR, which is a suppressor of antigen 43 expression [55]. 
OxyR transcription factor is activated through the formation of a disulfide bond and is 
deactivated by enzymatic reduction with glutaredoxin 1, GrxA [56]. We observed a 
decrease in the abundance of OxyR in mf_scFv (-0.67 log2 FC) and its upregulation in 
scFv expressing strain. These results could only be observed after the induction of the 
scFv expression, thus we assume that the accumulation of misfolded scFv leads to the 
Ag43-mediated cell clustering. We believe that the upregulation of Ag43 synthesis is 
related to the accumulation of oxidized misfolded scFv which perturbs the thiol-disulfide 
balance in the cytoplasm and causes a situation referred as 'disulfide stress'. Interestingly, 
the downregulation of OxyR was only observed in the mf_scFv expressing strain, in 
which we observed higher upregulation of redox proteins. This suggests that the activity 
of OxyR is responsive to the thiol-disulfide redox status of the cell, however its 
abundance in the cell is regulated by another, yet not known, mechanism. Additionally, 
the absence of CpxR, an antagonistic regulator of adhesion in E. coli [57], could 
contribute to the enhanced cell aggregation under misfolded protein expression stress. 
The aggregation phenomenon was not accompanied by the increase in bacterial motility 
in the strain expressing misfolded scFv (Supplementary Figure 1). 
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Fig. 6 
The E. coli CyDisCo strain expressing misfolded scFv shows Ag43-mediated cell 
aggregation. Phase-contrast microscopy images of CyDisCo: control (A1), scFv (A2) 
and misfolded scFv (A3) expressing strains. Samples were harvested 3 h post-induction 
with IPTG. (B) Sedimentation profile of E. coli CyDisCo strains. Cultures were grown 
for 3 h post-induction, transferred into tubes and incubated statically for 24 h. (C) 
Percentage of aggregation as quantified from the change in OD600 over 24 hours from the 
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Conclusions 
The E. coli CyDisCo strain enables folding of disulfide bond-containing scFv in the 
cytoplasm and its secretion in high amounts to the periplasm via the Tat system. The 
expression of an unfolded scFv led to protein aggregation and inclusion body formation. 
Decreased cell growth, low abundance of proteins involved in DNA replication and sigma 
70 factor in E. coli expressing a misfolded scFv when compared to a folded scFv suggest 
that the unfolded protein stress accelerates cell transition to a stationary phase. We 
confirmed that the recombinant protein overexpression triggers the upregulation of 
proteins involved in removing the aggregates, such as chaperones and proteases. The high 
abundance of GroEL-GroES, DnaK and ClpB in the insoluble fraction of E. coli 
expressing misfolded protein suggests their association with protein aggregates. We also 
observed that the formation of disulfide bonds in the cytoplasm of E. coli CyDisCo 
initiates the oxidative stress response and increases the abundance of redox regulation 
system proteins. This upregulation of thioredoxins and glutaredoxins was higher in the 
strain accumulating the misfolded oxidized scFv in the cytoplasm. Nevertheless, the 
redox protein ability to reduce oxidized proteins seems to be compromised by the 
oxidative environment of the cytoplasm. 
Interestingly, we observed an extreme downregulation of membrane transporters which 
could be related to a major decrease in the abundance of YidC transport system, 
responsible for protein folding and insertion into the membrane. Surprisingly, a high rate 
of Tat-dependent secretion caused an increase in tatA expression only just after induction 
of synthesis. The following post induction analysis revealed lower tatA and tatB 
expression levels, which correlate with lower TatA and TatB protein abundance. This 
could suggest that the presence of the Tat signal peptide actively regulates the amount of 
Tat components being produced in a feedback loop to prevent an unnecessarily high 
concentration of Tat substrates in the periplasm. Finally, the most distinct unfolded 
protein stress response we observed was the cell aggregation caused by the elevated levels 
of antigen 43. Interestingly, to the best of our knowledge, this phenomenon has not been 
reported yet as a consequence of misfolded protein expression, which makes it an 
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Supplementary Fig. 1 (.pptx) 
The swarming motilities of E. coli CyDisCo strains and P. aeruginosa 
A swarming motility assay was performed using E. coli CyDisCo with an empty plasmid; 
expressing scFv; expressing misfolded scFv (mf_scFv) and P. aeruginosa PA01 as a 
positive control. Swarming plates (0.3 % agar in LB medium) were spotted with 10 µL 
of overnight cultures and incubated for 24 h at 37 °C. After 24 h the E. coli CyDisCo 
strains did not show signs of cell swarming, while P. aeruginosa showed a positive 
swarming phenotype. Assays were performed in triplicate. Figure shows representative 
results from 24 h incubation. 
 
Supplementary Table 1 A-C (.xlsx) 
Average protein abundances and fold changes for proteins from cytoplasmic (A), 
periplasmic (B) and insoluble/membrane (C) fractions 
 
Supplementary Table 2 (.xlsx) 
Voronoi Treemap of log2 fold changes in protein abundance (E. coli CyDisCo vs. scFv 
and E. coli CyDisCo vs. mf_scFv) 
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2.3 Equal first author publication under review-Escherichia coli 
‘TatExpress’ strains export over 5g/L human growth hormone to the 
periplasm by the Tat pathway. 
Isabel Guerrero Montero, Kirsty L. Richards, Douglas F. Browning, Amber R. 
Peswani, Mickael Labrit, Matthew Allen, Cedric Aubry, Emma Davé, David P. 
Humphreys, Stephen J. W. Busby and Colin Robinson, Escherichia coli ‘TatExpress’ 
strains export over 5g/L human growth hormone to the periplasm by the Tat pathway. 
Biotechnology and Bioengineering, under review. 
 
2.3.1 Contribution 
For this project, I heavily contributed in concept and experimental design, performed the 
experiments, analysed the data, reviewed the literature available, made the figures and 
assisted with the writing of the manuscript. The manuscript was revised by all the authors, 
especially Colin Robinson.  
 
The initial premise of this project was to compare scaled up protein production and export 
to periplasm in wild type and TatExpress E. coli. To do so, I tested the strains of interest 
at shake flask with the defined fermentation medium modified from (Smales & James 
2005) to ensure that the cells grew to acceptable OD600 and continued to produce protein, 
in this case human growth hormone (hGH), as has been previously demonstrated 
(Browning et al. 2017). Afterwards, Dr Kirsty Richards and I were able to perform 5 
fermentation runs using 2L Sartorious fermenters at UCB under the guidance of their 
technical team. However, due to timing constraints it was not possible to continue to use 
the facility at UCB, so 3 Infors 1.5L benchtop bioreactors were purchased and installed. 
I was responsible for the optimisation of both the bioreactor setup, including modifying 
the height of the impellers, creating foam traps and the installing a more powerful cooling 
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system, and the fermentation protocol used for the rest of the runs necessary to acquire 
the remaining data.  
 
Samples were taken at different time-points and processed to visually measure the amount 
of protein being produced by by SDS-PAGE gel electrophoresis and immunoblotting. I 
was also responsible for optimizing the fractionation steps for purification to obtain high 
volumes of periplasmic material without the use of lysozyme which is regularly used in 
the standard fractionation protocol developed in the lab (Pierce et al. 1997). Once 
lysozyme free samples were obtained, I purified the extract using a His-column on the 
AKTA and then tested both a crude periplasmic sample against the purified to measure 
protein expression by SDS-PAGE gel electrophoresis and immunoblotting. These 
samples were also subjected to quantification via a specific hGH bioassay. 
 
Finally, the purified samples alongside a positive control consisting of hGH from a 
commercial house were taken for mass spectrometry, which was performed by Dr Kevin 
Howland at the University of Kent, who also aided in the interpretation of the results. 
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2.3.2 Preliminary data 
Due to the specifications of the journal it was decided that not all of the preliminary data 
generated for the paper was to be added to the final draft. Said data can be found in the 
following section since it provides the initial proof of concept for better protein export in 
TatExpress at shake flask level that is later worked upon in the fermentation publication. 
 
Characterisation of TatExpress: TE shows no additional metabolic burden on the cells 
in comparison with WT.  
The aim of this chapter was to characterize the E. coli TatExpress W3110 strain and 
determine its advantages for protein export in comparison with the WT W3110 strain. To 
do so we first compared the growth profiles of TatExpress producing and exporting hGH, 
a truncated version of hGH and an empty plasmid with no expressible protein of interest, 
as well as the profiles for when they were not induced.  
 
The truncated hGH was created from the TorA-hGH-H6 plasmid and has a 30 amino acid 
deletion between S80 and S109. This deletion is able to change the structure enough so 
that it is not able to be exported via Tat, as we can see in Figure 6.B. We observe that 
although the truncation consists of a deletion, the truncated hGH has a higher molecular 
band than the hGH. This can be explained by the fact that there is no export to the 
periplasm, meaning that cleavage of the TorA signal peptide would not have taken place. 
The TorA signal peptide and the deleted fragment have an approximate weight of 4.56 
kDa and 3.34 kDa respectively. In the end the combination of TorA and truncated hGH 
with His-tag has a final weight of 24.31 kDa and the cleaved hGH with His-tag has a final 
weight of 23.09 kDa, coinciding with the sizes shown on Figure 6.B. 
 








Figure 6: Comparison of hGH and truncated hGH: A: Sequence of original hGH and underline and 
bold the part of the sequence that was deleted. B: Samples 3 hours post-induction and fractionated in C/M/P 
fractions of the TorA-hGH and TorA-truncated_hGH are shown. Protein was expressed in W3110 TE cells. 
Molecular weight markers are shown on the left (in kDa) and mature and truncated hGH heights are 
indicated on the right.  
 
Figure 7 shows the growth curve for E. coli TatExpress W3110 expressing the TorA-
hGH-H6 construct (red), TorA-truncated hGH-H6 construct (green) and an identical 
plasmid as the ones mentioned but with no protein of interest expressed both in 
TatExpress (blue) and WT (black). Data for the strains bearing the plasmid but not 
induced were also obtained (dashed line). We observe that the strains producing protein 
show an important arrest in growth in comparison with the un induced samples due to 
resources being diverted to making protein, however, the strain with a plasmid that did 
not produce a protein of interest had an identical growth in comparison with the same but 
un induced. This is striking since even though the protein of interest is not being made 
the TatExpress strain is overproducing the tat components from the TatABCD operon. It 
appears that this production of additional tat components does not have an impact on the 
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growth and general wellbeing of the cells, as it not only does it show no growth difference 
in comparison to the un induced strain, it also has an identical growth pattern to un 
induced E. coli W3110 WT cells.  
 
Figure 7. Growth comparison of E. coli TatExpress W3110 induced and un induced strains expressing 
folded and truncated hGH and no protein of interest (POI) as well as a un induced E. coli W3110 as 
a control. Cultivations were performed in LB at 30 °C and 200 rpm for all conditions. Average growth and 
standard deviation of at least three independent experiments is shown. The perpendicular dashed and dotted 
lines show the time of IPTG induction and sampling point (3 h post-induction), respectively. 
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Pre-scale up evaluation of TatExpress in SM6 media.  
As has already been reported the TatExpress strain manages to export a significantly 
larger amount of protein to the periplasm than WT at shake flask level under laboratory 
conditions and does not seem to have any detrimental effects to cell viability and growth. 
However, to scale up the cultures it was necessary to assess what the growth and 
expression would be like in the minimal defined media used in fermentation. The protocol 
and recipe for shake flask expression and the media SM6c used for scale up was provided 
by Dr Emma Davé at UCB. SM6c uses glycerol as its sole carbon source and allows for 
slower growth over a longer period of time without affecting cell viability, letting us 
obtain higher ODs. During this period, a new TatExpress BL21 strain was developed and 
comparative trials in SM6c media took place.  
 
To prevent growth arrest due to lack of oxygen and high culture concentration (maximum 
obtained was OD of 8.57 after 40 hours) the growing conditions were modified from the 
usual protocol: cells were grown at 30C at 250 rpm until OD of 2 and then induced. 
Temperature was then lowered to 25C and samples taken for analysis. Figure 8 shows a 
comparison of the levels of expression during different time points between BL21 and 
W3110 TatExpress. We observe that while both strains are producing and exporting 
protein to the periplasm, and a high percentage of the protein is being accumulated in the 
cytoplasmic and insoluble fraction, in the case of the BL21 strain we also observe 
accumulation of the precursor hGH: the TorA signal peptide has not been cleaved during 
the processing. This does not occur with the W3110 strain, where we see that all the 
protein is immediately processed for export.  
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Figure 8. Comparison of hGH produced in TatExpress W3110 and BL21 in SM6c media. Samples 
taken at pre-induction and 2, 4 and 24 hours post-induction and fractionated in C/M/P fractions of the TorA-
hGH are shown. Molecular weight markers are shown on the left (in kDa) and mature and precursor hGH 
heights are indicated on the right. 
 
To accurately compare how well the TatExpress strain were exporting protein in 
comparison to the wild type the periplasmic bands on the blots for multiple repeats and 
serial dilutions were subject to densitometry. Figure 9 shows that for the same dilution 
(1:8) there is a band with a higher intensity at both 2 and 4 hours post induction for the 
TatExpress BL21 strain when compared to the WT. We determined that at 4 hours post 
induction the BL21 TatExpress strain has produced approximately 4.77 times more 
protein in the periplasm than BL21 WT at the same time point.  
 
Figure 9.  BL21 TatExpress exports more protein to the periplasm than BL21 WT. Periplasmic samples 
of TatExpress BL21 and WT BL21 expressing TorA-hGH 2 and 4 hours post induction grown in SM6c 
media. Lanes show no dilution, 1:2 and 1:8 dilution for each sample. Molecular weight markers are shown 
on the left (in kDa) and mature hGH height is indicated on the right.   
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2.3.3 Publication 
The paper was published after this work was submitted and the published version can be 
found in annex 1.  
 
The paper as was sent for publication in Biotechnology & Bioengineering is as follows:  
2.3 Escherichia coli ‘TatExpress’ strains export over 5g/L human growth hormone to the 
periplasm by the Tat pathway 
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Escherichia coli is a heavily used platform for the production of biotherapeutic and other 
high-value proteins, and a favoured strategy is to export the protein of interest to the 
periplasm in order to simplify downstream processing and facilitate disulphide bond 
formation. The Sec pathway is the standard means of transporting the target protein but 
it is unable to transport complex or rapidly folding proteins because the Sec system can 
only transport proteins in an unfolded state. The Tat system also operates to transport 
proteins to the periplasm, and it has significant potential as an alternative means of 
recombinant protein production because it transports fully folded proteins. Here, we have 
tested the Tat system's full potential for the production of biotherapeutics for the first time 
using fed-batch fermentation. We expressed human growth hormone (hGH) with a Tat 
signal peptide in E. coli W3110 'TatExpress' strains that contain elevated levels of the Tat 
apparatus. We show that the protein is efficiently exported to the periplasm during 
extended fed-batch fermentation, to the extent that it is by far the most abundant protein 
in the periplasm. The protein was shown to be homogeneous, disulphide bonded and 






Many high-value proteins are produced in E. coli, and a favoured strategy is to export the 
protein to the periplasm, usually by the well-characterised 'Sec' pathway (Walsh, 2014). 
Several strategies have been used, including expression of soluble proteins in the 
cytoplasm, expression in the form of insoluble inclusion bodies or export to the periplasm. 
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The latter approach is particularly favoured for the production of proteins that contain 
disulphide bonds, since the periplasm is the only oxidising compartment in wild type cells 
(Pooley et al., 1996).  Downstream processing is also simplified due to the lowered levels 
of cytoplasmic contaminants, including DNA (Balasundaram et al. (2009). Export of 
proteins to the periplasm is usually achieved by targeting via the well-characterised Sec 
pathway, whereby a cleavable Sec-specific signal peptide is present at the N-terminus of 
the target protein. However, the Sec pathway cannot handle many proteins and attention 
has focused on the alternative Tat pathway, which transports fully folded proteins by a 
completely different pathway (reviewed by Natale et al., 2008). Initial studies showed 
that Tat could export a model protein, GFP, at high levels with no large-scale release of 
cytoplasmic contents (Matos et al., 2012). This work was followed by additional studies 
that showed Tat to be capable of exporting a range of biotherapeutics including human 
growth hormone, single chain antibody fragments and interferons (DeLisa et al., 2003; 
Alanen et al., 2015; Tullman-Ercek et al., 2007; Browning et al., 2017; Matos et al., 
2014). 
 
Human Growth Hormone (hGH) is a 22 kDa protein consisting of 191 amino acids 
(Pooley et al., 1996) used to treat burn injuries, wound healing, hipopituitarism and 
obesity (Isaksson et al., 1985) since it is safe to use even in high doses (Van, 1998). Since 
hGH only has 2 disulphide bonds (Cys53-Cys165 and Cys182-Cys189) (Ultsch et al., 
1994) and no glycosylation, most of its large-scale production has used E. coli platforms, 
although a wide range of eukaryotic host systems have been tested (e.g. Hahm and Chung, 
2001; Ecamilla-Trevino et al., 2000). The highest recorded yield is 5 g of recombinant 
hGH per litre of milk in transgenic cows (Salamone et al., 2006).   
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One of the major difficulties in producing hGH in E. coli is its aggregation into insoluble 
bodies that complicate the production process. Until recently, most commercial hGH has 
been obtained from insoluble bodies that have been solubilized, with the hGH refolded 
into its active form (Olsen et al., 1981; Patra et al., 2000). Recent, novel approaches have 
managed to produce high quantities of soluble hGH in fed-batch fermentation, with 
reported yields of up to 678 mg/L cytosolic (Song et al., 2017).  
 
Although studies exporting hGH to the periplasm have reported relatively low yields 
(Sockolosky and Szoka, 2013), this is an attractive option due to the ease of downstream 
processing. In recent studies, we have shown that the Tat system can export hGH with 
high efficiency and that it is disulphide-bonded (Alanen et al., 2015). Their study 
concluded that, although the protein was presumably synthesised and exported in the 
reduced state, the periplasmic protein was fully disulphide-bonded by the normal Dsb 
machinery. We have also reported that a new series of engineered E. coli strains, which 
overexpress the Tat system components (termed TatExpress), demonstrate even higher 
export efficiencies (Browning et al. 2017). These strains bear a modified chromosomal 
tatABC operon, the expression of which  is induced by IPTG, so that the Tat system is 
over-expressed at the same time as the IPTG-induced target protein. However, the activity 
of the hGH was not assayed and our studies used laboratory shake flask systems that bear 
little resemblance to industrial production processes. Here, we have assessed the 
feasibility of this system for industrial production using TatExpress E. coli strains under 
fed-batch fermentation conditions. We report that the system is able to produce 5 g/L of 
purified, disulphide bonded, active hGH. 
 
2.0  Materials and Methods 
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Bacterial strains and plasmids  
The E. coli strain utilized for this study was W3110 WT and W3110 TatExpress which 
was previously described in Browning et al., 2017 alongside the plasmid pKRK7 
(pEXT22 expressing TorA-hGH-6His). pKRK38 was derived from pKRK7 to eliminate 
the TorA signal peptide that precedes the hGH. pKRK38 was constructed by PCR 
amplification using pKRK7 as a template and primers Mature_hGH_F (5’-
ATGTTCCCAACCATTCCCTTATCCA-3’) and Mature_hGH_R (5’- 
CATACATGTTCCTCTGTGGTAGGGT-3’) as forward and reverse primers. PCR 
solutions were made using 1 μL template DNA (100 ng/μL), 1 μL dNTPs (200 μM final), 
10 μL 5 × GC buffer, 1.25 μL of each primer (0.5 μM final), 0.5 μL Phusion High-fidelity 
DNA polymerase (2 U/μL stock, New England Biolabs, UK) and made up to a final 
volume of 50 μL with milliQ H2O. PCR was then carried out in Biometra T3 
Thermocycler (Biometra Anachem, UK) as per Phusion polymerase instructions with an 
annealing temperature of primer Tm minus 5 °C and annealing time extended to 10 min. 
PCR product was then treated with 1 μL DpnI restriction enzyme (New England Biolabs, 
UK) for 1 hour at 37 °C to digest template DNA and then heat inactivated for 20 min at 
80 °C. 2 μL of the product were mixed with 1 μL of ligase buffer, 1 μL of T4 DNA ligase 
(Roche) and made up to a final volume of 10 μL with milliQ H2O before incubation 
overnight at 4 °C. The next day 5 μL ligation product was used to transform 100 μL E. 
coli W3110 competent cells. Final plasmid sequence was confirmed by GATC-Biotech 
before use in this study. 
Fed-batch Fermentation 
Starter cultures were grown in 50 mL of 2xP media in 250 mL shake flasks for 6 h at 
37°C, 200 rpm with 1:1000 antibiotic (5 μL, 1 M kanamycin). 1 mL of culture was 
transferred to 200 mL of SM6 defined media and grown aerobically overnight at 30 °C, 
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200 rpm in shake flasks with 1:1000 antibiotic (5 μL, 1 M kanamycin). The next day an 
equivalent of 300 OD600 was used to inoculate fresh defined SM6 media to a final volume 
of 500 mL in Infors Multifors 1.5L fermenters (Infors UK Ltd., Reigate, UK). The pH 
was maintained at 7 using 25% (v/v) ammonia solution and 25% (v/v) sulphuric acid. 
Dissolved oxygen tension (DOT) was maintained at 30% using gas blending with 100% 
oxygen where necessary and the culture was maintained at 30°C until both stirrer and 
airflow was maximal and then dropped to 25°C. Cell density was measured by optical 
density in the range of 0.1-0.5 at 600 nm after dilution. Supplementation of MgSO4 
occurred when the OD600 reached 38-42 (8 mL/L of 1M MgSO4) and of Na2HPO4 when 
the OD600 reached 54-58 (5 mL/L of 232.8 g/L Na2HPO4) and when the OD600 reached 
66-77 (7 mL/L of 232.8 g/L Na2HPO4). A glycerol feed containing 80% w/w glycerol at 
a rate of 0.35% pump capacity was started at OD600 70. Induction with 9 ml/L of IPTG at 
a concentration of 4.31 g/L occurred at OD600 75.  
Fractionation 
Cells equivalent to a density of OD600 of 10 were taken and fractioned into Cytoplasm 
(C), Membrane (M) and Periplasm (P) fractions by the EDTA/lysozyme/ cold osmotic-
shock method. In brief, cells were pelleted by spinning at 3000 rpm, 4 °C, 10 min. The 
supernatant was discarded and the cell pellet resuspended in 500 µL of Buffer 1 (100 mM 
Tris-acetate pH 8.2, 500 mM sucrose, 5 mM EDTA pH 8.0) and 500 µL dH2O before 
addition of 40 µL hen egg white lysozyme (1 mg/mL) and incubation on ice for 5 min to 
digest the outer membrane. 20 µL MgSO4 (1M) was added to stabilize the inner 
membrane before centrifugation at 14,000 rpm, 4 ° C, 2 min. 500 µL of the supernatant 
was taken and frozen at − 20 °C as the Periplasmic fraction, P. The remaining supernatant 
was discarded and the pellet washed by resuspension in 750 µL Buffer 2 (50 mM Tris-
acetate pH 8.2, 250 mM sucrose, 10 mM MgSO4) and subsequently spun at 14,000 rpm, 
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4 °C, 5 min. The cell pellet was resuspended in 750 µL Buffer 3 (50 mM Tris-acetate pH 
8.2, 2.5 mM EDTA pH 8.0) and sonicated for 6 × 10 s, amplitude 8 µm to disrupt 
membranes (Soniprep 150plus, Sanyo Gallenkamp, Loughborough, UK). The resulting 
solution was then centrifuged at 70,000 rpm, 4 °C, 30 min to sediment the insoluble 
fraction. 500 μL of the supernatant was then taken and frozen at − 20 °C and designated 
as the Cytoplasmic fraction, C. The remainder of the supernatant was discarded and the 
pellet resuspended in 500 μL Buffer 3 before freezing at − 20 °C, and designated as the 
membrane or insoluble fraction, M. 
Protein purification 
For purification of 6x Histidine-tagged (C-term) proteins by Nickel IMAC, 10 mL of the 
culture post induction was taken centrifuged at 3000 rpm, 45 min, 4°C. Cell pellet was 
resuspended in 10 mL/g of chilled Buffer 1 without EDTA and 10 mL/g of milliQ H2O 
and incubated on ice for 30 min before centrifuging at 14 000 rpm, 20 min, 4°C (Beckman 
Avanti J- 25, JA 25.5 rotor). Supernatant was taken as the periplasmic fraction and placed 
into SnakeSkin® dialysis tubing (Thermo scientific) and dialysed at 4°C overnight into 
50 mM sodium phosphate, 150 mM sodium chloride. Using an ÄKTA™ pure protein 
purification system and a HisTrap HP histidine-tagged protein column (GE Healthcare, 
Buckinghamshire, UK) the protein was purified: storage solution (20% ethanol) was 
washed off with 10 column volumes (CV) of milliQ H2O before adding 5 mL 0.2 M 
NiCl, followed by another 2CV milliQ H2O wash. Columns were equilibrated with 3CV 
equilibration buffer (50 mM sodium phosphate pH 7.2, 0.3 M NaCl) before loading 
Periplasmic sample and collecting Flow Through (FT). Unbound matter was removed 
with 6CV Wash buffer (50 mM sodium phosphate pH 7.2, 50 mM Imidazole, 0.3 M 
sodium chloride) and sample collected as Wash (W). Finally, the 6x Histidine-tagged 
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protein was eluted with elution buffer with imidazole (50 mM sodium phosphate pH 7.2, 
0.3 M NaCl with 250 mM Imidazole) and the peaks collected for analysis.  
Protein expression analysis by Coomassie and Western blot 
Protein samples were resolved by reducing SDS–PAGE and analyzed using Coomassie 
blue staining and Western blotting. Protein was transferred to a PVDF-membrane (GE 
Healthcare, Buckinghamshire, UK) by wet-western-blotting, with electrophoresis for 1 h 
at 80 V, 300 A. The PVDF membrane was then immersed in blocking solution (2.5% 
(w/v) skimmed milk powder in 50 mL 1 × PBS-Tween20 (0.1%)) and incubated at 4 °C 
overnight. The following day, the membrane was washed 3 × for 5 min with 1 × PBS-
Tween20 (0.1%) before incubation with primary antibody (3.5 μL anti-6-His (Life 
Technologies, CA, USA) in 20 mL 1 × PBS-Tween20 (0.1%), 3% (w/v) BSA) for 1 h at 
room temperature. Membranes were then washed 3 × for 5 min with 1 × PBS-Tween20 
(0.1%) before incubation with secondary antibody (4 μL anti-Mouse HRP conjugate 
(Promega, WI, USA) in 20 mL 1 × PBS-Tween20 (0.1%)) for 1 h at room temperature. 
Finally, membranes were washed for 3 × for 5 min with 1 × PBS-Tween20 (0.1%). 
Immunoreactive bands were detected using an enhanced chemiluminescence (ECL) kit 
(BioRad, Herts, UK) following the manufacturer's instructions. Bands were visualised 
using BioRad Gel-doc chemiluminescence imager and associated software. Comparative 
densitometry of band-intensities was also carried out on a BioRad Gel-doc imager with 
an Image Lab™ Software 4.1. Periplasmic hGH was assayed using an hGH ELISA kit 
(Roche Diagnostics, Charles Ave, Burgess Hill, West Sussex RH15 9RY) and an hGH 
bioassay (PathHunter® Human Growth Hormone Bioassay Kit, Sigma) as per the 
manufacturer's protocol. Standardized OD10 periplasmic fractions were diluted 
1:500,000 using PBS and absorbance was read using a BMG Labtech Spectrostar 
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microplate reader at 405 nm, with a reference wavelength at 490 nm. Concentrations were 
calculated from two independent experiments and all samples measured in triplicate, and 
used to calculate average periplasmic yield (in mg/L) by factoring in culture OD readings 
at 600 nm. 
 
Intact Protein Electrospray LC-MS 
 
The electrospray mass spectrum was recorded on a Bruker micrOTOF-Q II mass 
spectrometer.  An aliquot of protein in solution, corresponding to approximately 20 
picomoles of protein, was desalted on-line by reverse-phase HPLC on a Phenomenex 
Jupiter C4 column (5 µm, 300Ǻ, 2.0 mm x 50 mm) running on an Agilent 1100 HPLC 
system at a flow rate of 0.2 ml/min using a short water, acetonitrile, 0.05% trifluoroacetic 
acid gradient.  The eluent was monitored at 280 nm and then directed into the electrospray 
source, operating in positive ion mode, at 4.5 kV and mass spectra recorded from 500-
3000 m/z.  Data was analysed and deconvoluted to give uncharged protein masses with 
Bruker’s Compass Data Analysis software. 
 
3.0 Results 
3.1 Fed-batch fermentation of WT and TatExpress cells expressing TorA-hGH 
 
We expressed a construct comprising the TorA signal peptide linked to hGH (TorA-hGH) 
in W3110 E. coli TatExpress cells under fed-batch fermentation conditions as detailed in 
Materials and Methods. The construct was previously used in shake flask studies 
(Browning et al., 2017) and comprises the signal peptide of E. coli TMAO reductase 
(TorA) linked to hGH via a 5-residue linker (the first 5 residues of mature TorA). The 
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construct also contain a C-terminal 6-His tag. Parallel cultures were carried out with the 
construct expressed in wild type (WT) cells. Figure 1 shows the growth curves from the 
cultures; duplicate WT and TatExpress cultures reached ODs of about 100 and the Figure 
shows the point at which induction of TorA-hGH and TatABC synthesis (in TatExpress) 
was induced using IPTG.  
 
Samples were removed 13, 17 and 21h after induction and the cells were fractionated to 
generate cytoplasmic, membrane and periplasmic samples. The periplasmic samples were 
analysed by immunoblotting to detect the hGH and the same samples were analysed using 
Coomassie stained SDS PAGE gels to analyse the total proteome of the periplasmic 
samples. Figure 2 shows the 13h and 21h samples from the two WT cultures, which 
indicate the presence of a clear hGH signal in the periplasm. The Coomassie-stained gel 
shows the presence of a 22 kDa protein, the relative abundance of which matches the 
strength of the blot signals. This was confirmed to be hGH (see below). 13h, 17h and 21h 
samples from the two TatExpress cultures were also analysed and the data show that the 
hGH blot signals are significantly higher than those of the WT cultures, confirming that 
TatExpress cells export this construct with much higher efficiency as observed by 
Browning et al. in shake flask culture (2017). The abundance of the 22 Da protein is 
correspondingly greater in the Coomassie stained gels, providing further evidence that 
this is indeed hGH.  
 
Figure 3 shows a time course analysis of the abundance of the periplasmic hGH after 
induction of synthesis in TatExpress cells. Samples were taken from 2 - 51 h after 
induction and the blot shows a steady increase in hGH level over this time period. Equal 
numbers of cells were used in each sample, so this reflects an increase in the amount of 
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hGH per cell. The Coomassie gel confirms that the abundant 22 kDa protein is indeed 
hGH, since its abundance increases in parallel and the protein is virtually absent in the 
absence of induction. Analysis of the later time points demonstrates that hGH is by far 
the most abundant periplasmic protein, which shows that Tat is exporting high amounts 
of protein.  
 
We have carried out controls for fractionation artefacts in previous studies, and the 
periplasmic proteome is clearly distinct from that of the cytoplasm, suggesting that 
contamination of cytoplasmic proteins is minimal. However, to confirm that hGH does 
not reach the periplasmic fraction 'spontaneously' we expressed hGH lacking any form of 
signal peptide. Mature hGH was expressed in parallel with Tor-hGH and samples were 
fractionated after 1h and 18 h induction (Figure 4). The immunoblot shows that the bulk 
of hGH is in the periplasm in the TorA-hGH culture, as expected, with a minimal level 
of protein present in the cytoplasm at the 18h point. In contrast, hGH is found exclusively 
in the cytoplasm in the sample expressing mature hGH, with none detected in the 
periplasmic fraction. These data confirm that the presence of hGH in the periplasm of the 
TorA-hGH cultures is due to Tat-dependent export and not contamination by cytoplasmic 
fraction or spontaneous transfer across the plasma membrane.  
 
It is notable that the total level of hGH in the culture producing mature hGH is far lower 
than that in the TorA-hGH culture. This reflects a phenomenon observed previously in 
our shake flask studies: that hGH is subjected to rapid turnover in the cytoplasm (Alanen 
et al., 2015).. 
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3.2 Tat-exported hGH is homogeneous and cleaved at the correct signal peptidase 
site 
 
To assess the homogeneity of the exported hGH we performed mass spectrometry 
analysis of the purified protein, using purified commercial hGH as a standard. The hGH 
construct used in this study should contain additional amino acids when compared to 
commercial hGH, specifically the 5 amino acid linker from the mature TorA protein 
(TMAO reductase) at the N-terminus, the initiation methionine (cleaved from hGH in 
vivo) and the 6-His tag at the C-terminus (Figure 5). The combined molecular weight of 
the additional amino acids is 609.7 for the N-terminal residues and 822.86 for the C-
terminal His tag (1432.56 in total). The predicted molecular weights are 22129.05 for the 
commercial hGH, and 23561.5 for the exported hGH. As shown in Figure 5, mass 
spectrometry analysis of commercial hGH gives a single prominent peak corresponding 
to 22124.3 Da, which matches almost exactly with the predicted molecular mass, having 
only a difference of 4.75 Da, 4 of which are a consequence of the formation of 2 
disulphide bonds. We purified the Tat-exported periplasmic hGH using affinity 
chromatography and an analysis of this protein again shows a single prominent peak, and 
the mass of 23555 Da is again very close to, but slightly smaller than the predicted mass 
of 23561 Da. The presence of 2 disulphide bonds again accounts for the difference. In 
both cases, the 1-2 Da deviation from the predicted protein masses is within the error 
range for the mass spectrometer. 
 
Other smaller peaks are observed in both samples, which appear to be an artefact of the 
hGH mass spectrometry since they are identical in the two samples. This would imply 
that the hGH produced in this study is (i) as homogeneous as the commercial protein (ii) 
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processed at the correct site, and (iii) fully disulphide bonded; there is no indication of a 
peak corresponding to the reduced form.  
 
3.3 High yields of active protein are obtained from fed-batch fermentation using 
TorA-hGH 
  
To quantify the yield of periplasmic hGH and to assess its activity, we used a 
commercially available hGH bioassay (PathHunter® Human Growth Hormone Bioassay 
Kit, Sigma). The bioassay uses engineered cells in which one fragment of β-galactosidase 
is present on the hGH receptor and the complementary fragment is present on a phosphor-
tyrosine SH2-domain-containing protein that is only able to bind the hGH receptor once 
it is activated. Binding of hGH to its receptor results in receptor phosphorylation by a 
cytosolic tyrosine kinase such as JAK1, enabling the SH2-EA fusion protein to bind the 
phosphorylated receptor and generate active β-galactosidase. Enzymatic activity is 
quantitatively measured using a chemiluminescent substrate, and the expected result is a 
dose-response sigmoidal function where the phosphorylation of the receptor will be 
dependent on the amount of hGH in the sample. A standard curve was produced with the 
supplied commercial hGH and all samples were done in triplicate and with dilution 
factors in the range of the standard curve (see Supplementary Figure 2). This assay gave 
a figure of 5.4 g purified hGH per litre of fed-batch culture (see Table 2). 
 
4.0  Discussion 
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The Tat system has been proposed to offer a viable alternative to the Sec pathway for the 
export of high-value proteins to the bacterial periplasm, but its potential for the production 
of biotherapeutic proteins has not been fully explored in previous studies. This is 
primarily because the vast majority of those studies were carried out using laboratory 
shake flask culture systems, whereas industrial processes almost invariably use fed-batch 
fermentation. Here, we have used fed-batch fermentation systems to test the robustness 
of the TatExpress cells and the yields of hGH that are obtained after export to the 
periplasm.  
 
It was important to assess the TatExpress strains in fermentation systems because they 
rely on the simultaneous expression of the target protein (in this case TorA-hGH) and 3 
different membrane proteins (TatABC). While the TatABC proteins are expressed to a 
much lower extent than TorA-hGH, the increased expression of any membrane protein 
can potentially lead to cell stress and lowered productivity in extended fed-batch 
fermentation systems. Here, we directly compared the growth characteristics of the 
TatExpress strain with its parental W3110 strain and we observed no significant 
differences. Clearly, TatExpress strains are viable production hosts. 
 
In terms of target protein yield, we consistently observe that the cells export TorA-hGH 
throughout an extended induction period and it is notable that the exported hGH is by far 
the most abundant periplasmic protein by the end of the induction period. In control tests, 
mature-size hGH is not exported at all and we can conclude that TorA-hGH is being 
exported by the TorA signal peptide system as reported in shake-flask studies (Alanen et 
al., 2015). The yields of protein are high: the bioassay indicates a yield of over 5 g/L 
active purified protein.  
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In summary, we have shown that a model biotherapeutic protein can be exported by the 
Tat system in high amounts, and that it is homogeneous, disulphide-bonded and active. It 
will be of interest to conduct further studies to assess the full capability of the Tat system, 
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Table I. Strains and plasmids used in this work. 
 
Strains/Plasmids Description Source/Reference 
W3110 E. coli K-12 strain. F- λ- IN(rrnD-rrnE)1 rph-1 
  
(Hayashi et al., 
2006) 
TatExpress W3110 Km   W3110 carrying a kanamycin resistance cassette and 
the ptac promoter upstream of tatABCD 
This work 
pKRK7 pEXT22 expressing TorA-hGH-6His This work 
pKRK36 pEXT22 expressing hGH-6His This work 






             Assay       Purified (g/L) Periplasmic extract (g/L) 
hGH Bioassay 5.4 10.01 
 
Table 2: Concentration of hGH in the periplasmic sample and after purification. Table 
showing concentration of hGH present in the fermenter calculated from the purified fraction and 
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Figure 1 Growth data during fed-batch fermentation of E. coli W3110 WT and 
TatExpress cells expressing TorA-hGH. Duplicate cultures of WT cells (WT1, WT2) 
and TatExpress (TE1, TE2) were analysed, with OD600 nm values shown. Fermentation 
was carried out at 30°C as detailed in Materials and Methods. At the indicated times, the 
cultures were induced with IPTG (0.1 mM) and samples were removed for analysis. 
Induction
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Figure 2. Tat-dependent export of TorA-hGH in W3110 wild type and TatExpress 
W3110 cells. Samples from duplicate fed-batch fermentation cultures of WT and 
TatExpress expressing TorA-hGH were removed at the indicated times post induction 
and fractionated to yield periplasmic samples. The periplasmic samples were analysed by 
Coomassie blue stained gels (A) and immunoblotting using antibodies to the His tag on 
hGH (B). For each lane a normalized amount of protein has been loaded, equivalent to 
OD600 0.08 AU total cells (Coomassie blue stained gels), and OD600 0.008 AU 
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Figure 3. High-level export of TorA-hGH during extended fed-batch fermentation 
of TatExpress cells. TorA-hGH was expressed in TatExpress cells in a fed-batch 
fermentation system and samples were removed at the indicated times post induction. The 
samples were fractionated to generate periplasm samples which were then analysed on 
Coomassie blue stained gels (A) and by immunoblotting using antibodies to the His tag 
on hGH (B). 
 
Figure 4. Mature hGH is not exported during fed-batch fermentation of TatExpress. 
Mature-size hGH and TorA-hGH were expressed in TatExpress cells using fed-batch 
fermentation systems. Samples were removed 1 h and 18 h post induction and fractionated 












2.3 Escherichia coli ‘TatExpress’ strains export over 5g/L human growth hormone to the 
periplasm by the Tat pathway 
 
 130 
to generate cytoplasm, membrane and periplasm samples (C, M, P) which were then 
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Figure 5:  Exported periplasmic hGH is homogeneous and cleaved at the correct 
site. Periplasmic hGH was purified by affinity chromatography (see Supplementary 
Figure 1) and subjected to mass spectrometry analysis as detailed in Materials and 
Methods. Commercial hGH was analysed in an identical manner. The mass spectra for 
commercial hGH is shown in panel A and for periplasmic hGH in B. C: amino acid 
sequence of TorA-hGH-H6. The sequence for the TorA signal peptide (TMAO reductase) 
can be seen in blue, along with the first five amino acids of the mature TMAO protein 
and the initial methionine for the hGH protein (yellow). The sequence for the commercial 
hGH is underlined and the 6 histidine for the His-tag are in bold. The cleavage site 
between ATA and AQA is indicated with a . The sequence for the commercial hGH is 
underlined, and this is followed by the 6-histidine tag.  
 
 
Supplementary Figure 1. Purification of periplasmic hGH. Purification of hGH from 
periplasmic sample of fed-batch fermentation after 51 hours post induction via Nickel 
affinity column. Coomassie showing periplasmic released with lysozyme (PL), 
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periplasmic release with lysozyme free method (PP), flow through after purification (FT) 
and purified hGH (Pure). Molecular weight markers are shown on the left (in kDa) and 
mature hGH height is indicated on the right.  
 
Supplementary Figure 2. Quantification of hGH concentration using the PathFinder 
bioassay. An hGH concentration standard curve was constructed using the supplied 
commercial hGH and all samples were analysed in triplicate using dilution factors in the 
range of the standard curve. The standard curve was adjusted using numpy, 
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3. General Discussion 
3.1 Far-reaching consequences of tat deletion in Escherichia coli 
revealed by comprehensive proteome analyses.  
3.1.1 Context 
The applications of the Tat pathway in E. coli as a tool to facilitate downstream processes 
for complex proteins in an industrial setting has gained interest in recent years since the 
discovery of this pathway in the 1990s (Mould & Robinson 1991; Sargent et al. 1998), 
however our understanding of the importance of this pathway is still vague. The lack of 
a functioning pathway causes significant growth defects, particularly due to the 
mislocalization of Tat-dependant AmiA and AmiC, which are involved in the splitting 
the murein septa and the separation of cells (Bernhardt & de Boer 2003) (Ize et al. 2003). 
This mislocalization provokes the formation of long chains of cells that are unable to 
complete the separation from one another (Stanley et al. 2001). Other phenotypes 
associated with the loss of the Tat pathway function are problems with copper 
detoxification and iron acquisition (Ize et al. 2004), however this study was done only 
with a ΔtatC mutant, not a ΔtatABCDE mutant, meaning that different phenotypes could 
apply to the total elimination of the pathway. Finally, the role of the Tat pathway in 
bacterial pathogenesis is under investigation (Ball et al. 2016) (Pradel et al. 2003) 
(Ochsner et al. 2002), and learning more about it could help to modify and develop this 
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3.1.2 Discussion of work presented 
In this study, we have sought to ascertain at a comprehensive level how E. coli responds 
to a defect in the Tat protein export pathway. The deletion mutant ΔtatABCDE was used 
to determine the E. coli phenotype and proteome alterations under disruption of the Tat 
pathway. To do so the samples were fractionated into cytoplasmic, periplasmic and 
membrane fractions before analysis to determine changes not only in protein regulation 
but in localization as well.  
 
The first problem we encountered was the abundance of impurities of cytoplasmic 
proteins in the periplasmic and membrane fractions due to both the limitation of the 
fractionation methods (Brown et al. 2010; Wolff et al. 2008) and the impairment of the 
Δtat membrane (Stanley et al. 2001). We calculated the relative the abundance of protein 
impurities in all fractions based on signal intensity. Due to the high percentage of 
cytoplasmic proteins in the periplasmic and membrane fractions of the E. coli 
ΔtatABCED, but not in the control strain we concluded that the complete deletion of the 
Tat system leads to the disruption of the inner membrane and cytoplasmic protein leakage 
during fractionation.  
 
As stated before, the most notable phenotype of Δtat is the formation of filamentous, 
chain like structures where the cells have not been able to separate. During this study, we 
observed two novel phenotypes by examining transmission electron micrographs of the 
cells. The first was the formation of outer membrane vesicles (OMV), mostly 
predominant in cells that had failed to divide and likely due as a stress response to the 
cell envelope defect. The second phenotype was the moderate increase in inclusion body 
formation in comparison with the wild type. Although these features are interesting, since 
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the focus of the paper was the proteomic data this information was taken as a guideline 
to look more closely at the modifications in wall membrane regulation, which is why no 
statistical analysis of how common these features appeared in the sample was done. 
Although the low number of selected images do not truly reflect if the OMVs and IBs are 
a definitive feature, the fact that they are not present in the WT samples makes it likely 
that they are indirectly or directly caused by the deletion of tat. 
 
By revising the proteomic data, we found that GroEL and DnaK, the main drivers of 
protein folding (Thomas & Francois Baneyx 1996), and IbpA and ClpB, identified as 
cytoplasmic components of E. coli IBs (Carrió & Villaverde 2002) were found to be more 
abundant in the membrane fraction of Δtat. We also found ZipA, an essential protein that 
forms the septal ring structure that mediates cell division (Hale & de Boer 1997), 
mislocalized to the membrane fraction in Δtat cells. Since none of these proteins are tat 
dependant their mislocalization and regulation is most likely a consequence of the 
membrane defect phenotype.  
 
We then examined the tat substrates themselves. Of 27 reported proteins exported through 
the tat pathway and 8 additional hitchhiker proteins the data only showed 8 tat substrates 
and 3 hitchhikers. This low number of hits is due to the growth conditions used for this 
study, since the other Tat-dependant proteins have been found to be expressed under 
anaerobiosis (Hussain et al. 1994; Méjean et al. 1994; Jack et al. 2001), presence of 
cinnamaldehyde (Neumann et al. 2009) or hydroxyurea (Davies et al. 2009), or to be 
inhibited by other proteins present (Constantinidou et al. 2006). For the identified Tat 
substrates, we could distinguish 3 different localization and expression profiles. The first 
4 proteins, HybA, EfeB, AmiA and AmiC, were found only in the periplasm of the WT 
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but not in the Δtat strain, strongly suggestion that they are exported exclusively by tat. Of 
these 4 proteins 2 of them, AmiA and AmiC were also found to be accumulated in the 
membrane fraction of both WT and the Δtat mutant, which may be due to association 
with the membrane before export. The next 2 proteins, CueO and NapA, were found in 
the periplasm of both WT and the Δtat mutant, however the relative quantity of protein 
was very low, suggesting that these traces of protein are artefacts of the fractionation 
process previously discussed. The next localization group consists of another 2 proteins, 
FdnG and DmsA, that are not present in the periplasmic fraction in either strain due to 
their tight association with inner membrane proteins. This association makes it likely that 
during the fractionation process these proteins were not separated with the rest of the 
periplasmic proteins. Finally, the last group are the before mentioned hitchhiker proteins: 
DmsB, HyaB and HybC. Unfortunately, none of them were found in the periplasm of 
either strain, so we rationalized that this was due to the lack of the proteins with which 
they form the multimeric complexes before export.  
 
After analysing the destiny of the available Tat-substrates we turned our attention to other 
noticeable changes in the proteome linked to the loss of Tat export. A set of 98 proteins 
related to stress response were identified as having significant variation and were separate 
according to their functional group and represented in the heat map in Fig 3. We 
highlighted the activation of different chaperones and proteases in the periplasm involved 
in protein folding and degradation and other general cellular stress responses related to 
oxidative, detoxification, osmotic and heat stress. We also encountered changes in 
proteins involved in cell division and in cell wall, iron and molybdenum homeostasis. 
Overall, we obtained a thorough view of the different regulation patterns occurring in the 
cells when faced with the lack a functioning Tat system.   
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Finally, the last major change we observed was the presence of many of the proteins from 
the cps operon in ΔtatABCDE under aerobic conditions. The proteins from the cps genes 
found were those responsible for the production of colanic acid, an exopolysaccharide 
necessary for the formation of biofilms (Danese et al. 2000). To test if the presence of 
these proteins corresponded with production of colanic acid an assay was performed to 
determine the quantity of L-fucose, a specific component in colanic acid (Stevenson et 
al. 1996). In Figure 4C we can see that there is an increased amount in the Δtat strain in 
comparison with the WT. An additional assay to determine the ability of the cells to 
adhere to plastic surface to test for biofilm development was performed in both LB and 
minimal media since it has been reported that biofilm formation in E. coli can be observed 
mostly in minimal media (Naves et al. 2008). We found that that there was enhanced 
biofilm formation in E. coli Δtat, especially after 48 h in both media, although previous 
studies have reported a decrease in biofilm formation of the ΔtatC mutant (Ize et al. 2004).  
 
In conclusion, we have identified novel phenotypes for this mutant such as the production 
of OMVs, increased inclusion body formation and colanic acid production which 
contributes to biofilm formation. We have also presented a global view of the 
consequences of a tatABCDE deletion through a comprehensive analysis of the proteome 
changes. This analysis has revealed the upregulation of proteins involved in protein 
folding, degradation and response to heat, oxidation, osmolarity and cold, as well as the 
induction of proteins responsible for cell wall biogenesis and the negative effect on the 
synthesis of iron and molybdenum transporters.  
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3.1.3 Future prospects 
The major obstacle we encountered when analysing the data was distinguishing the 
effects of the ΔtatABCDE from the effects of the membrane defect, as the most notable 
stress responses seemed to be a consequence of the lack of cell separation. The cell chain 
phenotype has been successfully reversed by overexpression of AmiB (Ize et al. 2003). 
To repeat a similar study with this variation would provide insight as to which of the 
observed changes are related to the lack of Tat system and which are a stress response to 
not being able to correctly divide. It would also be of great interest to repeat this study 
under the specific conditions needed for the expression of the other Tat substrates, such 
as anaerobiosis or the presence of cinnamaldehyde or hydroxyurea, to examine what the 
effects of the mislocalization of those substrates has on the cells.  
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3.2 Comparative proteome analysis in an Escherichia coli CyDisCo 
strain identifies stress responses related to protein production oxidative 
stress and accumulation of misfolded protein. 
3.2.1 Context 
In this study, we sought to understand the physiological changes that result from the 
expression of a recombinant protein in both its correctly folded state and in a deliberately 
misfolded state using an E. coli CyDisCo platform. The expression of heterologous 
proteins in E. coli often results in protein misfolding and aggregation because the cell is 
not able to sustain non-physiological rates of expression. For its industrial application, 
the production process must be optimized to achieve high protein yields. Thus, under 
protein production process conditions it is important to identify stress parameters to 
circumvent and improve the process efficiency. For this reason, we were interested in 
characterizing the changes that occur during the expression of a misfolded Tat substrate, 
in order to understand whether additional responses occur. The substrate used was an 
scFv antibody construct that is efficiently exported by Tat while the 'misfolded' variant 
contains a 26-residue C-terminal extension that blocks export by Tat (Jones et al. 2016). 
Both proteins were synthesised with an N-terminal TorA signal peptide that directs export 
by Tat. For our study, we used a comprehensive proteomic approach to monitor the 
changes in cell physiology and proteome caused by recombinant protein secretion, 
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3.2.2 Discussion of work presented 
This study examined the differences between cells that were exporting a correctly folded 
protein (scFv) through the Tat pathway and cells producing a mutant of that protein 
incapable of transport (Jones et al. 2016). After 3h post induction we see that the bulk of 
the correctly folded scFv is transported to the periplasm, but a fraction of the uncleaved 
protein is found in the insoluble body fraction, whereas the misfolded scFv does not 
export to the periplasm and is entirely found in the insoluble body fraction. This is also 
supported by the transmission electron micrographs showing that IBs are formed in the 
cells expressing the unfolded protein in Figure 2. This difference in protein localization 
must be putting additional strain on the system and the objective of this project was to 
identify this stress response.  
 
The first indication of stress observable from the cells was the metabolic burden caused 
by the expression of recombinant protein and the maintenance of the plasmid (Bentley et 
al. 1990). Under the same growth conditions cells reached the stationary plateau at 
different ODs depending on if they were carrying a plasmid or not and if this plasmid was 
induced and was producing a protein of interest or not. Although the doubling times for 
all strains were similar we showed that cells with no plasmid had the reached the highest 
OD before the stationary phase, followed by those with uninduced plasmids. Of the 
induced cells, the one carrying a plasmid with no protein of interest reached a slightly 
higher OD than the other two carrying scFv and misfolded scFv. In the case of the cells 
producing the correctly folded scFv, this additional growth stress is most likely due to the 
recombinant protein synthesis and its export to the periplasm of the protein: although Tat 
transport does not consume ATP it uses the proton motive force to export the proteins to 
the periplasm (Natale et al. 2008), causing an energetic and resource deficit in comparison 
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to the control. In case of the misfolded scFv, the resources are diverted to the synthesis 
of a recombinant protein in a large quantity, which unlike the correctly folded scFv, is 
not secreted to the periplasm but deposited in inclusion bodies (visible in Fig. 2C).  
 
To examine the stress responses of the cells we did a comprehensive proteome analysis 
on induced cells carrying a plasmid with the scFv, another with the misfolded scFv and a 
control plasmid that had no protein of interest. The changes to the amount of proteins 
were visualized using a Voronoi treemap where the proteins were clustered by their 
functional category so that the functionally related proteins were placed together for 
easier interpretation. The first conclusion is that expression of misfolded protein results 
in downregulation of many proteins involved in general metabolism and membrane 
transport. In addition, both strains expressing correctly folded scFv and misfolded showed 
a high number of significant changes mostly in proteins associated with protein folding 
and degradation, oxidative stress, membrane transport and integrity.  
 
The first set of data we will look into is the stress response affecting transcription factors 
and DNA replication. The proteomic analysis revealed that there was an increase in the 
levels of different sigma factors in the cells producing misfolded and folded scFv. This 
observation confirms that these cells are compensating for the additional production of 
the protein of interest by increasing the capacity of the cells to handle the metabolic 
burden. We also observed an upregulation of many proteins involved in DNA replication 
occurring only in the cells producing the correctly folded TorA-scFv. For example, a 
protein as essential in DNA replication as PolA (DNA polymerase I) were found to be 
upregulated in scFv producing strain whereas the cells expressing mf_scFv showed no 
change. The upregulation of proteins involved in DNA replication only in cells producing 
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the folded protein suggests that, even though according to the growth curve all three 
conditions seem to either have reached (scFv and mf_scFv) or be entering (control) the 
stationary phase, the strain producing folded scFv is maintaining expression of proteins 
involved in DNA replication, repair and recombination (Meyer & Laine 1990). Finally, 
RlmJ, a protein involved in the catabolism of external DNA (Finkel & Kolter 2001) that 
has also been identified to repress cell-to-cell plasmid transfer (Matsuda et al. 2012), was 
upregulated in both strains producing folded and misfolded protein. Notably, the 
abundance of RlmJ is lower in the cells producing misfolded scFv, meaning that even 
though the misfolded protein stress seems to be partially responsible for the observed 
upregulation, this effect is greater with the production and transport of a folded protein to 
the periplasm. 
 
The next data set involves changes in proteins involved in folding and the degradation 
process. We observed the upregulation of the chaperone systems DnaK-DnaJ-GrpE and 
GroEL-GroES, which can recognize unfolded proteins, refold or direct them to the 
cellular protein degradation machinery (Ziemienowicz et al. 1993). The highest 
abundance of these proteins was observed in the membrane fraction containing IBs, and 
the upregulation of GroES-GroEL and DnaK was notably increased in the strain 
expressing misfolded scFv. This observation correlates with our previous results and 
confirms the aggregation of moderate amounts of scFv in the cytoplasm and the high-
level accumulation of misfolded scFv in IBs. The inclusion body formation in the 
CyDisCo scFv and misfolded strains was also confirmed by the presence of IbpA 
(Matuszewska et al. 2005), a heat shock protein with a strong ability to associate to 
protein aggregates, that was not identified in the empty plasmid control strain, in which 
we did not find any traces of IBs. Additionally, several other chaperones were found to 
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be highly abundant in the scFv and mf_scFv expressing strains. The accumulation of 
protein aggregates in the cytoplasm of E. coli CyDisCo is followed by activation of 
protein degradation machineries. We observed the upregulation of the ATPase 
components ClpA and ClpX of the Clp protease, Lon and HslV/U, together with 
periplasmic proteases DegP/Q. All these proteins are responsible for recognition, 
resolubilization and degradation of unfolded protein (Hoskins et al. 2000; Gottesman et 
al. 1998; Gao & O’Brian 2007). The highest difference between the abundance of scFv 
and mf_scFv expressing strains and the control was identified for periplasmic DegP and 
DegQ proteases. This suggests that in both conditions, scFv secretion to the periplasm 
and misfolded scFv aggregation in the cytoplasm, the cell envelope is exposed to 
unfavourable and harmful changes. The high upregulation of periplasmic proteases in the 
strain expressing misfolded scFv is particularly interesting and could indicate that some 
of the protein is in fact successfully exported to the periplasm, rather than being blocked 
by the Tat proofreading machinery. However, a previous study showed no evidence for 
transport of this misfolded substrate to the periplasm and it is more likely that the cell 
either senses the production of precursor protein and upregulates expression, or the 
proteases are upregulated as part of a general stress response. 
 
Another point of interest we wanted to explore was the oxidative stress and redox 
regulation in the cytoplasm as a consequence of disulphide bonds being formed thanks to 
the CyDisCo components. Since the oxidative state of the cytoplasm does not occur 
naturally, we expected that this will provoke an oxidative stress response and changes in 
the abundance of redox proteins. Indeed, the proteomic analysis revealed the upregulation 
of several proteins related to oxidative stress response. Among these, major thiol-
disulfide oxidoreductases: thioredoxin TrxA, glutaredoxin GrxA, together with thiol-
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specific peroxidase Bcp, were upregulated in strains expressing protein. The upregulation 
of oxidoreductases was significantly higher in the strain producing misfolded scFv, 
probably due to the increased protein accumulation in IBs. In the cytoplasm of E. coli, 
thioredoxin and glutathione/glutaredoxin systems are required for the reduction of 
proteins that become oxidized, and thus they maintain the redox homeostasis (Prinz et al. 
1997). However, during severe oxidative stress both systems can be overwhelmed, or 
their protein function can shift from reductase to oxidase, leaving cytosolic proteins 
susceptible to oxidation. It has been shown that thioredoxins and glutaredoxins can act as 
oxidases when exported to the oxidizing periplasm (Debarbieux & Beckwith 1998; Eser 
et al. 2009) and both, TrxA and TrxC, shift their function to oxidases in a trxB mutant 
(Stewart et al. 1998). A related point to consider is the fact that in the periplasm of E. coli, 
which is an oxidizing environment, other thioredoxin-related proteins such as DsbA, B, 
C, D, G catalyze the disulfide-bond formation and rearrangement. Thus, it appears that 
the function of thioredoxins and glutaredoxins is influenced by the redox potential of the 
cellular environment and in an oxidized cytoplasm of E. coli CyDisCo they will promote 
disulfide bond formation, rather than their reduction. In conclusion, the production of 
disulfide bond-containing scFv in CyDisCo increases the abundance of cellular redox 
proteins in the cytoplasm.  
 
Finally, we also observed interesting changes occurring to membrane transporter 
proteins. The amount of Sec system components showed an increase abundance in strains 
producing recombinant protein. The upregulation of Sec machinery is likely an effect of 
elevated oxidative stress in the periplasm and changes in the cell envelope to which the 
cell is responding by secretion of cytoprotective stress proteins. Proteins involved in other 
transport systems were found in lowered amounts in both secreting strains: YidC, 
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involved in inserting proteins in the membrane, and ABC transporter proteins responsible 
for the utilization of di- and tripeptides as well as substrate-binding proteins (SBPs) of 
the main E. coli peptide transporters. Moreover, some essential components of other 
transport systems such as maltose (MalE/M/T/Y), glutathione (GsiB), Tol-Pal (TolB, 
CpoB) and lipid (Blc), or osmoregulated- periplasmic glucan (OPG) biosynthesis 
pathway (MdoB) were also downregulated. One feature that these downregulated proteins 
have in common is their role in membrane protein synthesis and membrane maintenance 
under stress conditions. This suggests that the scFv expression in the E. coli CyDisCo 
causes membrane impairment through a decrease in number of membrane transporters. 
Generally, it is plausible that downregulation of so many transporter proteins involved in 
metabolite uptake is a consequence of previously mentioned metabolic burden that occurs 
in cells expressing scFv and misfolded scFv. Lastly and most surprising we observed 
moderately lower levels of TatA and TatB as well as higher level of TatE in the strains 
expressing scFv and misfolded scFv. To follow up on this data we performed an RE-
qPCR experiment on cells grown under the same conditions, taking additional samples 
both pre-induction and immediately, 30 min and 3h post-induction to assess the evolution 
of the changes in the cells. We found that induction has an immediate impact on 
expression level of tatA when expressing an exportable Tat substrate. After induction, a 
significant decrease of transcription levels of tatA and tatB genes, which matches with 
the proteomic data obtained. The decrease of expression of these proteins may be due to 
a negative feedback loop responsible for assuring that export remains low to avoid 
toxicity in the periplasm since many of the Tat substrates are involved in cell division, 
biofilm formation and pathogenicity (Lee et al. 2006).  
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Our proteome studies revealed significantly higher (5.71 log2 FC) abundance of antigen 
43 (Ag43) in the strain expressing a misfolded scFv. Ag43 is an outer membrane protein 
that confers bacterial cell-to-cell aggregation (Diderichsen 1980). To verify if Ag43 
upregulation promotes the cell aggregation in our strain, we first performed phase-
contrast microscopy (Fig. 6 A1-3). Additionally, since the cell aggregation leads to 
enhanced sedimentation, we applied a simple sedimentation assay (Fig. 6 B) and 
calculated the aggregation rate in all CyDisCo strains (Fig. 6 C). Indeed, a comparison of 
the aggregation and sedimentation rate of these strains confirmed that the E. coli 
expressing misfolded scFv shows enhanced sedimentation and aggregation. We propose 
that the increase in the abundance of Ag43 is related to the lowered abundance of the 
transcription factor OxyR, which is a suppressor of antigen 43 expression (Ulett et al. 
2007). OxyR transcription factor is activated through the formation of a disulfide bond 
and is deactivated by enzymatic reduction with glutaredoxin 1, GrxA (Zheng et al. 1998). 
We observed a decrease in the abundance of OxyR in the misfolded (-0.67 log2 FC) and 
its upregulation in scFv expressing strain. These results could only be observed after the 
induction of the scFv expression, thus we assume that the accumulation of misfolded scFv 
leads to the Ag43-mediated cell clustering.  
 
In conclusion, E. coli CyDisCo strain enables folding of disulfide bond-containing scFv 
in the cytoplasm and its secretion in high amounts to the periplasm via the Tat system. 
The expression of an unfolded scFv led to protein aggregation and inclusion body 
formation. Decreased cell growth, low abundance of proteins involved in DNA 
replication and sigma 70 factor in E. coli expressing a misfolded scFv when compared to 
a folded scFv suggest that the unfolded protein stress accelerates cell transition to a 
stationary phase. We confirmed that the recombinant protein overexpression triggers the 
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upregulation of proteins involved in removing the aggregates, such as chaperones and 
proteases. The high abundance of GroEL-GroES, DnaK and ClpB in the insoluble 
fraction of E. coli expressing misfolded protein suggests their association with protein 
aggregates. We also observed that the formation of disulfide bonds in the cytoplasm of 
E. coli CyDisCo initiates the oxidative stress response and increases the abundance of 
redox regulation system proteins. This upregulation of thioredoxins and glutaredoxins 
was higher in the strain accumulating the misfolded oxidized scFv in the cytoplasm. 
Nevertheless, the redox protein ability to reduce oxidized proteins seems to be 
compromised by the oxidative environment of the cytoplasm. We also observed an 
extreme downregulation of membrane transporters which could be related to a major 
decrease in the abundance of YidC transport system, responsible for protein folding and 
insertion into the membrane. Surprisingly, a high rate of Tat-dependent secretion caused 
an increase in tatA expression only just after induction of synthesis. The following post 
induction analysis revealed lower tatA and tatB expression levels, which correlate with 
lower TatA and TatB protein abundance. Finally, the most distinct unfolded protein stress 
response we observed was the cell aggregation caused by the elevated levels of antigen 
43. Interestingly, to the best of our knowledge, this phenomenon has not been reported 
yet as a consequence of misfolded protein expression, which makes it an interesting topic 
for further investigation. 
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3.2.3 Future prospects 
The study identified characteristic changes occurring as a result of the production of both 
a folded and a misfolded protein, but also highlights an exclusive unfolded stress 
response. Countering and compensating for these changes may result in higher yields of 
pharmaceutically relevant proteins exported to the periplasm, however we acknowledge 
that to gain further insight into this topic further research must be done. It would be 
interesting to determine the structure of the misfolded scFv to see how much the 
additional 26 amino acid tail is disrupting the protein, however, many attempts have been 
made in the lab and due to its low stability, it has proved difficult to purify. It would also 
be interesting to observe how these changes occur over time by repeating these 
experiments with various time-points, both pre- and post-induction, as was done with the 
qRT-PCR experiment. A study of these characteristics was begun, using hGH and a 
misfolded variant of hGH as the protein of interest, but the analysis of the data generated 
was not complete by the time of writing. Finally, as mentioned before we see an 
upregulation of TatE and a downregulation of TatA when expressing proteins with a Tat 
signal peptide. TatA and TatE share 53% homology and have overlapping functions. It 
has been shown that individual deletions of TatA and TatE are still functional, however 
the double deletion blocks export to the periplasm via the Tat pathway (Sargent et al. 
1998) (Baglieri et al. 2012). This preference for the use of either TatA or TatE is 
understudied and may be due to the additional stress conditions of the study or for a 
determined preference for the TorA signal peptide employed. To follow up on this 
observation we could more closely monitor the abundances of the Tat components at 
different time-points, under the expression of different proteins and with the use of 
different signal peptides to establish a pattern.  
 
  149 
3.3 Escherichia coli ‘TatExpress’ strains export over 5g/L human 
growth hormone to the periplasm by the Tat pathway. 
3.3.1 Context 
In the previous segments, we have studied the response of the cells to a lack of Tat system 
(3.1) and to the use of said system for the export of a correctly folded and incorrectly 
folded protein (3.2) in order to better understand how the Tat system interacts with the 
rest of the cellular components. One of the findings from these studies was the 
downregulation both on a proteomic and transcriptomic level of TatA and TatB when a 
protein with a Tat specific signal peptide was induced. To compensate for this shift in the 
amount of TatA and TatB available and better exploit this pathway for commercial use 
we studied a new strain developed in collaboration with the university of Birmingham: 
TatExpress. The TatExpress strain has a pTac promoter introduced before the original 
promoter of the TatABCD operon (Browning et al. 2017), thus allowing for constitutive 
levels of Tat to be expressed until the moment of induction in which both the protein of 
interest and the Tat components will be overexpressed. In this chapter, we studied the 
robustness of TatExpress for the production and export of protein to the periplasm both 
at shake flask level as well as its up-scalability for use in a bioprocessing plant. The 
protein chosen to conduct this export study was hGH; a biopharmaceutical with great 
commercial worth and that has shown to give good export through the Tat pathway. Some 
of the experiments for the up-scale studies took place during a secondment to UCB’s 
upstream and downstream processing department using 2L Sartorious bioreactors, while 
the rest of the study was carried out in house on 1.5L Minifors 2 bioreactors.  
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3.3.2 Discussion on work presented and future prospects 
We have previously highlighted the advantages of using E. coli for protein production, 
from the ease of genetic manipulation to the affordable and fast growth profile that make 
this organism and ideal platform for making biopharmaceuticals. In this chapter, we have 
shown that the new TatExpress strain created in collaboration with the University of 
Birmingham is a versatile and robust strain that can greatly increase the amount of protein 
exported to the periplasm. Not only is this strain capable of surviving fermentative growth 
during up-scale to high ODs, it also continues producing and exporting protein to the 
periplasm for a prolonged time. This protein is easily purified from the periplasm and 
quantitative and activity assays suggest that the yields are comparable to industrial 
production in other platforms.  
 
Initial steps towards the study of high yielding protein production in a non-industrial 
setting have been made. The optimization of the fermentation facility and of the protocols 
used are an important contribution towards the study of “up-scale” and will allow us to 
further contribute to the improvement of E. coli strains for the production of 
biopharmaceuticals. However, these are just the first stepping stones and there are several 
challenges that still need to be addressed before being able to move on to larger up-scale 
projects. Currently we were only able to optimize the fed-batch fermentation protocol for 
use of the W3110 TatExpress cells, however attempts to use BL21 TatExpress cells under 
the same conditions for up-scale have not been successful. Further modifications of the 
growth conditions need to be made before this strain may be used for fermentation.  
 
Although there are studies about fermentative stress of different organisms using a 
proteomic approach (Helmel et al. 2014), little is recorded about fermentation stress in E. 
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coli (Kim et al. 2005). These studies pose a special difficulty due to the heterogeneity of 
the cells inside the bioreactor: though much effort is put into homogeneous stirring 
occurring the general shape and size of the vessel create isolated zones with specific 
conditions, from low oxygen spaces where cells enter micro-anaerobiosis to film 
formation around the probes or accessible tubing. These difference in cell clusters would 
make difficult any proteomic study since it would be easy for any cross contamination to 
occur within the own sample. However, a proteomic study similar to what we have seen 
in sections 3.1 and 3.2 would provide great insight into the fermentation process and may 
signal new stress response routes different from those already studied. The integration of 
this knowledge to reduce the stress in the cells by creating knockouts or overproduce 
determined proteins that would allow faster growth or better export would be an 
interesting and important contribution for industry. 
 
Finally, there are still many more Tat specific proteins both from E. coli and from other 
organisms, whose signal peptide may be a better choice for protein export. However, for 
high-throughput screening the 1.5 L bioreactors pose a serious limitation, both on time 
and resources since each run is long and labour intensive. For this reason, alternative 
bioreactors should be considered. Although the cost of each run would be higher than that 
of the Infors bioreactors, the Ambr250 system allows for many more experiments to take 
place in parallel under the same conditions and would prove a time efficient way of 
selecting the best signal peptides for further upscale. The need to study different 
combinations of signal peptide is caused by limitations of the Tat transport proofreading 
mechanism itself. Although we see high yields of hGH and ScFv in the earlier chapters 
of this work, other proteins of interest tested at shake flask level did not give us similar 
results. Grown in the same conditions as those used for generating Fig 7, we tried 
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expressing a list of POI obtained through different collaborations with other laboratories 
or industry. The list of proteins can be found in annex 2. Of all the TorA-POI-His Tag 
constructs tried, the only one that was able to successfully translocate to the periplasm 
was WxL1, a surface cell wall-binding domain. This poses a unique challenge since 
although TatExpress has proved to be an excellent platform for protein production, the 
selectivity with which proteins are transported makes it difficult to design a system in 
which one POI can easily be interchanged with another.  
 
In summary, the new bioreactors provide multiple opportunities for the better study of E. 
coli fed-batch fermentation and allows us to simulate industrial conditions in a lab setting. 
Although initial breakthroughs have been made during this study there are still many 
angles that need to be explored before a comprehensive understanding of high yielding 
protein production is obtained.  
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4 Concluding remarks 
 
The aim of this project was to investigate the Twin Arginine Translocation Pathway in 
depth and determine if it is a suitable platform for biopharmaceutical production. 
Currently most industrial processes for protein production in E. coli is harvested from 
inclusion bodies by breaking both the inner and outer membrane, and then solubilizing 
the inclusion bodies and submitting the proteins to refolding, which makes this method 
not ideal for complex biopharmaceuticals. Although alternative host systems for these 
complex biopharmaceuticals are already available, they are excessively time consuming 
and expensive, as well as easily contaminated. For this reason, a bacterial system capable 
of replicating the essential post-translational modifications necessary for activity and also 
able to ease downstream processing by exporting the product to the periplasm where it 
can be easily obtained would be a welcome contribution to the current industrial market.  
 
The focus of this project was therefor to investigate the Tat Pathway and its relationship 
with protein export and with the stress response this generates. Two proteomic studies 
took place to observe the changes occurring in the proteome when the Tat pathway is 
lacking and when it is being used to produce a protein of interest, even if said protein of 
interest activates the proof-reading mechanism and is rejected. These studies provided 
insight into the different defense mechanisms and stress responses that were occurring in 
the cells under said conditions and with this knowledge new strains can be designed to 
compensate for the additional stress the cells are subject to. A scale-up study was 
performed and not only showed that obtaining correctly folded, disulfide bonded and 
active protein from the periplasm can be achieved, but it helped to set up a protocol for 
in lab fermentation at the University of Kent. Taking together the obtained results it will 
now be easier to design new strains capable of better export by reducing the stressful 
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environment of the cells and then test them in bioreactors to determine their efficiency. 
In conclusion, this study has provided the stepping stones towards a future bacterial 
production platform able to compete with others in terms of ease of downstream 
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Abstract 
Escherichia coli is a heavily used platform for the production of biotherapeutic and other 
high-value proteins, and a favoured strategy is to export the protein of interest to the 
periplasm in order to simplify downstream processing and facilitate disulphide bond 
formation. The Sec pathway is the standard means of transporting the target protein but 
it is unable to transport complex or rapidly folding proteins because the Sec system can 
only transport proteins in an unfolded state. The Tat system also operates to transport 
proteins to the periplasm, and it has significant potential as an alternative means of 
recombinant protein production because it transports fully folded proteins. Here, we have 
tested the Tat system's full potential for the production of biotherapeutics for the first time 
using fed-batch fermentation. We expressed human growth hormone (hGH) with a Tat 
signal peptide in E. coli W3110 'TatExpress' strains that contain elevated levels of the Tat 
apparatus. This construct contained 4 amino acids from TorA at the hGH N-terminus. We 
show that the protein is efficiently exported to the periplasm during extended fed-batch 
fermentation, to the extent that it is by far the most abundant protein in the periplasm. 
The protein was shown to be homogeneous, disulphide bonded and active. The bioassay 
showed that the yields of purified periplasmic hGH are 5.4 g/L culture whereas an ELISA 
gave a figure of 2.39 g/L. Separate analysis of a TorA-hGH construct lacking any 
additional amino acids likewise showed efficient export to the periplasm, although yields 
were approximately 2-fold lower. 
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1.0 Introduction 
Many high-value proteins are produced in E. coli, and a favoured strategy is to export the 
protein to the periplasm, usually by the well-characterised 'Sec' pathway (Walsh, 2014). 
Several strategies have been used, including expression of soluble proteins in the 
cytoplasm, expression in the form of insoluble inclusion bodies, or export to the 
periplasm. The latter approach is particularly favoured for the production of proteins that 
contain disulphide bonds, since the periplasm is the only oxidising compartment in wild 
type cells (Pooley et al., 1996).  Downstream processing is also simplified due to the 
lowered levels of cytoplasmic contaminants, including DNA (Balasundaram et al. (2009). 
Export of proteins to the periplasm is usually achieved by targeting via the well-
characterised Sec pathway, whereby a cleavable Sec-specific signal peptide is present at 
the N-terminus of the target protein. However, the Sec pathway cannot transport some 
heterologous proteins and attention has focused on the alternative Tat pathway, which 
transports fully folded proteins by a completely different pathway (reviewed by Natale et 
al., 2008). Initial studies showed that Tat could export a model protein, GFP, at high 
levels and that the cells were robust under fermentation conditions (Matos et al., 2012). 
This work was followed by additional studies that showed Tat to be capable of exporting 
severa; biotherapeutics including human growth hormone, single chain antibody 
fragments and interferons (DeLisa et al., 2003; Alanen et al., 2015; Tullman-Ercek et al., 
2007; Browning et al., 2017; Matos et al., 2014). 
 
Human Growth Hormone (hGH) is a 22 kDa protein consisting of 191 amino acids 
(Pooley et al., 1996) used to treat burn injuries, wound healing, hypopituitarism and 
obesity (Isaksson et al., 1985) since it is safe to use even in high doses (Van, 1998). Since 
hGH only has 2 disulphide bonds (Cys53-Cys165 and Cys182-Cys189) (Ultsch et al., 
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1994) and no glycosylation, most of its large-scale production has used E. coli platforms, 
although a wide range of eukaryotic host systems have been tested (e.g. Hahm and Chung, 
2001; Ecamilla-Trevino et al., 2000). The highest recorded yield is 5 g of recombinant 
hGH per litre of milk in transgenic cows (Salamone et al., 2006).   
 
A major difficulty in producing hGH in E. coli is its aggregation into insoluble bodies 
that complicate the production process. Until recently, most commercial hGH has been 
obtained from insoluble bodies that have been solubilized, with the hGH refolded into its 
active form (Olsen et al., 1981; Patra et al., 2000). Recent, novel approaches have 
managed to produce high quantities of cytosolic hGH in fed-batch fermentation, with 
reported yields of up to 678 mg/L protein (Song et al., 2017).  
 
Although studies exporting hGH to the periplasm have reported relatively low yields  
(Sockolosky and Szoka, 2013), this is an attractive option due to the ease of downstream 
processing. In recent studies, we have shown that the Tat system can export hGH with 
high efficiency and that it is disulphide-bonded (Alanen et al., 2015). Out study concluded 
that, although the protein was presumably synthesised and exported in the reduced state, 
the periplasmic protein was fully disuphide bonded by the normal DSB disulphide 
bonding system. We have also reported that a new series of engineered E. coli strains, 
which overexpress the Tat system components (termed TatExpress), demonstrate even 
higher export efficiencies (Browning et al. 2017). These strains bear a modified 
chromosomal tatABC operon, the expression of which  is induced by IPTG, so that the 
Tat system is over-expressed at the same time as the IPTG-induced target protein. 
However, the activity of the hGH was not assayed and our studies (Alanen et al., 2015; 
Browning et al., 2017) used laboratory shake flask systems that bear little resemblance to 
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industrial production processes. Here, we have assessed the feasibility of this system for 
industrial production using TatExpress E. coli strains under fed-batch fermentation 
conditions. We report that the system is able to produce 5 g/L of purified, disulphide 
bonded, active hGH. 
 
2.0  Materials and Methods 
Bacterial strains and plasmids  
Strains and plasmids are summarised in Table 1. E. coli strain W3110 was used, together 
with W3110 TatExpress which was previously described in Browning et al., 2017 
alongside the plasmid pKRK7 (pEXT22 expressing TorA-hGH-6His). pKRK38 was 
derived from pKRK7 to eliminate the TorA signal peptide that precedes the hGH. 
pKRK38 was made by PCR amplification using pKRK7 as a template and primers 
Mature_hGH_F (5’-ATGTTCCCAACCATTCCCTTATCCA-3’) and Mature_hGH_R 
(5’- CATACATGTTCCTCTGTGGTAGGGT-3’) as forward and reverse primers. PCR 




Initial cultures were grown in 50 mL of 2xP media (16g/L of Bacto-tryptone/peptone, 
10g/L of Yeast extract, 10 g/L NaCl) in 250 mL shake flasks for 6 h at 37°C, 200 rpm 
with 1:1000 antibiotic (5 μL, 1 M kanamycin). 1 mL of culture was transferred to 200 mL 
of SM6 defined media (Humphreys et al., 1998) and grown aerobically overnight at 30 
°C, 200 rpm in shake flasks with 1:1000 antibiotic (5 μL, 1 M kanamycin). On the 
following day an equivalent of 300 OD600 was used to inoculate fresh defined SM6 media 
to a final volume of 500 mL in Infors Multifors 1.5L fermenters (Infors UK Ltd., Reigate, 
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UK). The pH was kept at 7 using 25% (v/v) ammonia solution and 25% (v/v) sulphuric 
acid. Dissolved oxygen tension (DOT) was kept at 30% using gas blending with 100% 
oxygen where necessary and the culture was maintained at 30°C until both stirrer and 
airflow was maximal and then dropped to 25°C. Supplementation of MgSO4 occurred 
when the OD600 reached 38-42 (8 mL/L of 1M MgSO4) and of Na2HPO4 when the OD600 
reached 54-58 (5 mL/L of 232.8 g/L Na2HPO4) and when the OD600 reached 66-77 (7 
mL/L of 232.8 g/L Na2HPO4). A glycerol feed containing 80% w/w glycerol at a rate of 
0.35% pump capacity was started at OD600 70. Induction with 9 ml/L of IPTG at a 
concentration of 4.31 g/L occurred at OD600 75.  
Fractionation  
Cytoplasm, membrane and periplasm fractions were prepared by an osmotic-shock 
method. Cells were centrifuged at 3000 x g, 4°C, for 10 min and resuspended in 500 µL 
of Buffer 1 (100 mM Tris-acetate pH 8.2, 500 mM sucrose, 5 mM EDTA pH 8.0) and 
500 µL dH2O before addition of 40 µL hen egg white lysozyme (1 mg/mL) and incubation 
on ice for 5 min. 20 µL MgSO4 (1M) was added and the suspension was centrifuged at 
14,000 rpm, 4 ° C, 2 min. The supernatant containing the periplasmic fraction was 
removed and the pellet washed once in 750 µL Buffer 2 (50 mM Tris-acetate pH 8.2, 250 
mM sucrose, 10 mM MgSO4). The cell pellet was resuspended in 750 µL Buffer 3 (50 
mM Tris-acetate pH 8.2, 2.5 mM EDTA pH 8.0) and sonicated for 6 × 10 s, amplitude 8 
µm to disrupt membranes (Soniprep 150plus, Sanyo Gallenkamp, Loughborough, UK). 
The suspension was centrifuged at 70,000 rpm, 4 °C, 30 min to sediment the insoluble 
fraction. 500 μL of the supernatant was removed (designated cytoplasmic fraction). The 
remainder of the supernatant was discarded and the pellet resuspended in 500 μL Buffer 
3 and designated membrane (or insoluble) fraction. 
Protein purification 
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For purification of 6x Histidine-tagged (C-term) proteins by Nickel IMAC, 10 mL of the 
culture post induction was taken, centrifuged at 3000 rpm, 45 min, 4°C. Cell pellet was 
resuspended in 10 mL/g of chilled Buffer 1 without EDTA and 10 mL/g of milliQ H2O 
and incubated on ice for 30 min before centrifuging at 14 000 rpm, 20 min, 4°C (Beckman 
Avanti J- 25, JA 25.5 rotor). Supernatant was taken as the periplasmic fraction and placed 
into SnakeSkin® dialysis tubing (Thermo scientific) and dialysed at 4°C overnight into 
50 mM sodium phosphate, 150 mM NaCl, pH 7.2. Using an ÄKTA™ pure protein 
purification system and a HisTrap HP histidine-tagged protein column (GE Healthcare, 
Buckinghamshire, UK) the protein was purified: storage solution (20% ethanol) was 
washed off with 10 column volumes (CV) of milliQ H2O before adding 5 mL 0.2 M 
NiCl, followed by another 2CV milliQ H2O wash. Columns were equilibrated with 3CV 
equilibration buffer (50 mM sodium phosphate pH 7.2, 0.3 M NaCl) before loading 
Periplasmic sample and collecting Flow Through (FT). Unbound matter was removed 
with 6CV Wash buffer (50 mM sodium phosphate pH 7.2, 50 mM Imidazole, 0.3 M 
sodium chloride) and sample collected as Wash (W). Finally, the 6x Histidine-tagged 
protein was eluted with elution buffer with imidazole (50 mM sodium phosphate pH 7.2, 
0.3 M NaCl with 250 mM Imidazole) and the peaks collected for analysis.  
Protein expression analysis by Coomassie and Western blot 
Protein samples were resolved by reducing SDS–PAGE and analyzed using Coomassie 
blue staining and Western blotting. All immunoblottingh procedures were as described in 
Guerrero-Montero et al. (in press). Periplasmic hGH activity was assayed using an hGH 
bioassay (PathHunter® Human Growth Hormone Bioassay Kit, Sigma) using the 
manufacturer's protocol. Standardized OD10 periplasmic fractions were diluted 
1:500,000 using PBS and absorbance was read using a BMG Labtech Spectrostar 
microplate reader at 405 nm, with a reference wavelength at 490 nm. Concentrations were 
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calculated from two independent experiments and all samples were measured in triplicate 
when calculating periplasmic yield. Periplasmic hGH was also assayed using an hGH 
ELISA kit (Roche Diagnostics, Charles Ave, Burgess Hill, West Sussex RH15 9RY) 
using the manufacturer's protocol. Concentrations were calculated from two independent 
experiments and all samples measured in triplicate, and used to calculate average 
periplasmic yield (in mg/L) by reference to culture OD readings at 600 nm. 
 
Intact Protein Electrospray LC-MS 
The electrospray mass spectrum was recorded on a Bruker micrOTOF-Q II mass 
spectrometer.  An aliquot of protein in solution, corresponding to approximately 20 
picomoles of protein, was desalted on-line by reverse-phase HPLC on a Phenomenex 
Jupiter C4 column (5 µm, 300Ǻ, 2.0 mm x 50 mm) running on an Agilent 1100 HPLC 
system at a flow rate of 0.2 ml/min using a short water, acetonitrile, 0.05% trifluoroacetic 
acid gradient.  The eluent was monitored at 280 nm and directed into the electrospray 
source, operating in positive ion mode, at 4.5 kV and mass spectra recorded from 500-
3000 m/z.  Data were analysed and deconvoluted to give uncharged protein masses using 
Bruker’s Compass Data Analysis software. 
 
3.0  Results 
3.1 Fed-batch fermentation of WT and TatExpress cells expressing TorA-hGH 
 
We first expressed a construct comprising the TorA signal peptide linked to hGH (TorA-
hGH) in W3110 E. coli TatExpress cells under fed-batch fermentation conditions as 
detailed in Materials and Methods. The construct was previously used in shake flask 
studies (Browning et al., 2017) and comprises the signal peptide of E. coli TMAO 
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reductase (TorA) linked to hGH via a 4-residue linker (the first 4 residues of mature TorA; 
AQAA). The construct also contains a C-terminal 6-His tag. Parallel cultures were carried 
out with the construct expressed in wild type (WT) W3110 cells. Figure 1 shows the 
growth curves from the cultures; duplicate WT and TatExpress cultures reached ODs of 
about 100 and the Figure shows the point at which induction of TorA-hGH and TatABC 
synthesis (in TatExpress) was induced using IPTG.  
 
Samples were removed 13, 17 and 21h after induction and the cells were fractionated to 
generate cytoplasmic, membrane and periplasmic samples. The periplasmic samples were 
analysed by immunoblotting to detect the hGH and the same samples were analysed using 
Coomassie stained SDS PAGE gels to analyse the proteome of the periplasmic samples. 
Figure 2 shows the 13h and 21h samples from the two WT cultures, which indicate the 
presence of a clear hGH protein band in the periplasm. The Coomassie-stained gel shows 
the presence of a 22 kDa protein, the relative abundance of which matches the strength 
of the blot signals. This was confirmed to be hGH (see below). 13h, 17h and 21h samples 
from the two TatExpress cultures were also analysed and the data show that the hGH blot 
signals are significantly higher than those of the WT cultures, confirming that TatExpress 
cells export this construct with much higher efficiency as observed by Browning et al. 
(2017) in shake flask culture. The abundance of the 22 kDa protein is correspondingly 
greater in the Coomassie stained gels, providing further evidence that this is indeed hGH.  
 
Figure 3 shows a time course analysis of the abundance of the periplasmic hGH after 
induction of synthesis in TatExpress cells. Samples were taken from 2 - 51 h after 
induction and the blot shows a steady increase in hGH level over this time period. Equal 
numbers of cells were used in each sample, so this reflects an increase in the amount of 
  180 
hGH per cell. The Coomassie gel confirms that the abundant 22 kDa protein is indeed 
hGH, since its abundance increases in parallel and the protein is virtually absent in the 
induction time point samples. Analysis of the later time points demonstrates that hGH is 
by far the most abundant periplasmic protein, which shows that Tat is exporting high 
amounts of protein.  
 
We have carried out controls for fractionation artefacts in previous studies, and the 
periplasmic proteome is clearly distinct from that of the cytoplasm, suggesting that 
contamination of cytoplasmic proteins is minimal (e.g. Matos et al., 2012). However, to 
confirm this point we fractionated samples at the 21 h time point and the data are shown 
in Figure 4. The results show that the fractions are indeed 'clean' with the periplasmic 
proteome clearly distinct from those of the cytoplasm and membrane fractions. To further 
confirm that hGH does not reach the periplasmic fraction 'spontaneously' we expressed 
hGH lacking any form of signal peptide. Mature hGH was expressed in parallel with Tor-
hGH and samples were fractionated after 1h and 18 h induction (Figure 5). The 
immunoblot shows that the bulk of hGH is in the periplasm in the TorA-hGH culture, as 
expected, with a minimal level of protein present in the cytoplasm at the 18h point. In 
contrast, hGH is found exclusively in the cytoplasm in the sample expressing mature 
hGH, with none detected in the periplasmic fraction. These data confirm that the presence 
of hGH in the periplasm of the TorA-hGH cultures is due to Tat-dependent export and 
not contamination by cytoplasmic fraction or spontaneous transfer across the plasma 
membrane.  
 
It is notable that the total level of hGH in the culture producing mature hGH is about 6-
fold lower than that in the TorA-hGH culture. This reflects a phenomenon observed 
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previously in our shake flask studies: that hGH is subjected to rapid turnover in the 
cytoplasm (Alanen et al., 2015). Clearly, this protein is more stable in the periplasm, and 
this is another advantage of using an effective protein export strategy for the production 
of this particular protein. 
 
3.2 Tat-exported hGH is homogeneous and cleaved at the correct signal peptidase 
site 
To assess the homogeneity of the exported hGH, we performed mass spectrometry 
analysis of the purified protein, using purified commercial hGH as a standard (provided 
with the Pathfinder Bioassay - see below). The exported, periplasmic hGH construct used 
in this study should contain additional amino acids when compared to commercial hGH, 
specifically the 4 amino acid linker from the mature TorA protein (TMAO reductase) at 
the N-terminus, the initiation methionine (cleaved from hGH in vivo) and the 6-His tag at 
the C-terminus (Figure 6). The combined molecular weight of the additional amino acids 
is 609.7 for the N-terminal residues and 822.86 for the C-terminal His tag (1432.56 in 
total). The predicted molecular weights are 22129.05 for the commercial hGH, and 
23561.5 for the exported hGH. As shown in Figure 6, mass spectrometry analysis of 
commercial hGH gives a single prominent peak corresponding to 22124.3 Da, which 
matches almost exactly with the predicted molecular mass, having only a difference of 
4.75 Da, 4 of which are a consequence of the formation of 2 disulphide bonds. We purified 
the Tat-exported periplasmic hGH using affinity chromatography and an analysis of this 
protein again shows a single prominent peak, and the mass of 23555 Da is again very 
close to, but 6 Da smaller than the predicted mass of 23561 Da. The presence of 2 
disulphide bonds again accounts for the difference. In both cases, the 1-2 Da deviation 
from the predicted protein masses is within the error range for the mass spectrometer. 
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Other smaller peaks are observed in both samples, which appear to be an artefact of the 
hGH mass spectrometry since they are identical in the two samples. This implies that the 
hGH produced in this study is (i) as homogeneous as the commercial protein (ii) 
processed at the correct site, and (iii) fully disulphide bonded; there is no indication of a 
peak corresponding to the reduced form.  
 
To confirm that the hGH is indeed disulphide-bonded, we ran samples of the periplasmic 
samples from the 51 h time point shown in Figure 3 on an SDS-PAGE gel in the presence 
and absence of reducing agent.  The oxidised, disulphide-bonded form of hGH was shown 
to migrate more rapidly than the reduced form (Alanen et al., 2015) and Figure 7 shows 
the periplasmic hGH from the fed-batch fermentation likewise runs more rapidly under 
oxidising conditions, further confirming that the protein is disulphide-bonded. It is 
unclear why the intensity of the blot signal is lower; presumably, the C-terminal His tag 
is less exposed in the oxidised protein and the antibodies bind less effectively.  
 
3.3 High yields of active protein are obtained from fed-batch fermentation using 
TorA-hGH 
  
To quantify the yield of periplasmic hGH and to assess its activity, we used a 
commercially available hGH bioassay (PathHunter® Human Growth Hormone Bioassay 
Kit, Sigma). This uses engineered cells in which one fragment of β-galactosidase is 
present on the hGH receptor and the complementary fragment is present on a phosphor-
tyrosine SH2-domain-containing protein that is only able to bind the hGH receptor once 
it is activated. Binding of hGH to its receptor results in receptor phosphorylation by a 
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cytosolic tyrosine kinase such as JAK1, enabling the SH2-EA fusion protein to bind the 
phosphorylated receptor and generate active β-galactosidase. Enzymatic activity is 
quantitatively measured using a chemiluminescent substrate, and the expected result is a 
dose-response sigmoidal function where the phosphorylation of the receptor will be 
dependent on the amount of hGH in the sample. A standard curve was produced with the 
supplied commercial hGH and all samples were done in triplicate and with dilution 
factors in the range of the standard curve (see Supplementary Figure 2). This assay gave 
a figure of 5.4 g hGH per litre of fed-batch culture for the purified periplasmic hGH 
shown in Supplementary Figure 1. 
 
We also calculated hGH levels using a commercial ELISA, which uses pre-bound 
antibodies to hGH on the surface of the microplate modules. The sample to analyse was 
added in triplicate (with various dilution factors) to the wells, and the hGH present in the 
samples binds to the anti-hGH antibodies. Afterwards a digoxigenin-labelled antibody to 
hGH is added which binds to the hGH as well. An antibody to digoxigenin conjugated to 
peroxidase is added and binds to the digoxigenin, and finally the peroxidase substrate 
ABTS is added. The peroxidase catalyses the cleavage of the substrate yielding a coloured 
reaction product that can be measured using a plate reader that reads at 405 and 490 nm. 
The absorbance is directly correlated to the level of hGH present in the sample and can 
be determined by comparison to the calibration curve (shown in Supplementary Figure 
3). Using this ELISA the concentration of the purified periplasmic hGH was calculated 
to be 2.39 g/L culture. This is lower than the figure obtained using the bioassay, but since 
the assays are so different it is difficult to determine which is more accurate. 
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3.4 Export of TorA-hGH lacking the 4-residue linker between the signal peptide and 
hGH 
The above experiments were all carried out using a construct that comprises the TorA 
signal peptide, 4 residues from the N-terminus of mature TorA and hGH. This construct 
was used in order to compare results with shake flask studies carried out using the same 
construct (Browning et al., 2017), but we considered it important to assess the export of 
a 'linker-less' construct lacking any linker residues, since industrial processes are unlikely 
to incorporate such linkers. We therefore removed the 4 residues and carried out fed-
batch fermentation studies on this 'clean' construct; the periplasmic fractions are analysed 
in Figure 8). The immunoblot and gel data show that hGH production is induced and that 
high levels of hGH are exported to the periplasm over the 38 h induction period. As with 
the original construct, periplasmic hGH accumulates to the extent that it is an abundant 
periplasmic protein. The data thus show that removal of the 4-residue linker does not 
block export of hGH.  
 
Figure 8C shows a test in which fermentation samples were fractionated into cytoplasm, 
membrane and periplasm extractss, which were then blotted for the presence of hGH. The 
data show that in each case, the majority of hGH is present in the preiplasm, confirming 
that both constructs are efficiently exported. However, the hGH signal after export of the 
linker-less construct is less intense than that of the original construct containing the 
additional 4 residues. In addition, analysis of the stained gel in Figure 8A shows that 
while the periplasmic hGH is a major band, the abundance is not as striking as that of 
thye periplasmic accumulation of hGH obser4ved in Figures 2 and 3. We therefore 
believe that the linker-less hGH is exported with lowered efficiency, and quantification 
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of the blots suggests that, one average, its export is in the region of 40% as efficient as 
that of the original TorA-hGH construct. 
 
4.0  Discussion 
 
The Tat system has been proposed to offer a viable alternative to the Sec pathway for the 
export of high-value proteins to the bacterial periplasm, but its potential for the production 
of biotherapeutic proteins has not been fully explored in previous studies. This is 
primarily because the majority of those studies were carried out using laboratory shake 
flask culture systems, whereas industrial processes almost invariably use fed-batch 
fermentation. Here, we have used fed-batch fermentation systems to test the robustness 
of the TatExpress cells and the yields of hGH that are obtained after export to the 
periplasm.  
 
A major aim in this work was to test for any deleterious effects due to the increased 
expression of the TatABC membrane proteins in the TatExpress strain. While the 
TatABC proteins are expressed to a much lower extent than TorA-hGH, the increased 
expression of any membrane protein can potentially lead to cell stress and lowered 
productivity in extended fed-batch fermentation systems. Here, we directly compared the 
growth characteristics of the TatExpress strain with its parental W3110 strain and we 
observed no significant differences. Clearly, TatExpress strains are viable production 
hosts. 
 
In terms of target protein yield, we consistently observe that the cells export TorA-hGH 
throughout an extended induction period and it is notable that the exported hGH is by far 
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the most abundant periplasmic protein by the end of the induction period. In control tests, 
mature-size hGH is not exported at all and we can conclude that TorA-hGH is being 
exported by the TorA signal peptide as reported in shake-flask studies (Alanen et al., 
2015). The yields of protein are high: the bioassay indicates a yield of over 5 g/L active 
purified protein while the ELISA gives a figure of 2.39 g/L. This is one of the highest 
yields reported and clear evidence that this platform has potential for industrial use. 
Nevertheless, further study would serve to illustrate the potential in more detail, and it is 
notable that, while a 'clean' fusion of a Tat signal peptide and hGH is efficiently exported, 
the presence of a short linker region appears to enhance export. An optimal signal peptide-
passenger protein junction may be an important factor for efficient Tat-dependent export, 
as previously suggested by Tullman-Ercek et al., 2007. 
 
In summary, we have shown that a model biotherapeutic protein can be exported by the 
Tat system in high amounts, and that it is homogeneous, disulphide-bonded and active. It 
will be of interest to conduct further studies to assess the full capability of the Tat system, 
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Figure Legends 
 
Figure 1. Growth data during fed-batch fermentation of E. coli W3110 WT and 
TatExpress cells expressing TorA-hGH. Duplicate cultures were analysed of WT cells 
(WT1, WT2) and TatExpress (TE1, TE2), with OD600 nm values shown. Fermentation was 
carried out at 30°C as detailed in Materials and Methods. At the indicated times, the 
cultures were induced with IPTG (0.1 mM) and samples were removed for analysis. 
Induction
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Figure 2. Tat-dependent export of TorA-hGH in W3110 wild type and TatExpress 
W3110 cells. Samples from duplicate fed-batch fermentation cultures of WT and 
TatExpress expressing TorA-hGH were removed at the indicated times post induction 
and fractionated to yield periplasmic samples. The periplasmic samples were analysed by 
Coomassie blue stained gels (A) and immunoblotting using antibodies to the His tag on 
hGH (B). For each lane a normalized amount of protein has been loaded, equivalent to 
OD600 0.08 AU total cells (Coomassie blue stained gels), and OD600 0.008 AU 
(immunoblots). Mobilites of molecular weight markers (in kDa) are shown on the left.  
WT1
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Figure 3. High-level export of TorA-hGH during extended fed-batch fermentation 
of TatExpress cells. TorA-hGH was expressed in TatExpress cells in a fed-batch 
fermentation system and samples were removed at the indicated times post induction (PI). 
The samples were fractionated to generate periplasm samples which were then analysed 
on Coomassie blue stained gels (A) and by immunoblotting using antibodies to the His 
tag on hGH (B).  
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Figure 4. Fractionation of samples from fed-batch fermentation of W3110 wild type 
and TatExpress cells expressing TorA-hGH. Samples from the 21 h time point of fed-
batch fermentation cultures of WT and TatExpress (TE) expressing TorA-hGH (shown 
in Figure 2) were fractionated to yield cytoplasm, membrane and periplasm samples (C, 
M, P). The samples were analysed by Coomassie blue stained gels (A) and 
immunoblotting using antibodies to the His tag on hGH (B). For each lane a normalized 
amount of protein has been loaded, equivalent to OD600 0.08 AU total cells (Coomassie 
blue stained gels), and OD600 0.008 AU (immunoblots). Mobilites of molecular weight 
markers (in kDa) are shown on the left 
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Figure 5. Mature hGH is not exported during fed-batch fermentation of TatExpress. 
Mature-size hGH and TorA-hGH were expressed in TatExpress cells using fed-batch 
fermentation systems. Samples were removed 1 h and 18 h post induction and fractionated 
to generate cytoplasm, membrane and periplasm samples (C, M, P) which were then 


















Figure 6:  Exported periplasmic hGH is homogeneous and cleaved at the correct 
site. Periplasmic hGH was purified by affinity chromatography (see Supplementary 
Figure 1) and subjected to mass spectrometry analysis as detailed in Materials and 
Methods. Commercial hGH was analysed in an identical manner. The mass spectra for 
commercial hGH is shown in panel A and for periplasmic hGH in B. C: amino acid 
sequence of TorA-hGH-H6. The C-terminal half of the TorA signal peptide is shown, 
along with the first five amino acids of the mature TMAO protein and the initial 
methionine for the hGH protein. The signal peptidase cleavage site between ATA and 
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AQA is denoted by . The sequence for the commercial hGH is underlined, and this is 
followed by the 6-histidine tag.  
 
Figure 7. Periplasmic hGH is disulphide-bonded after fed-batch fermentation. 
Samples of the periplasmic fraction from the 51 h time point shown in Figure 3 were run 
(in triplicate) on an SDS polyacrylamide gel under standard reducing conditions 
(‘reducing’ or in the absence of reducing agent (oxidising’). The samples were 
immunoblotted using antibodies to the C-terminal His tag on hGH. hGH ‘ox’ and ‘red’: 
oxidised and reduced forms of hGH, respectively. Mobilties of molecular mass markers 
(in kDa) are shown on the left. 
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Figure 8. Export of ‘linkerless’ TorA-hGH during fed-batch fermentation of 
TatExpress cells. TorA-hGH lacking a 4-residue linker was expressed in TatExpress 
cells in a fed-batch fermentation system and samples were removed at the indicated times 
post induction (PI). The samples were fractionated to generate periplasm samples which 
were then analysed on Coomassie blue stained gels (A) and by immunoblotting using 
antibodies to the His tag on hGH (B). C: TorA-hGH constructs with or without the 4-
residue linker were expressed in fed-batch fermentation with 40 h induction and 
fractionated to generate cytoplasm, membrane and periplasm samples (C, M, P).  The 
samples were analysed by immunoblotting using antibodies to the C-terminal His tag. 
hGH(ls) denotes linker-less mature hGH 
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Figure 9. Comparison of export levels achieved during the export of TorA-hGH with 
and without a 4-residue linker during fed-batch fermentation of TatExpress cells: 
TorA-hGH constructs with or without the 4-residue linker were expressed in fed-batch 
fermentation with 40 h induction and samples were fractionated to generate cytoplasm, 
membrane and periplasm samples (C, M, P).  The samples were analysed by 
immunoblotting using antibodies to the C-terminal His tag (A) or by Coomassie staining 
of SDS polyacrylamide gels (B). hGH(ls) denotes linker-less mature hGH construct; 
asterisks denote the mature hGH forms 
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Supplementary Figure 1. Purification of periplasmic hGH. Purification of hGH from 
periplasmic sample of fed-batch fermentation after 51 hours post induction via Nickel 
affinity column. Coomassie showing periplasmic released with lysozyme (PL), 
periplasmic release with lysozyme free method (PP), flow through after purification (FT) 
and purified hGH (Pure). Molecular weight markers are shown on the left (in kDa) and 
mature hGH height is indicated on the right.  
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Supplementary Figure 2. Quantification of hGH concentration using the PathFinder 
bioassay. An hGH concentration standard curve was constructed using the supplied 
commercial hGH and all samples were analysed in triplicate using dilution factors in the 
range of the standard curve. The standard curve was adjusted using numpy, 
matplotlib.pyplot and scipy in Python.
 
 
Supplementary Figure 3: Calibration curve and quantification of fed-batch 
fermentation samples obtained using an hGH ELISA kit.  The calibration curve 
obtained from the ELISA kit using the standard hGH provided is shown, with 
concentration shown on the X axis (picogram per µL) and Absorbance at 490 nm shown 
on the Y axis. The purified periplasmic hGH was found to be present at a concentration 
that corresponds to 2.39 g hGH per litre of culture. 
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Annex 2: List of proteins of interest expressed at shake flask level with 
unsuccessful export to the periplasm.  
 





Fab fragment obtained from Fujifilm. None 
Fab 
Fragment 
Fab fragment obtained from Lloyd Ruddock None 
Fab 
Fragment 
Fab fragment obtained from MedImmune None 
Sel1 
Part of a protein complex required for the retrotranslocation or 
dislocation of misfolded proteins from the endoplasmic reticulum 
lumen to the cytosol, where they are degraded by the proteasome 
in a ubiquitin-dependent manner. 
None 




WxL1 Hypothetical protein: leucine Rich repeat-containing WxL 
domain surface cell wall-binding protein 
Low 
WxL2 





The proteins of interest were cloned between a TorA signal peptide and a 6xHis-tag in a pET23 vector. 
The vector was then transformed into W3110 cellas and cultures were grown at 30 °C, 200 rpm in 
250mL Erlenmeyer flask. At OD600 of 0.4-0.6 plasmids were induced with 0.5 mM IPTG (25 μL, 1 M 
IPTG). After 3h induction, cells equivalent to a density of OD600 of 10 (~8 mL) were taken and 
fractioned into cytoplasmic (C), insoluble/membrane (M), periplasmic (P) and inclusion bodies (IBs) 
samples. Periplasmic (P) fractions were collected. Protein expression was analysed by western blot.  
 
